Վիճակագրական գրքույկ - 2020-ին ընդառաջ: Հետադարձ հաշվարկ

2020-ÇÝ ÀÜ¸²è²æª Ðºî²¸²ðÒ Ð²Þì²ðÎ²ÞÊ²î²ÜøÜºð ºì ìÆÖ²Î²¶ðàôÂÚàôÜÐ²ÚÎ²Î²Ü ²ÎÜ²´àôÄàôÂÚ²Ü Ü²Ê²¶ÆÌ

COUNTDOWN TOWARDS 2020ACTIVITIES AND STATISTICSTHE ARMENIAN EYECARE PROJECT

ÈáõÛë Ñ³ÛÇ ³ãù»ñÇÝ

bringing sight to armenian eyes

2020-ÇÝ ÀÜ¸²è²æª Ðºî²¸²ðÒ Ð²Þì²ðÎ²ÞÊ²î²ÜøÜºð ºì ìÆÖ²Î²¶ðàôÂÚàôÜ

Ð²ÚÎ²Î²Ü ²ÎÜ²´àôÄàôÂÚ²Ü Ü²Ê²¶ÌÆ Æð²Î²Ü²òð²Ì ²ÞÊ²î²ÜøºðÀ Ð²Ú²êî²ÜÆ Ð²Üð²äºîàôÂÚàôÜàôØ ºì ÐÐ ´Ü²ÎâàôÂÚ²Ü ²ÎÜ²ÚÆÜ ²èàÔæàôÂÚ²Ü Æð²ìÆÖ²Î²ÚÆÜ

ìºðÈàôÌàôÂÚàôÜÀ

ºðºì²Ü YEREVAN

Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÇÍ The Armenian EyeCare Project

2010

COUNTDOWN TOWARDS 2020

ACTIVITIES AND STATISTICS

ACTIVITIES CARRIED OUT BY THE ARMENIAN EYECARE PROJECT AND THE EYE HEALTH

SITUATION ANALYSIS IN THE REPUBLIC OF ARMENIA

êáõÛÝ Ññ³ï³ñ³ÏáõÃÛáõÝÁ ÑÝ³ñ³íáñ ¿ ¹³ñÓ»É ²Ù»ñÇÏÛ³Ý ÅáÕáíñ¹Ç ³ç³ÏóáõÃÛ³Ùμª ²ØÜ ØÇç³½·³ÛÇÝ ½³ñ·³óÙ³Ý ·áñÍ³Ï³ÉáõÃÛ³Ý (²ØÜ Ø¼¶) ¨ Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÍÇ (Ð²Ü) ÙÇçáóáí:

Ðñ³ï³ñ³ÏáõÃÛáõÝáõÙ ³ñï³Ñ³Ûïí³Í ï»ë³Ï»ïÝ»ñÁ å³ïÏ³ÝáõÙ »Ý Ñ»ÕÇÝ³ÏÝ»ñÇÝ, ¨ ÑÝ³ñ³íáñ ¿, áñ ãÑ³ÙÁÝÏÝ»Ý ²ØÜ Ø¼¶ Ï³Ù ²ØÜ Î³é³í³ñáõÃÛ³Ý ï»ë³Ï»ïÝ»ñÇ Ñ»ï:

This publication was made possible with the support of the American People through the U.S. Agency for International Development (USAID) and the Armenian EyeCare Project (AECP).

The contents of this publication are the sole responsibility of the authors and do not necessarily refl ect the views of USAID or the U.S. Government.

4

Ü»ñÏ³Û³óíáÕ ÝÛáõÃÁ ÝÏ³ñ³·ñáõÙ ¿ Ð²Ü-Ç ÏáÕÙÇó ÐÐ-áõÙ Çñ³Ï³Ý³óí³Í ³ßË³ï³ÝùÝ»ñÁ ¨ »ñÏñÇ μÝ³ÏãáõÃÛ³ÝÁ ïñ³Ù³¹ñí³Í ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñÁ: ØÇ¨ÝáõÛÝ Å³Ù³Ý³Ï, ÝÛáõÃÁ å³ñáõÝ³ÏáõÙ ¿ ÐÐ μÝ³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ ³éáÕçáõÃÛ³Ý áõ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ï³ñ³Íí³ÍáõÃÛ³Ý ·Çï³Ï³Ý ·Ý³Ñ³ï³Ï³ÝÝ»ñ, áñáÝù áñáßáõÙ ÁÝ¹áõÝáÕÝ»ñÇÝ ÑÝ³ñ³íáñáõÃÛáõÝ Ïï³Ý ·Ý³Ñ³ï»É ÇÝãå»ë μÝ³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ ³éáÕçáõÃÛ³Ý íÇ×³ÏÁ, ³ÛÝå»ë ¿É ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñÇ å³Ñ³Ýç³ñÏÁ »ñÏñáõÙ:

This pubication presents the activities carried out by the Armenian EyeCare Proj-ect (AECP) in Armenia and services provided to the population. At the same time, it presents the estimates of main indicators of eye health and incidence of main eye diseases in Armenia. These indicators will serve as a basis for policy makers to analyze the eye health situation and estimate the demand of eye care services in the country.

Ð»ÕÇÝ³Ï³ÛÇÝ ËáõÙμÐ»ÕÇÝ³Ï³ÛÇÝ ËáõÙμ

Ü³ÇñáõÑÇ æñμ³ßÛ³Ýèáç»ñ úÑ³Ý»ëÛ³Ý²É»ùë³Ý¹ñ Ø³É³Û³ÝÜáõÝ» ºÕÇ³½³ñÛ³Ýì³ñí³ñ³ ø³É³ßÛ³Ý

îíÛ³ÉÝ»ñÇ í»ñÉáõÍáõÃÛáõÝÁª Ü³ÇñáõÑÇ æñμ³ßÛ³ÝÇÒ¨³íáñáõÙÁª ØÇÝ³ë Ð³Ùμ³ñÓáõÙÛ³ÝÇ

Group of AuthorGroup of Authors

Nairuhi JrbashyanRoger Ohanesian

Alexander MalayanNune Yeghiazaryan

Varvara Kalashyan

Data Analysis by Nairuhi JrbashyanDesign by Minas Hambardzumyan

Copyright 2010 Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÇÍ, The Armenian EyeCare Projectîå³ù³Ý³ÏÁ, Print Run - 500

Ðñ³ï³ñ³ÏÇã, Printed by §ì¾È²ê öñÇÝÃ¦ êäÀ, Velas Print Ltd.

Ðî¸ 617.7:31¶Øä 56.7+60.6º899

º899 §2020-ÇÝ ÀÜ¸²è²æª Ðºî²¸²ðÒ Ð²Þì²ðÎ ²ÞÊ²î²ÜøÜºð ºì ìÆÖ²Î²¶ðàôÂÚàôÜ¦/Ü³ÇñáõÑÇ æñμ³ßÛ³Ý, èáç»ñ úÑ³Ý»ëÛ³Ý, ²É»ùë³Ý¹ñ Ø³É³Û³Ý, ÜáõÝ» ºÕÇ³½³ñÛ³Ý, ì³ñí³ñ³ ø³É³ßÛ³Ý/: §Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÇÍ¦ ´³ñ»·áñÍ³Ï³Ý ÑÇÙÝ³¹ñ³Ù, 2010 Ã., 118 ¿ç

ISBN 978-99941-2-463-3 Ðî¸ 617.7:31¶Øä 56.7+60.6

º899

5

´àì²Ü¸²ÎàôÂÚàôÜ

Üºð²ÌàôÂÚàôÜ................................................................................................... 6

1. Ð²ÚÎ²Î²Ü ²ÎÜ²´àôÄàôÂÚ²Ü Ü²Ê²¶ÆÌ Ìð²¶ðÆ Üä²î²ÎÜ àô ÜºðÎ²ÚÆê Üì²ÖàôØÜºðÀ.................................................................................. 81.1. Ìð²¶ðÆ Üä²î²ÎÀ, ¾àôÂÚàôÜÀ ºì ¶àðÌÀÜÎºðÜºðÀ............................. 81.2. Ìð²¶ðÆ ÐÆØÜ²Î²Ü Üì²ÖàôØÜºðÀ............................................................. 92. Ð²Ü-Æ §ÈàôÚê Ð²ÚÆ ²âøºðÆÜ¦ Ü²Ê²ÒºèÜàôÂÚàôÜÀ, ¸ð² ´²Ô²¸ðÆâÜºðÜ àô ²ð¸ÚàôÜøÜºðÀ........................................................... 102.1. Ü²Ê²ÒºèÜàôÂÚ²Ü ¾àôÂÚàôÜÜ àô ÐÆØÜ²Î²Ü ²ð¸ÚàôÜøÜºðÀ................ 102.2. Ü²Ê²ÒºèÜàôÂÚ²Ü ´²Ô²¸ðÆâÜºðÆ ÀÜ¸Ð²Üàôð ÜÎ²ð²¶ÆðÀ................. 12 - ´Ý³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ É³ÛÝ³ï³ñ³Í ½ÝÝáõÙÝ»ñ ¨ μáõÅû·ÝáõÃÛáõÝ............... 12 - îíÛ³ÉÝ»ñÇ í»ñÉáõÍáõÃÛáõÝ ¨ ·Çï³·áñÍÝ³Ï³Ý ³ßË³ï³ÝùÝ»ñ.................... 12 - ´ÅßÏ³Ï³Ý áõëáõóáõÙ ¨ í»ñ³å³ïñ³ëïáõÙ.................................................... 13 - Ð³Ýñ³ÛÇÝ áõëáõóáõÙ......................................................................................... 14 - Î³ñáÕáõÃÛáõÝÝ»ñÇ ½³ñ·³óáõÙ........................................................................ 153. 2003-2009 ÃÃ. ÐÐ ´Ü²ÎâàôÂÚ²ÜÀ Ð²Ü-Ç Ø²îàôò²Ì ²ÎÜ²´àôÄ²Î²Ü Ì²è²ÚàôÂÚàôÜÜºðÆ êºÔØ ÜÎ²ð²¶ÆðÀ............................................................ 203.1. 2003-2009 ÃÃ. ºðºø Þðæ²ÚòºðÆ ÀÜÂ²òøàôØ Ð²Ü-Æ îð²Ø²¸ð²Ì ²ÎÜ²´àôÄ²Î²Ü Ì²è²ÚàôÂÚàôÜÜºðÆ ²Øöàö ÜÎ²ð²¶ÆðÀ............................. 203.2. 2007-2009 ÃÃ. Ð²Ü-Ç ºððàð¸ Þðæ²ÚòÆ ÀÜÂ²òøàôØ Æð²Î²Ü²òì²Ì ²ÞÊ²î²ÜøÜºðÆ êºÔØ ÜÎ²ð²¶ÆðÀ.................................................................... 254. Ð²Ü-Ç îìÚ²ÈÜºðÆ ÞîºØ²ð²ÜÆ ìºðÈàôÌàôÂÚ²Ü ²ð¸ÚàôÜøÜºðÆ ²ØöàöàôØÀ.............................................................................. 274.1. Ð²Ü-Ç ÎàÔØÆò ¼ÜÜì²Ì ´Ü²ÎâàôÂÚ²Ü ²ÎÜ²ÚÆÜ ²èàÔæàôÂÚ²Ü Ø²êÆÜ îìÚ²ÈÜºðÆ Ð²ì²øØ²Ü àô ØÞ²ÎØ²Ü ØºÂà¸²´²ÜàôÂÚàôÜÀ..............4.2. Ð²Ü-Ç 2003-2009 ÃÃ. ºðºø Þðæ²ÚòºðÆ ÀÜÂ²òøàôØ ÐÐ ´Ü²ÎâàôÂÚ²Ü Þðæ²ÜàôØ ¶ð²Üòì²Ì ²ÎÜ²ÚÆÜ ÐÆì²Ü¸àôÂÚàôÜÜºðÀ.................................. 294.3. ÐÐ ´Ü²ÎâàôÂÚ²Ü Þðæ²ÜàôØ ²ÎÜ²ÚÆÜ ÐÆì²Ü¸àôÂÚàôÜÜºðÆ î²ð²Ìì²ÌàôÂÚ²Ü ¶Ü²Ð²î²Î²ÜÜºðÀ` Àêî Ð²Ü-Ç îìÚ²ÈÜºðÆ.................... 345. 2003-2009 ÃÃ. Ð²Ü-Ç ºðºø Þðæ²ÚòÜºðÆ ÀÜÂ²òøàôØ ÐÐ ´Ü²ÎâàôÂÚ²ÜÀ îð²Ø²¸ð²Ì ²ÎÜ²´àôÄ²Î²Ü Ì²è²ÚàôÂÚàôÜÜºðÀ` Ø²ð¼²ÚÆÜ Îîðì²Ìàì......................................................................................... 395.1. ²ð²¶²ÌàîÜÆ Ø²ð¼....................................................................................... 395.2. ²ð²ð²îÆ Ø²ð¼............................................................................................. 415.3. ²ðØ²ìÆðÆ Ø²ð¼........................................................................................... 425.4. Îàî²ÚøÆ Ø²ð¼.............................................................................................. 435.5. Èàèàô Ø²ð¼ ................................................................................................... 445.6. ÞÆð²ÎÆ Ø²ð¼................................................................................................. 455.7. êÚàôÜÆøÆ Ø²ð¼............................................................................................ 465.8. î²ìàôÞÆ Ø²ð¼.............................................................................................. 475.9. ì²Úàò ÒàðÆ Ø²ð¼....................................................................................... 48Ð²ìºÈì²ÌÜºð....................................................................................................... 50

ENGLISH VERSION OF THE BROCHURE................................................................................ 65

6

889

1010121212141415

20

20

25

27

27

29

34

3939414243444546474850

65

6

Üºð²ÌàôÂÚàôÜ

ÎáõñáõÃÛ³Ý å³ï×³é³Í ó³íÝ áõ ï³é³å³ÝùÁ ³ÝÝÏ³ñ³·ñ»ÉÇ ¿, ÇëÏ ï»ëáÕáõÃÛ³Ý í»ñ³Ï³Ý·ÝáõÙÁ` ³Ý·Ý³Ñ³ï»ÉÇ:

î»ëáÕáõÃÛ³Ý Ë³Ý·³ñáõÙÝ»ñÝ ÇÝãå»ë ³ÙμáÕç ³ßË³ñÑáõÙ, ³ÛÝå»ë ¿É Ð³Û³ëï³ÝáõÙ Ñ³Ù³ñíáõÙ »Ý Ñ³Ýñ³ÛÇÝ ³éáÕçáõÃÛ³ÝÁ ëå³éÝ³óáÕ ËÝ¹Çñ: ´Ý³ÏãáõÃÛ³Ý ÙÇ ½·³ÉÇ Ù³ëÁ, Ñ³ïÏ³å»ë 50 ï³ñ»Ï³ÝÇó μ³ñÓñ ³ÝÓÇÝù, ·ïÝíáõÙ »Ý ÏáõñáõÃÛ³Ý éÇëÏ³ÛÇÝ ËÙμáõÙ:

§ìÇÅÁÝ-2020¦-Á ²éáÕç³å³ÑáõÃÛ³Ý Ñ³Ù³ßË³ñÑ³ÛÇÝ Ï³½Ù³Ï»ñåáõÃÛ³Ý (²ÐÎ) ¨ ÎáõñáõÃÛ³Ý Ï³ÝË³ñ·»ÉÙ³Ý ÙÇç³½·³ÛÇÝ ·áñÍ³Ï³ÉáõÃÛ³Ý (International Agency for the Prevention of Blind-ness /IAPB) Ñ³Ù³ï»Õ Ý³Ë³Ó»éÝáõÃÛáõÝÝ ¿: ²ÛÝ ÙÇÝã¨ 2020 Ãí³Ï³ÝÁ ³ÙμáÕç ³ßË³ñÑáõÙ ³í»ÉÇ ù³Ý 100 ÙÇÉÇáÝ Ù³ñ¹Ï³Ýó ÏáõñáõÃÛáõÝÁ Ï³ÝË³ñ·»É»Éáõ ³í»ÉÇ ³ÏïÇí ·áñÍáÕáõÃÛáõÝÝ»ñÇ Ïáã ¿ ³ÝáõÙ: Ü³Ë³Ó»éÝáõÃÛ³Ý ßñç³Ý³ÏáõÙ 1999 Ãí³Ï³ÝÇó Ç í»ñ ³Ù»Ý ï³ñÇ ³ÙμáÕç ³ßË³ñÑáõÙ ÝßíáõÙ ¿ î»ëáÕáõÃ³Ý Ñ³Ù³ßË³ñÑ³ÛÇÝ ûñÁ, áñÇ Ýå³ï³ÏÝ ¿ μ³ñÓñ³Ó³ÛÝ»É ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñ áõÝ»óáÕÝ»ñÇ ËÝ¹ÇñÝ»ñÁ ¨ Ù»Ï ³Ý·³Ù ¨ë ÑÇß»óÝ»É í»ñçÇÝÝ»ñÇë ÝÏ³ïÙ³Ùμ ï³ñμ»ñ »ñÏñÝ»ñáõÙ ëï³ÝÓÝ³Í å³ñï³íáñáõÃÛáõÝÝ»ñÇ Ù³ëÇÝ:

²Ûë ï³ñÇ §ìÇÅÁÝ-2020¦-Á î»ëáÕáõÃ³Ý Ñ³Ù³ßË³ñÑ³ÛÇÝ ûñÁ ÝßáõÙ ¿ §2020-ÇÝ ÁÝ¹³é³çª Ñ»ï³¹³ñÓ Ñ³ßí³ñÏ¦ Ëáñ³·ñáí: ì»ñçÇÝë ³é³ç³ñÏáõÙ ¿ ³Ù÷á÷»É ³Û¹ áÉáñïÇ ·áñÍáÕáõÃÛáõÝÝ»ñÁ ¨ Ýí³×áõÙÝ»ñÁ, Ë»É³Ùïáñ»Ý åÉ³Ý³íáñ»É ³å³·³ ù³ÛÉ»ñÁ ÙÇÝã¨ 2020 Ãí³Ï³ÝÁª Ý»ñ³éÛ³É ÎáõñáõÃÛ³Ý Ï³ÝË³ñ·»ÉÙ³Ý ³½·³ÛÇÝ Íñ³·ñ»ñÇ ·áñÍáÕáõÃÛáõÝÝ»ñÁ: Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÇÍÁ (Ð²Ü) Ù»ÏÝ ¿ ³ÛÝ Ï³½Ù³Ï»ñåáõÃÛáõÝÝ»ñÇó, áñÁ Ð³Û³ëï³ÝáõÙ ³ÏÝ³μáõÅáõÃÛ³Ý áÉáñïáõÙ É³ÛÝ³Í³í³É ³ßË³ï³ÝùÝ»ñ ¿ Çñ³Ï³Ý³óÝáõÙ: Ð²Ü-Ç ³é³ù»ÉáõÃÛáõÝÝ ¿ Ï³ÝË³ñ·»É»É Ó»éùμ»ñáíÇ ÏáõñáõÃÛáõÝÁ Ð³Û³ëï³ÝáõÙ ¨ Ñ³ë³Ý»ÉÇ ¹³ñÓÝ»É 21-ñ¹ ¹³ñÇ ³ÏÝ³μáõÅáõÃÛáõÝÁ Ûáõñ³ù³ÝãÛáõñ Ñ³ÛÇÝ:

Æñ ³é³ù»ÉáõÃÛ³ÝÝ áõ §ìÇÅÁÝ-2020¦-Ç ³é³çÝ³Ñ»ñÃáõÃÛáõÝÝ»ñÇÝ Ñ³Ù³ÑáõÝãª Ð²Ü-Á Ñ³×áõÛùáí ÝßáõÙ ¿ 2010 Ã. î»ëáÕáõÃ³Ý Ñ³Ù³ßË³ñÑ³ÛÇÝ ûñÁ` Ý»ñÏ³Û³óÝ»Éáí §2020-ÇÝ ÀÜ¸²è²æª Ðºî²¸²ðÒ Ð²Þì²ðÎ, ²ÞÊ²î²ÜøÜºð ºì ìÆÖ²Î²¶ðàôÂÚàôÜ¦ Ëáñ³·ñáí Çñ í»ñÉáõÍ³Ï³Ý ½»ÏáõÛóÁ, áñÁ Ññ³ï³ñ³Ïí»É ¿ ÐÐ ²éáÕç³å³ÑáõÃÛ³Ý Ý³Ë³ñ³ñáõÃÛ³Ý ¨ ²ØÜ ØÇç³½·³ÛÇÝ ¼³ñ·³óÙ³Ý ¶áñÍ³Ï³ÉáõÃÛ³Ý Ñ³Ù³·áñÍ³ÏóáõÃÛ³Ùμ:

7

êáõÛÝ Ññ³å³ñ³ÏáõÙÝ Çñ μÝáõÛÃáí Ñ»ï¨áõÙ ¿ î»ëáÕáõÃ³Ý Ñ³Ù³ßË³ñÑ³ÛÇÝ ûñí³ 2010Ã. Ëáñ³·ñÇÝ: ²ÛÝ ³Ù÷á÷áõÙ ¿ 1992 Ãí³Ï³ÝÇó Ç í»ñ Ð³Û³ëï³ÝáõÙ Ð²Ü-Ç Çñ³Ï³Ý³óñ³Í ³ßË³ï³ÝùÝ»ñÁ, ³Ý¹ñ³¹³éÝáõÙ ¿ Ð²Ü-Ç ÑÇÙÝ³Ï³Ý Ý³Ë³Ó»éÝáõÃÛáõÝÝ»ñÇÝ áõ Ýí³×áõÙÝ»ñÇÝ ¨ Ý»ñÏ³Û³óÝáõÙ ¿ ÐÐ μÝ³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ ³éáÕçáõÃÛáõÝÝ áõ »ñÏñáõÙ ³ÏÝ³ÛÇÝ Í³é³ÛáõÃÛáõÝÝ»ñÇ å³Ñ³Ýç³ñÏÁ ·Ý³Ñ³ï»Éáõ Ð²Ü-Ç ·Çï³Ñ»ï³½áï³Ï³Ý ³ßË³ï³ÝùÇ ÷áñÓÁ:

Æ ÉñáõÙÝ, Ñ»ï¨»Éáí î»ëáÕáõÃ³Ý Ñ³Ù³ßË³ñÑ³ÛÇÝ ûñí³ Ã»Ù³ïÇÏ ïñ³Ù³μ³ÝáõÃÛ³ÝÁ, ½»ÏáõÛóÁ Ý»ñÏ³Û³óÝáõÙ ¿ Ý³¨ ÐÐ-áõÙ ÎáõñáõÃÛ³Ý Ï³ÝË³ñ·»ÉÙ³Ý ³½·³ÛÇÝ Íñ³·ñÇ Çñ³Ï³Ý³óÙ³Ý ³ñ¹ÛáõÝùÝ»ñÁ, ÇÝãå»ë Ý³¨ Ð²Ü-Ç Ý»ñ¹ñáõÙÝ ³Û¹ é³½Ù³í³ñáõÃÛ³Ý Ýå³ï³ÏÝ»ñÇÝ Ñ³ëÝ»Éáõ ·áñÍáõÙ (ï»ë` Ñ³í»Éí³Í 2-áõÙ Ý»ñÏ³Û³óí³Í ÝÛáõÃÁ, áñÁ ïñ³Ù³¹ñí»É ¿ ÐÐ ²éáÕç³å³ÑáõÃÛ³Ý Ý³Ë³ñ³ñáõÃÛ³Ý ÏáÕÙÇó):

îå³íáñÇã ³ñ¹ÛáõÝùÝ»ñ »Ý ·ñ³Ýóí»É Ð²Ü-Ç §ÈáõÛë Ñ³ÛÇ ³ãù»ñÇÝ¦ Íñ³·ñÇ, ²ØÜ ØÇç³½·³ÛÇÝ ¼³ñ·³óÙ³Ý ¶áñÍ³Ï³ÉáõÃÛ³Ý ¨ Ð²Ü-Ç §²é³çÝ³ÛÇÝ ¨ ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñÇ ¹³ßÇÝù¦ Íñ³·ñÇ Ñ³Ù³Ï³ñ·í³Í ³ßË³ï³ÝùÝ»ñÇ ¨ μ³½Ù³ÃÇí ·áñÍÁÝÏ»ñ-¹áÝáñÝ»ñÇ ßÝáñÑÇí:

îíÛ³É í»ñÉáõÍ³Ï³Ý íÇ×³Ï³·ñáõÃÛáõÝÁ μ³ó³éÇÏ ¿ Ð³Û³ëï³ÝÇ Ñ³Ù³ñ: ºñÏ³ñ ï³ñÇÝ»ñ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇÝ í»ñ³μ»ñáÕ Ñ³Ù³å³ñ÷³Ï ï»Õ»Ï³ïíáõÃÛáõÝÁ ËÇëï ë³ÑÙ³Ý³÷³Ï ¿ »Õ»É:

¼»ÏáõÛóÇ í»ñÉáõÍ³Ï³Ý Ù³ëáõÙ ½»ï»Õí³Í »Ý Ð²Ü-Ç ·Ý³Ñ³ï³Ï³ÝÝ»ñÁ` Ð³Û³ëï³ÝáõÙ ÏáõÛñ áõ ÃáõÛÉ ï»ëáÕáõÃÛ³Ùμ μÝ³ÏãáõÃÛ³Ý Ý»ñÏ³Û³óí³ÍáõÃÛ³Ý, ÏáõñáõÃÛ³Ý Ñ³Ý·»óÝáÕ ÑÇÙÝ³Ï³Ý ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ï³ñ³Íí³ÍáõÃÛ³Ý, Ï³ï³ñ³ÏïÇ íÇñ³Ñ³ïáõÃÛáõÝÝ»ñÇ Í³ÍÏáõÛÃÇ í»ñ³μ»ñÛ³É: ´»ñí³Í ¿ Ý³¨ ³ÏÝ³ÛÇÝ Ëáó»ÉÇáõÃÛ³Ý Ñ³Ù³ÃÇíÁ` 50-Çó μ³ñÓñ ï³ñÇùÇ μÝ³ÏãáõÃÛ³Ý Ñ³Ù³ñ: Üßí³Í ·Ý³Ñ³ï³Ï³ÝÝ»ñÁ Ñ³ßí³ñÏí»É »Ý ³é³çÇÝ ³Ý·³Ù ÇÝãå»ë »ñÏñÇ, ³ÛÝå»ë ¿É Ýñ³ Ù³ñ½»ñÇ Ïïñí³Íùáí: Ø»Ýù ÑáõÛë áõÝ»Ýù, áñ ³Ûë ³ßË³ï³ÝùÁ Ïû·ÝÇ áñáßáõÙ ÁÝ¹áõÝáÕÝ»ñÇÝ, ·ÇïÝ³Ï³ÝÝ»ñÇÝ ¨ ÏÇñ³é³Ï³Ý áÉáñïáõÙ ½μ³Õí³Í Ù³ëÝ³·»ïÝ»ñÇÝ` Ã»° Ï»ÝïñáÝ³Ï³Ý ¨ Ã»° Ù³ñ½³ÛÇÝ Ù³Ï³ñ¹³ÏÝ»ñáõÙ ³ÏÝ³ÛÇÝ Í³é³ÛáõÃÛáõÝÝ»ñÇ åÉ³Ý³íáñÙ³Ý ¨ Çñ³Ï³Ý³óÙ³Ý ·áñÍáõÙ:

Ð»ÕÇÝ³ÏÝ»ñÁ ³ç³ÏóáõÃÛ³Ý Ñ³Ù³ñ ßÝáñÑ³Ï³ÉáõÃÛáõÝ »Ý Ñ³ÛïÝáõÙ Çñ»Ýó ·áñÍÁÝÏ»ñÝ»ñÇÝ, Ð²Ü-Ç ³ÝÓÝ³Ï³½ÙÇÝ ¨ μÅßÏ³Ï³Ý ËÙμ»ñÇÝ, áñáÝù áñ¨¿ Ï»ñå Ù³ëÝ³Ïó»É »Ý ³Ûë ³ßË³ïáõÃÛ³Ý å³ïñ³ëïÙ³ÝÁ:

8

1. §Ð²ÚÎ²Î²Ü ²ÎÜ²´àôÄàôÂÚ²Ü Ü²Ê²¶ÆÌ¦ Ìð²¶ðÆ Üä²î²ÎÜ àô ÜºðÎ²ÚÆê Üì²ÖàôØÜºðÀ

1.1. Ìð²¶ðÆ Üä²î²ÎÀ, ¾àôÂÚàôÜÀ ºì ¶àðÌÀÜÎºðÜºðÀ

Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÇÍÁ (³ÛëáõÑ»ï` Ð²Ü) μ³ñ»·áñÍ³Ï³Ý Ï³½Ù³Ï»ñåáõÃÛáõÝ ¿, áñ 1992 Ã. ²ØÜ-áõÙ ÑÇÙÝ³¹ñ»É ¿ ³Ù»ñÇÏ³Ñ³Û ³ÏÝ³μáõÛÅ èáç»ñ úÑ³Ý»ëÛ³ÝÁ: Î³½Ù³Ï»ñåáõÃÛ³Ý ³é³ù»ÉáõÃÛáõÝÝ ¿ Ï³ÝË³ñ·»É»É Ð³Û³ëï³ÝáõÙ Ó»éùμ»ñáíÇ ÏáõñáõÃÛáõÝÁ: ²Û¹ Ýå³ï³Ïáí Çñ»Ýó ÷áñÓÁ Ñ³Õáñ¹»Éáõ ¨ ÑÇí³Ý¹Ý»ñÇÝ μáõÅ»Éáõ ³é³ù»ÉáõÃÛ³Ùμ ²ØÜ-Çó Ð³Û³ëï³Ý »Ý ³Ûó»É»É μ³½Ù³ÃÇí μ³ñÓñ³Ï³ñ· ³ÏÝ³μáõÛÅÝ»ñ:

ê÷ÛáõéùÇ Ù»ñ Ñ³Ûñ»Ý³ÏÇóÝ»ñÇ ¨ ³ÛÉ Ñ³Ý·³Ý³ÏáõÃÛáõÝÝ»ñÇ ßÝáñÑÇí Ð³Û³ëï³Ý »Ý μ»ñí»É μ³½Ù³ÃÇí Ã³ÝÏ³ñÅ»ù ³ÏÝ³μáõÅ³Ï³Ý μáõÅå³ñ³·³Ý»ñ, ë³ñù³íáñáõÙÝ»ñ ¨ ¹»Õáñ³Ûù:

Ð²Ü-Ý Çñ ³é³ù»ÉáõÃÛáõÝÁ ÐÐ-áõÙ Çñ³Ï³Ý³óÝáõÙ ¿ »ñÏñáõÙ áõ ¹ñ³ÝÇó ¹áõñë ·ïÝíáÕ Çñ ·áñÍÁÝÏ»ñÝ»ñÇ Ñ»ï ë»ñï Ñ³Ù³·áñÍ³ÏóáõÃÛ³Ùμ: Ð²Ü-Ç ÑÇÙÝ³Ï³Ý ·áñÍÁÝÏ»ñÝ»ñÝ »Ý`

- ÐÐ ³éáÕç³å³ÑáõÃÛ³Ý Ý³Ë³ñ³ñáõÃÛáõÝÁ,- ÐÐ ³ßË³ï³ÝùÇ ¨ ëáóÇ³É³Ï³Ý Ñ³ñó»ñÇ Ý³Ë³ñ³ñáõÃÛáõÝÁ,- ÐÐ μáÉáñ Ù³ñ½»ñÇ Ù³ñ½å»ï³ñ³ÝÝ»ñÁ, ºñ¨³ÝÇ ù³Õ³ù³å»ï³ñ³ÝÁ, ·ÛáõÕ³Ï³Ý Ñ³Ù³ÛÝù³å»ï³ñ³ÝÝ»ñÁ- ê. Ø³É³Û³ÝÇ ³Ýí³Ý ³ÏÝ³μáõÅ³Ï³Ý Ï»ÝïñáÝÁ,- ø³Ý³ù»é-¼»ÛÃáõÝ μÅßÏ³Ï³Ý Ï»ÝïñáÝÁ,- ºñ¨³ÝÇ å»ï³Ï³Ý μÅßÏ³Ï³Ý Ñ³Ù³Éë³ñ³ÝÇ ÃÇí 1 ÐÎÐ ³ÏÝ³μáõÅ³Ï³Ý ÏÉÇÝÇÏ³Ý, - Ø³ñ½³ÛÇÝ μÅßÏ³Ï³Ý Ï»ÝïñáÝÝ»ñÁ, ³éáÕçáõÃÛ³Ý Ï»ÝïñáÝÝ»ñÝ áõ ´ØÎ-Ý»ñÁ, - ²ØÜ ØÇç³½·³ÛÇÝ ½³ñ·³óÙ³Ý ·áñÍ³Ï³ÉáõÃÛáõÝÁ (²ØÜ Ø¼¶) ¨ Ñ³ñ³ÏÇó ³éáÕç³å³Ñ³Ï³Ý ¨ ÏñÃ³Ï³Ý Íñ³·ñ»ñ,- ´³½Ù³ÃÇí Ï³½Ù³Ï»ñåáõÃÛáõÝÝ»ñ áõ ³ÝÑ³ïÝ»ñ ê÷ÛáõéùáõÙ,- ØÇ ß³ñù »ñÏñÝ»ñÇ ¹»ëå³ÝáõÃÛáõÝÝ»ñ,- ´³½Ù³ÃÇí Ñ³ë³ñ³Ï³Ï³Ý ¨ ÙÇç³½·³ÛÇÝ Ï³½Ù³Ï»ñåáõÃÛáõÝÝ»ñ:

Ð²Ü-Ç ·áñÍáõÝ»áõÃÛáõÝÁ Ù»Í³å»ë Ýå³ëï»É ¿ Ð³Û³ëï³ÝáõÙ §ÎáõñáõÃÛ³Ý Ï³ÝË³ñ·»ÉÙ³Ý é³½Ù³í³ñ³Ï³Ý Íñ³·ñÇ¦ Çñ³Ï³Ý³óÙ³ÝÁ: (î»°ë Ñ³í»Éí³Í 2, ÐÐ Ï³é³í³ñáõÃÛ³Ý 02/11/2006 Ãí³Ï³ÝÇ N-43-Ü áñáßÙ³Ý Ï³ï³ñÙ³Ý í»ñ³μ»ñÛ³É ï»Õ»Ï³ÝùÁ:)

9

1.2. Ìð²¶ðÆ ÐÆØÜ²Î²Ü Üì²ÖàôØÜºðÀ

Ð³Û³ëï³ÝáõÙ Çñ ·áñÍáõÝ»áõÃÛ³Ý ³ÙμáÕç ÁÝÃ³óùáõÙ (ëÏë³Í 1992 Ãí³Ï³ÝÇó) Ð²Ü-Á ß³ñáõÝ³Ï³μ³ñ É³ÛÝ ·áñÍáõÝ»áõÃÛáõÝ ¿ Í³í³É»É, áñÇ ÑÇÙÝ³Ï³Ý Ýí³×áõÙÝ»ñÁ Ãí³ñÏí³Í »Ý ëïáñ¨.

- Î³½Ù³Ï»ñåí»É ¿ 33 μÅßÏ³Ï³Ý ³é³ù»ÉáõÃÛáõÝ ²ØÜ-Çó Ð³Û³ëï³Ý. 55 ³ÏÝ³μáõÛÅÝ»ñ ²ØÜ-Çó Çñ»Ýó ÙÇçáóÝ»ñáí ³Ûó»É»É »Ý Ð³Û³ëï³Ý` Çñ»Ýó ÷áñÓÁ ÷áË³Ýó»Éáõ Ð³Û³ëï³ÝÇ ³ÏÝ³μáõÛÅÝ»ñÇÝ ¨ μáõÅ»Éáõ ÑÇí³Ý¹Ý»ñÇÝ: - îñ³Ù³¹ñí»É »Ý ³í»ÉÇ ù³Ý 18,5 ÙÇÉÇáÝ ²ØÜ ¹áÉ³ñ ³ñÅáÕáõÃÛ³Ùμ ³ÏÝ³μáõÅ³Ï³Ý ë³ñù³íáñáõÙ ¨ μáõÅå³ñ³·³Ý»ñ ³Ù»ñÇÏÛ³Ý ¹»Õ³·áñÍ³Ï³Ý áõ μÅßÏ³Ï³Ý ë³ñù³íáñáõÙÝ»ñ ³ñï³¹ñáÕ Ï³½Ù³Ï»ñåáõÃÛáõÝÝ»ñÇ ¨ ³ÝÑ³ïÝ»ñÇ ÏáÕÙÇó: - Øß³Ïí»É »Ý ³ñ¨ÙïÛ³Ý ³ÏÝ³μáõÅáõÃÛ³Ý ã³÷³ÝÇßÝ»ñÇÝ Ñ³Ù³å³ï³ëË³ÝáÕ Ñ»ï¹ÇåÉáÙ³ÛÇÝ áõëáõÙÝ³Ï³Ý Íñ³·ñ»ñ ¨ Ù»Ãá¹Ý»ñ: ÆÝãå»ë Ý³¨ Ñ»ÕÇÝ³Ïí»É ¨ ïå³·ñí»É »Ý §²ãùÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñ¦ (2005 Ã.) ¨ §²ÏÝ³μáõÅáõÃÛ³Ý ÁÝïñ³ÝÇ¦ (2007 Ã.) áõëáõÙÝ³Ï³Ý Ó»éÝ³ñÏÝ»ñÝ ³é³çÝ³ÛÇÝ ûÕ³ÏÇ μáõÅ³ßË³ïáÕÝ»ñÇ ¨ ³ÏÝ³μáõÛÅÝ»ñÇ Ñ³Ù³ñ:- Øß³Ïí»É ¨ 1998 Ã. ÷»ïñí³ñÇÝ ÐÐ Ï³é³í³ñáõÃÛ³ÝÝ ¿ Ý»ñÏ³Û³óí»É ²ãùÇ μ³ÝÏÇ í»ñ³μ»ñÛ³É ûñ»Ýë¹ñáõÃÛáõÝ: - üÇÝ³Ýë³íáñí»É ¿ 8 Ñ³Û ³ÏÝ³μáõÛÅÇ Ù³ëÝ³·Çï³Ï³Ý í»ñ³å³ïñ³ëïáõÙÁ, ÇÝãå»ë Ý³¨` 3 ¹Çïáñ¹³Ï³Ý ³é³ù»ÉáõÃÛáõÝ ²ØÜ-áõÙ: - üÇÝ³Ýë³íáñí»É ¨ ³ÝóÏ³óí»É ¿ ºñ¨³ÝáõÙ 11 ÙÇç³½·³ÛÇÝ ³ÏÝ³μáõÅ³Ï³Ý Ñ³Ù³ÅáÕáí: - üÇÝ³Ýë³íáñí»É ¿ íÇñ³Ñ³ï³Ï³Ý Ñ³ïáõÏ ÙÇç³ÙïáõÃÛáõÝ å³Ñ³ÝçáÕ 15 ÑÇí³Ý¹Ç μáõÅáõÙÝ ²ØÜ-áõÙ: - ê. Ø³É³Û³ÝÇ ³ÏÝ³μáõÅ³Ï³Ý Ï»ÝïñáÝáõÙ ë³ñù³íáñáõÙÝ»ñáí ³å³Ñáíí»É ¨ Ñ³Ù³Éñí»É ¿ ÑÇÝ· Ù³ëÝ³·Çï³óí³Í μ³Å³ÝÙáõÝù ` - íÇïñ»á-é»ïÇÝ³É, 1998 Ã. - ·É³áõÏáÙ³ÛÇ, 2000 Ã. - »Õçñ³Ã³Õ³ÝÃÇ ¨ áõí»ÇïÇ, 2001 Ã. - ÝÛ³ñ¹³-³ÏÝ³μáõÅáõÃÛ³Ý ¨ ûñμÇï³É íÇñ³Ñ³ïáõÃÛáõÝÝ»ñÇ, 2004 Ã. - ³ãùÇ μ³ÝÏ, 2005 Ã.- 2002 Ã. ³Ù»ñÇÏÛ³Ý Ñ³Ý·³Ý³ÏáõÃÛáõÝÝ»ñÇ ßÝáñÑÇí ëï»ÕÍí»É ¨ Ð³Û³ëï³Ý ¿ μ»ñí»É ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóÁ (³ÛëáõÑ»ï` ²ÞÐ), áñÝ ³Ýí×³ñ ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñ Ù³ïáõó»Éáõ Ýå³ï³Ïáí ßñçáõÙ ¿ Ð³Û³ëï³ÝÇ Ù³ñ½»ñáõÙ: - 2003 Ã. ÑáõÝÇëÇÝ Ð³Û³ëï³ÝÇ áÕç ï³ñ³ÍùáõÙ Ù»ÏÝ³ñÏ»É ¿ μÝ³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñÇ, Ëáñ³óí³Í Ñ»ï³½áïáõÃÛáõÝÝ»ñÇ

10

¨ μáõÅû·ÝáõÃÛ³Ý Ñ³Ù³å³ñ÷³Ï Íñ³·ÇñÁ: ²é ³Ûëûñ Ð²Ü-Ç μÅßÏ³Ï³Ý ËÙμ»ñÁ ¨ ²ÞÐ-Ý Ï³ï³ñ»É »Ý »ñ»ù ßñç³Ûó Ð³Û³ëï³ÝÇ Ù³ñ½»ñáõÙ: - 2005 Ã. Ð³Û³ëï³ÝÇ áÕç ï³ñ³ÍùáõÙ Ù»ÏÝ³ñÏ»É ¿ Ñ³Ýñ³ÛÇÝ áõëáõóÙ³Ý ¨ Çñ³½»ÏÙ³Ý Íñ³·ÇñÁ: îå³·ñí»É ¨ ï³ñ³Íí»É ¿ 12 ³ÝáõÝ (600 Ñ³½. ûñÇÝ³Ï) ï»Õ»Ï³ïáõ ·ñùáõÛÏ ³ãùÇ ËÝ³ÙùÇ, ³Ýíï³Ý·áõÃÛ³Ý ¨ »ñ»Ë³Ý»ñÇ áõ Ù»Í³Ñ³ë³ÏÝ»ñÇ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ í»ñ³μ»ñÛ³É:- 2006 Ã. Ù³ÛÇëÇÝ, Ø³É³Û³ÝÇ ³Ýí³Ý ³ÏÝ³μáõÅ³Ï³Ý Ï»ÝïñáÝÇ ¨ ²ØÜ ØÇç³½·³ÛÇÝ ½³ñ·³óÙ³Ý ·áñÍ³Ï³ÉáõÃÛ³Ý Ñ³Ù³·áñÍ³ÏóáõÃÛ³Ùμ, ÑÇÙÝ³¹ñí»É ¨ ë³ñù³íáñáõÙÝ»ñáí ³å³Ñáíí»É ¿ àõëáõóÙ³Ý ¨ ³ËïáñáßÙ³Ý Ï»ÝïñáÝÁ: - 2006 Ã. ø³Ý³ù»é-¼»ÛÃáõÝ μÅßÏ³Ï³Ý Ï»ÝïñáÝáõÙ ÑÇÙÝ³¹ñí»É ¿ ó³Íñ ï»ëáÕáõÃÛ³Ý μ³Å³ÝÙáõÝùÁ: - 2007 Ã. §öý³Û½»ñ¦ ÁÝÏ»ñáõÃÛ³Ý ÝíÇñ³ïíáõÃÛ³Ý ßÝáñÑÇí Ð³Û³ëï³Ý ¿ Ý»ñÙáõÍí»É íÇñ³Ñ³ï³Ï³Ý ÑÙïáõÃÛáõÝÝ»ñÇ ½³ñ·³óÙ³Ý É³μáñ³ïáñÇ³Ý (Wet Lab), áñÁ Í³é³ÛáõÙ ¿ ³ÏÝ³μáõÛÅÝ»ñÇ ¨ áõë³ÝáÕÝ»ñÇ íÇñ³Ñ³ï³Ï³Ý ÑÙïáõÃÛáõÝÝ»ñÇ Ï³ï³ñ»É³·áñÍÙ³ÝÁ:- 2010 Ã. Ð²Ü-Ç ³ÝÙÇç³Ï³Ý Ù³ëÝ³ÏóáõÃÛ³Ùμ Ð³Û³ëï³ÝáõÙ Ý»ñ¹ñí»É ¿ ²ÝÑ³ëáõÃÛ³Ý é»ïÇÝáå³ÃÇ³ÛÇ (²è) ³ËïáñáßÙ³Ý ¨ μáõÅÙ³Ý Íñ³·ÇñÁ:

2. Ð²Ü-Æ §ÈàôÚê Ð²ÚÆ ²âøºðÆÜ¦ Ü²Ê²ÒºèÜàôÂÚàôÜÀ, ¸ð² ´²Ô²¸ðÆâÜºðÜ àô ²ð¸ÚàôÜøÜºðÀ

2.1. Ü²Ê²ÒºèÜàôÂÚ²Ü ¾àôÂÚàôÜÜ àô ÐÆØÜ²Î²Ü ²ð¸ÚàôÜøÜºðÀ

ÐÐ-áõÙ ÑÇÙÝ³¹ñí»Éáí áñå»ë §Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÇÍ¦ μ³ñ»·áñÍ³Ï³Ý ÑÇÙÝ³¹ñ³Ùª Ð²Ü-Á, ëÏë³Í 2003 Ãí³Ï³ÝÇó, Çñ³Ï³Ý³óÝáõÙ ¿ §ÈáõÛë Ñ³ÛÇ ³ãù»ñÇÝ¦ Ý³Ë³Ó»éÝáõÃÛáõÝÁ, áñÝ áõÕÕí³Í ¿ Ð³Û³ëï³ÝáõÙ ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñÇ μ³ñ»É³íÙ³ÝÁ ¨ Ó»éùμ»ñáíÇ ÏáõñáõÃÛ³Ý Ï³ÝË³ñ·»ÉÙ³ÝÁ: 2004 Ã. Ç í»ñ Ð²Ü-Á Ñ³Ù³·áñÍ³ÏóáõÙ ¿ ²ØÜ ØÇç³½·³ÛÇÝ ½³ñ·³óÙ³Ý ·áñÍ³Ï³ÉáõÃÛ³Ý (USAID/²ØÜ Ø¼¶) Ñ»ï` ¶Éáμ³É ½³ñ·³óÙ³Ý ¹³ßÇÝùÇ ßñç³Ý³ÏÝ»ñáõÙ: Ü³Ë³Ó»éÝáõÃÛáõÝÝ Çñ ÑÇÙÝ³Ï³Ý Ýå³ï³ÏÝ Çñ³·áñÍáõÙ ¿ ÑÇÝ· ß³ÕÏ³åí³Í áõÕÕáõÃÛáõÝÝ»ñáí, áñáÝù í»ñçÇÝÇë μ³Õ³¹ñãÝ»ñÝ »Ý`

- μÝ³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ É³ÛÝ³ï³ñ³Í ½ÝÝáõÙÝ»ñ ¨ μáõÅû·ÝáõÃÛáõÝ, - ïíÛ³ÉÝ»ñÇ í»ñÉáõÍáõÃÛáõÝ ¨ ·Çï³Ñ»ï³½áï³Ï³Ý ³ßË³ï³ÝùÝ»ñ, - μÅßÏ³Ï³Ý áõëáõóáõÙ ¨ í»ñ³å³ïñ³ëïáõÙ,

11

- Ñ³Ýñ³ÛÇÝ áõëáõóáõÙ ¨ Çñ³½»ÏáõÙ, - Ï³ñáÕáõÃÛáõÝÝ»ñÇ ½³ñ·³óáõÙ:

ê÷ÛáõéùÇó, ï³ñμ»ñ Ñáí³Ý³íáñÝ»ñÇó ëï³óíáÕ Ñ³Ý·³Ý³ÏáõÃÛáõÝÝ»ñÇ, ÇÝãå»ë Ý³¨ ²ØÜ Ø¼¶-Ç ïñ³Ù³¹ñ³Í ¹ñ³Ù³ßÝáñÑÇ ³ç³ÏóáõÃÛ³Ùμ Ð²Ü-Ç ³ÏÝ³μáõÅ³Ï³Ý ËÙμ»ñÁ ¨ ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóÁ å³ñμ»ñ³μ³ñ ßñç³Ûó»ñ »Ý Ï³ï³ñáõÙ ÐÐ μáÉáñ Ù³ñ½»ñáõÙ áõ ºñ¨³ÝáõÙ` Çñ³Ï³Ý³óÝ»Éáí ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñ, Ëáñ³óí³Í Ñ»ï³½áïáõÃÛáõÝÝ»ñ áõ ÙÇç³ÙïáõÃÛáõÝÝ»ñ: àñå»ë ³é³ÝÓÇÝ Íñ³·Çñ` Ð²Ü-Á ÝáõÛÝ ³é³ù»ÉáõÃÛ³Ùμ ³Ûó»É»É ¿ Ý³¨ È»éÝ³ÛÇÝ Ô³ñ³μ³ÕÇ Ð³Ýñ³å»ïáõÃÛáõÝ ` 2004, 2006, 2008 ¨ 2010 ÃÃ.:

§ÈáõÛë Ñ³ÛÇ ³ãù»ñÇÝ¦ Íñ³·ÇñÁ 2003 Ã. ÑáõÝÇëÇó ÙÇÝã¨ 2010 Ã. ë»åï»Ùμ»ñ ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ áõÝ»ó»É ¿ Ñ»ï¨Û³É ³ñ¹ÛáõÝùÝ»ñÁ.

- ÐÐ ³ÙμáÕç ï³ñ³ÍùáõÙ 264,568 Ù³ñ¹ Ð²Ü-Ç ³ÏÝ³ÛÇÝ ½ÝÝáõÙ ¿ ³Ýó»É Çñ Ï³Ù Ùáï³Ï³ Ñ³Ù³ÛÝùáõÙ (Ý»ñ³éÛ³É 128,933 »ñ»Ë³):- 27,091 Ù³ñ¹ ³Ýó»É ¿ Ëáñ³óí³Í Ñ»ï³½áïáõÃÛáõÝ ²ÞÐ-áõÙ:- 11,303 Ù³ñ¹ ²ÞÐ-áõÙ íÇñ³Ñ³ïí»É Ï³Ù É³½»ñ³ÛÇÝ μáõÅáõÙ ¿ ëï³ó»É:- ä³ïñ³ëïí»É áõ ³Ýí×³ñ ïñ³Ù³¹ñí»É ¿ 29,546 ³ÏÝáó:- êï»ÕÍí»É ¿ Ð²Ü-Ç μÅßÏ³Ï³Ý ËÙμ»ñÇ ÏáÕÙÇó ½ÝÝí³Í μÝ³ÏãáõÃÛ³Ý ïíÛ³ÉÝ»ñÇ ßï»Ù³ñ³Ý, áñÇ ·Çï³Ñ»ï³½áï³Ï³Ý í»ñÉáõÍáõÃÛáõÝÝ áõ ³Ù÷á÷áõÙÁ ÑÝ³ñ³íáñáõÃÛáõÝ ¿ ïí»É ·Ý³Ñ³ï»Éáõ ÐÐ-áõÙ μÝ³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ áõ ï»ëáÕáõÃÛ³Ý Ë³Ã³ñáõÙÝ»ñÇ ï³ñ³Íí³ÍáõÃÛáõÝÁ:- ì»ñ³å³ïñ³ëïí»É ¿ 1,684 μáõÅ³ßË³ïáÕ, ³Û¹ ÃíáõÙ` ³ÏÝ³μáõÛÅÝ»ñ, ÁÝï³Ý»Ï³Ý μÅÇßÏÝ»ñ ¨ ³ÏÝ³μáõÅ³Ï³Ý ùáõÛñ»ñ ÐÐ Ù³ñ½»ñÇó ¨ ºñ¨³ÝÇ åáÉÇÏÉÇÝÇÏ³Ý»ñÇó:- ´³Å³Ýí»É ¿ 501,156 ï»Õ»Ï³ïáõ ·ñùáõÛÏ:- ²ÝóÏ³óí»É ¿ Ñ³Ýñ³ÛÇÝ ÏñÃáõÃÛ³Ý 360 ¹³ëÁÝÃ³ó` 9000 »ñ»Ë³Ý»ñÇ ¨ 900 Ù»Í³Ñ³ë³ÏÝ»ñÇ Ñ³Ù³ñ:

12

2.2. Ü²Ê²ÒºèÜàôÂÚ²Ü ´²Ô²¸ðÆâÜºðÆ ÀÜ¸Ð²Üàôð ÜÎ²ð²¶ÆðÀ

´Ý³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ É³ÛÝ³ï³ñ³Í ½ÝÝáõÙÝ»ñ ¨ μáõÅû·ÝáõÃÛáõÝ §ÈáõÛë Ñ³ÛÇ ³ãù»ñÇÝ¦ Íñ³·ÇñÁ Ýå³ï³Ï áõÝÇ Ï³ÝË³ñ·»É»É Ó»éùμ»ñáíÇ ÏáõñáõÃÛáõÝÁ` Ð³Û³ëï³ÝÇ μáÉáñ Ñ³Ù³ÛÝùÝ»ñÇ μÝ³ÏÇãÝ»ñÇ Ñ³Ù³ñ μ³ñÓñáñ³Ï ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñÁ Ñ³ë³Ý»ÉÇ ¹³ñÓÝ»Éáí: Ìñ³·ñÇ ßñç³Ý³ÏÝ»ñáõÙ Ð²Ü-Ç ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóÁ (²ÞÐ) ¨ μÅßÏ³Ï³Ý ËÙμ»ñÝ ³Ûó»ÉáõÙ »Ý Ð³Û³ëï³ÝÇ μáÉáñ Ù³ñ½»ñÇ ·ÛáõÕ³Ï³Ý áõ ù³Õ³ù³ÛÇÝ Ñ³Ù³ÛÝùÝ»ñ` Çñ³Ï³Ý³óÝ»Éáõ Ñ»ï¨Û³É ³ßË³ï³ÝùÝ»ñÁ` - ÁÝ¹Ñ³Ýáõñ ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñ Ù»Í³Ñ³ë³ÏÝ»ñÇ ¨ »ñ»Ë³Ý»ñÇ Ñ³Ù³ñ, - Ëáñ³óí³Í Ñ»ï³½áïáõÃÛáõÝ, íÇñ³Ñ³ïáõÃÛáõÝ Ï³Ù É³½»ñ³ÛÇÝ μáõÅáõÙ ²ÞÐ-áõÙ,- ³ÏÝáóÇ Ýß³Ý³ÏáõÙ, ÇëÏ ³Ý³å³Ñáí ËÙμ»ñÇÝ Ý³¨` ³ÏÝáóÇ ïñ³Ù³¹ñáõÙ:

²ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÁ í³Õ Ñ³ÛïÝ³μ»ñ»Éáõ ¨ Å³Ù³Ý³ÏÇÝ μáõÅ»Éáõ Ýå³ï³Ïáí Ñ³ïáõÏ áõß³¹ñáõÃÛáõÝ ¿ ¹³ñÓíáõÙ ÏáõñáõÃÛ³Ý å³ï×³é ¹³ñÓáÕ ÙÇ ß³ñù ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ Ñ³ÛïÝ³μ»ñÙ³ÝÁ, ÇÝãå»ë ûñÇÝ³Ï` Ï³ï³ñ³ÏïÇ, ·É³áõÏáÙ³ÛÇ, ß³ù³ñ³Ëï³ÛÇÝ ó³Ýó»Ý³ËïÇ, Ù³ÏáõÉÛ³ñ ¹ÇëïñáýÇ³ÛÇ ¨ ³ÛÉÝ: ÀÝ¹Ñ³Ýáõñ ½ÝÝáõÙÝ»ñÇó Ñ»ïá Ñ³ñÏ »Õ³Í ¹»åùáõÙ μÝ³ÏÇãÝ»ñÝ áõÕ»·ñíáõÙ »Ý ²ÞÐ` Ëáñ³óí³Í Ñ»ï³½áïáõÃÛ³Ý, É³½»ñ³ÛÇÝ Ï³Ù íÇñ³Ñ³ï³Ï³Ý μáõÅÙ³Ý Ñ³Ù³ñ: Ð³ë³Ý»ÉÇ ÉÇÝ»Éáõ Ýå³ï³Ïáí Ð²Ü-Á Ï³Û³ÝáõÙ ¿ ²ÞÐ-Ý ÐÐ μáÉáñ Ù³ñ½»ñÇ Ï»ÝïñáÝ³Ï³Ý ù³Õ³ùÝ»ñáõÙ: 2003 Ã. ÑáõÝÇëÇó ÙÇÝã¨ 2009 Ã. ë»åï»Ùμ»ñ ³ÙÇëÁ Ð³Û³ëï³ÝÇ Ù³ñ½»ñáõÙ Ð²Ü-Ý Çñ³Ï³Ý³óñ»É ¿ »ñ»ù ßñç³Ûó: Ü»ñÏ³ÛáõÙ ÁÝÃ³óùÇ Ù»ç ·ïÝíáÕ ãáññáñ¹ ßñç³ÛóÝ ëÏëí»É ¿ 2009 Ã. ÑáÏï»Ùμ»ñÇ ëÏ½μÇÝ ¨ ³ÏÝÏ³ÉíáõÙ ¿ ³í³ñïí»É 2011 Ã. ë»åï»Ùμ»ñÇÝ:

îíÛ³ÉÝ»ñÇ í»ñÉáõÍáõÃÛáõÝ ¨ ·Çï³Ñ»ï³½áï³Ï³Ý ³ßË³ï³ÝùÝ»ñ

Ð»ï³½áï³Ï³Ý ¨ ·Çï³·áñÍÝ³Ï³Ý ³ßË³ï³ÝùÝ»ñÁ Ð²Ü-Ç ·áñÍáõÝ»áõÃÛáõÝáõÙ ³é³çÝ³ÛÇÝ ï»Õ »Ý ½μ³Õ»óÝáõÙ: Ð³Û³ëï³ÝÇ Ù³ñ½»ñáõÙ 2003 Ã. Ç í»ñ Çñ³Ï³Ý³óñ³Í ³ßË³ï³ÝùÝ»ñÇ ßÝáñÑÇí Ð²Ü-Á Ñ³í³ù»É ¿ Ð²Ü-Ç »ñ»ù ßñç³Ûó»ñÇ ÁÝÃ³óùáõÙ ³ÏÝ³μáõÅ³Ï³Ý

13

½ÝÝáõÙ ³Ýó³Í ßáõñç 160 Ñ³½³ñ ß³Ñ³éáõÝ»ñÇ ïíÛ³ÉÝ»ñÁ ¨ ëï»ÕÍ»É ¿ ßï»Ù³ñ³Ý, áñÇ í»ñÉáõÍáõÃÛ³Ý ÑÇÙ³Ý íñ³ ëï³óí»É »Ý Ð³Û³ëï³ÝáõÙ μÝ³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ ³éáÕçáõÃÛáõÝÝ áõ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ï³ñ³Íí³ÍáõÃÛáõÝÁ μÝáõÃ³·ñáÕ, ÙÇç³½·³ÛÝáñ»Ý ÁÝ¹áõÝí³Í Ù»Ãá¹³μ³ÝáõÃÛ³Ùμ Ñ³ßí³ñÏí³Í óáõó³ÝÇßÝ»ñ` ÇÝãå»ë »ñÏñÇ, ³ÛÝå»ë ¿É Ýñ³ Ù³ñ½»ñÇ Ïïñí³Íùáí:

Ð³í³ùí³Í ïíÛ³ÉÝ»ñÁ ÑÝ³ñ³íáñáõÃÛáõÝ »Ý ÁÝÓ»éáõÙ μ³ó³Ñ³Ûï»Éáõ »ñÏñáõÙ áõ Ýñ³ Ù³ñ½»ñáõÙ ï»ëáÕáõÃÛ³Ý Ë³Ý·³ñáõÙÝ»ñÇ ÑÇÙÝ³Ï³Ý å³ï×³éÝ»ñÁ ¨ ·Ý³Ñ³ï»Éáõ ÏáõñáõÃÛ³Ý, ÃáõÛÉ ï»ëáÕáõÃÛ³Ý ¨ ³ÛÝåÇëÇ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ï³ñ³Íí³ÍáõÃÛáõÝÁ, ÇÝãåÇëÇù »Ý Ï³ï³ñ³ÏïÁ, ·É³áõÏáÙ³Ý, »Õç»ñ³Ã³Õ³ÝÃÇ ¨ ³ÏÝ³Ñ³ï³ÏÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÁ:

²ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ï³ñ³Íí³ÍáõÃÛ³Ý ïíÛ³ÉÝ»ñÇ ÑÇÙ³Ý íñ³ Ð²Ü-Á Ý³¨ Ùß³Ï»É áõ Ý»ñ¹ñ»É ¿ 50-Çó μ³ñÓñ ï³ñÇùÇ μÝ³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ ³éáÕçáõÃÛ³Ý Ëáó»ÉÇáõÃÛ³Ý Ñ³Ù³ÃÇíÁ, áñÁ, Áëï ¿áõÃÛ³Ý, »ñÏñÇ ³Û¹ ï³ñÇùÇ μÝ³ÏãáõÃÛ³Ý ÏáõñáõÃÛ³Ý íï³Ý·Ç ·Ý³Ñ³ï³Ï³ÝÝ ¿: Ð²Ü-Á Çñ³Ï³Ý³óñ»É ¿ »ñÏáõ ³ÛÉ Ñ»ï³½áïáõÃÛáõÝ ³ÏÝ³ÛÇÝ Í³é³ÛáõÃÛáõÝÇó û·ïíáÕÝ»ñÇ ·áÑáõÝ³ÏáõÃÛáõÝÁ ·Ý³Ñ³ï»Éáõ Ýå³ï³Ïáí: Àëï ³Û¹ Ñ»ï³½áïáõÃÛ³Ý ³ñ¹ÛáõÝùÝ»ñÇ` Ð²Ü-Ç Í³é³ÛáõÃÛáõÝÝ»ñÇó û·ïí³Í ÑÇí³Ý¹Ý»ñÇ 94%-Á ¹ñ³Ýù ·Ý³Ñ³ï»É ¿ É³í Ï³Ù ·»ñ³½³Ýó:

´ÅßÏ³Ï³Ý áõëáõóáõÙ ¨ í»ñ³å³ïñ³ëïáõÙ

Ð²Ü-Ç ÏáÕÙÇó Ù³ïáõóíáÕ μÅßÏ³Ï³Ý áõëáõóáõÙÁ ¨ í»ñ³å³ïñ³ëïáõÙÁ ÑÝ³ñ³íáñáõÃÛáõÝ ¿ ï³ÉÇë Ð³Û³ëï³ÝÇ ³é³çÝ³ÛÇÝ, »ñÏñáñ¹³ÛÇÝ ¨ »ññáñ¹³ÛÇÝ Ù³Ï³ñ¹³ÏÝ»ñÇ μáõÅ³ßË³ïáÕÝ»ñÇÝ ½³ñ·³óÝ»Éáõ ³ÏÝ³μáõÅáõÃÛ³Ý Ù³ëÇÝ ·Çï»ÉÇùÝ»ñÝ áõ ÑÙïáõÃÛáõÝÝ»ñÁ, ÇÝãÁ Ï³å³ÑáíÇ μ³ñÓñáñ³Ï ³ÏÝ³ÛÇÝ Í³é³ÛáõÃÛáõÝÝ»ñÇ Ù³ïáõóáõÙÁ μÝ³ÏãáõÃÛ³ÝÁ Ð³Û³ëï³ÝÇ ³ÙμáÕç ï³ñ³ÍùáõÙ: Ð²Ü-Á μ³½Ù³ÃÇí Ù³ëÝ³·Çï³Ï³Ý ¹³ëÁÝÃ³óÝ»ñ ¿ Ï³½Ù³Ï»ñå»É Ð³Û³ëï³ÝÇ Ù³ñ½³ÛÇÝ ³ÏÝ³μáõÛÅÝ»ñÇ áõ ÁÝï³Ý»Ï³Ý μÅÇßÏÝ»ñÇ Ñ³Ù³ñ: ²Û¹ ·áñÍáõÙ Ýñ³ ÑÇÙÝ³Ï³Ý ·áñÍÁÝÏ»ñÝ»ñÝ »Ý ²ØÜ Ø¼¶ §²éáÕçáõÃÛ³Ý ³é³çÝ³ÛÇÝ å³Ñå³ÝÙ³Ý μ³ñ»÷áËáõÙÝ»ñÇ Íñ³·ÇñÁ¦ (PHCR) ¨ §ÎñÃáõÃÛ³Ùμ ½³ñ·³óÙ³Ý ³Ï³¹»ÙÇ³Ý¦ (AED): ²é ³Ûëûñ Ð²Ü-Á Ð³Û³ëï³ÝÇ Ù³ñ½»ñáõÙ ¨ ºñ¨³ÝáõÙ í»ñ³å³ïñ³ëï»É ¿ ³í»ÉÇ ù³Ý 1600 Ù³ëÝ³·»ïÇ: ¸³ëÁÝÃ³óÝ»ñÇ Å³Ù³Ý³Ï ÏÇñ³éíáõÙ »Ý Ð²Ü-Ç Ñ»ÕÇÝ³Ï³Í §²ãùÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñ¦ ¨ §²ÏÝ³μáõÅáõÃÛ³Ý ÁÝïñ³ÝÇ¦ áõëáõÙÝ³Ï³Ý Ó»éÝ³ñÏÝ»ñÁ, áñáÝù Ð³Û³ëï³ÝÇ ³ÝÏ³ËáõÃÛáõÝÇó Ç í»ñ Ññ³ï³ñ³Ïí³Í ³é³çÇÝ Ñ³Û»ñ»Ý ³ÏÝ³μáõÅáõÃÛ³Ý ¹³ë³·ñù»ñÝ »Ý:

14

î»ë³Ï³Ý ¹³ëÁÝÃ³óÝ»ñÇó ½³ï, Ð³Û³ëï³ÝÇ Ù³ñ½»ñÇ ³ÏÝ³μáõÛÅÝ»ñÝ áõ ÁÝï³Ý»Ï³Ý μÅÇßÏÝ»ñÁ ÑÝ³ñ³íáñáõÃÛáõÝ áõÝ»Ý Ý³¨ Í³ÝáÃ³Ý³Éáõ Å³Ù³Ý³Ï³ÏÇó ³ÏÝ³μáõÅ³Ï³Ý ë³ñù³íáñáõÙÝ»ñÇÝ ¨ ½³ñ·³óÝ»Éáõ Çñ»Ýó ÏÇñ³é³Ï³Ý ÑÙïáõÃÛáõÝÝ»ñÁ: Üñ³Ýù Ù³ëÝ³ÏóáõÙ »Ý Çñ»Ýó μÝ³Ï³í³Ûñ»ñáõÙ Ð²Ü-Ç μÅßÏ³Ï³Ý ËÙμ»ñÇ ÏáÕÙÇó Çñ³Ï³Ý³óíáÕ ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñÇÝ, ÇÝãå»ë Ý³¨ Ð²Ü-Ç ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóáõÙ Ï³ï³ñíáÕ íÇñ³Ñ³ïáõÃÛáõÝÝ»ñÇÝ áõ É³½»ñ³ÛÇÝ μáõÅáõÙÝ»ñÇÝ:

ÎñÃ³Ï³Ý Ýå³ï³Ïáí 2006 Ã., ²ØÜ Ø¼¶ ýÇÝ³Ýë³íáñÙ³Ùμ, Ð²Ü-Á ê. Ø³É³Û³ÝÇ ³Ýí³Ý ³ÏÝ³μáõÅ³Ï³Ý Ï»ÝïñáÝáõÙ μ³ó»É ¿ Ýáñ³·áõÛÝ ë³ñù³íáñáõÙÝ»ñáí Ñ³·»ó³Í àõëáõóÙ³Ý ¨ ³ËïáñáßÙ³Ý Ï»ÝïñáÝÁ, áñï»Õ μÅÇßÏÝ»ñÁ ¨ áõë³ÝáÕÝ»ñÁ Í³ÝáÃ³ÝáõÙ »Ý ³ÏÝ³μáõÅáõÃÛ³Ý áÉáñïÇ í»ñçÇÝ ½³ñ·³óáõÙÝ»ñÇÝ ¨ Ýí³×áõÙÝ»ñÇÝ: ²Ûëï»Õ ·áñÍáõÙ ¿ μ³ñ»ñ³ñ Ð³ÛÏ ´³μÇÏÛ³ÝÇ ³Ýí³Ý ·ñ³¹³ñ³ÝÁ` ³ÏÝ³μáõÅáõÃÛ³Ý í»ñ³μ»ñÛ³É ·ñ³Ï³ÝáõÃÛ³Ý ³Ù»Ý³Ñ³ñáõëï Ñ³í³ù³ÍáõÝ»ñÇó Ù»ÏÁ Ð³Û³ëï³ÝáõÙ: ÜáõÛÝ Ãí³Ï³ÝÇÝ, §öý³Û½»ñ¦ ÁÝÏ»ñáõÃÛ³Ý ÝíÇñ³ïíáõÃÛ³Ý ßÝáñÑÇí, áõëáõÙÝ³Ï³Ý Ï»ÝïñáÝÁ Ñ³Ù³Éñ»É ¿ íÇñ³Ñ³ï³Ï³Ý ÑÙïáõÃÛáõÝÝ»ñÇ ½³ñ·³óÙ³Ý É³μáñ³ïáñÇ³Ý (Wet lab):

Ð³Ýñ³ÛÇÝ áõëáõóáõÙ

Ð³Ýñ³ÛÇÝ áõëáõóÙ³Ý μ³Õ³¹ñÇãÇ ÑÇÙÝ³Ï³Ý Ýå³ï³ÏÝ»ñÝ »Ý μÝ³ÏãáõÃÛ³ÝÝ Çñ³½»Ï»É ï»ëáÕáõÃÛ³Ý å³Ñå³ÝÙ³Ý ¨ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ Ï³ÝË³ñ·»ÉÙ³Ý ÙÇçáóÝ»ñÇ Ù³ëÇÝ, ÇÝãå»ë Ý³¨ ß»ßï³¹ñ»É ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñÇó û·ïí»Éáõ Ï³ñ¨áñáõÃÛáõÝÁ: Ð³Ýñ³ÛÇÝ áõëáõóáõÙÁ ÙÇïí³Í ¿ ï»Õ»Ï³ïíáõÃÛáõÝ ¨ ·Çï»ÉÇùÝ»ñ ïñ³Ù³¹ñ»Éáõ ÙÇçáóáí μÝ³ÏãáõÃÛ³Ý, Ù³ëÝ³íáñ³å»ë »ñ»Ë³Ý»ñÇ ßñç³ÝáõÙ ³éáÕç í³ñù³·ÇÍ Ó¨³íáñ»ÉáõÝ:

Ø»Í³Ñ³ë³ÏÝ»ñÇ áõ »ñ»Ë³Ý»ñÇ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ¨ ³ãùÇ ËÝ³ÙùÇ áõ ³Ýíï³Ý·áõÃÛ³Ý Ù³ëÇÝ Ñ³Ýñ³Ù³ïã»ÉÇ ï»Õ»Ï³ïíáõÃÛáõÝ ï³ñ³Í»Éáõ Ýå³ï³Ïáí Ð²Ü-Á ïå³·ñ»É ¿ 12 ³ÝáõÝ ï»Õ»Ï³ïáõ ·ñùáõÛÏ` 600 Ñ³½³ñ ûñÇÝ³Ïáí: Ð²Ü-Ç ³ßË³ï³ÝùÝ»ñÇ ÁÝÃ³óùáõÙ ¹ñ³Ýù ï³ñ³ÍíáõÙ »Ý Ð³Û³ëï³ÝÇ μáÉáñ Ù³ñ½»ñáõÙ ¨ ßñç³ÝÝ»ñáõÙ: Ð³Ýñ³ÛÇÝ Çñ³½»ÏÙ³Ý ³ßË³ï³ÝùÝ»ñÁ ï³ñíáõÙ »Ý Ýå³ï³Ï³ÛÇÝ ï³ñμ»ñ ËÙμ»ñáõÙ` Ï³½Ù³Ï»ñå»Éáí ³ãùÇ ËÝ³ÙùÇ ¨ ³Ýíï³Ý·áõÃÛ³Ý ùÝÝ³ñÏáõÙÝ»ñ ¹åñáó³Ï³ÝÝ»ñÇ, Ýñ³Ýó ÍÝáÕÝ»ñÇ, áõëáõóÇãÝ»ñÇ ¨ ¹åñáóÝ»ñÇ μáõÅ³ÝÓÝ³Ï³½ÙÇ Ñ³Ù³ñ: Îñïë»ñ ¹åñáóÇ »ñ»Ë³Ý»ñÇ Ñ³Ù³ñ Ã»Ù³ïÇÏ ¹³ë»ñ »Ý ³ÝóÏ³óí»É ÙÝç³Ë³ÕÇ ¨ ïÇÏÝÇÏ³ÛÇÝ Ý»ñÏ³Û³óáõÙÝ»ñÇ Ó¨áí: ØÇç³½·³ÛÇÝ ¨ ï»Õ³Ï³Ý ³ÛÉ Íñ³·ñ»ñÇ

15

Ñ³Ù³·áñÍ³ÏóáõÃÛ³Ùμ Ð²Ü-Á ³ÝóÏ³óÝáõÙ ¿ Ñ³Ý¹ÇåáõÙÝ»ñ Ý³¨ Ñ³Ù³ÛÝù³ÛÇÝ ³ÏïÇí ËÙμ»ñÇ ¨ μáõÅ³ßË³ïáÕÝ»ñÇ Ñ»ï, áñáÝù ëï³ó³Í ·Çï»ÉÇùÝ»ñÁ ÷áË³ÝóáõÙ »Ý μÝ³ÏãáõÃÛ³ÝÁ` ï»Õ»Ï³ïíáõÃÛáõÝÁ Ñ³ë³Ý»ÉÇ ¹³ñÓÝ»Éáí ³é³í»É Ù»Í Ãíáí Ù³ñ¹Ï³Ýó:

Î³ñáÕáõÃÛáõÝÝ»ñÇ ½³ñ·³óáõÙ

Ð²Ü-Á ¨ Ýñ³ ·áñÍÁÝÏ»ñÝ»ñÁ Ýå³ï³Ï áõÝ»Ý Ð³Û³ëï³ÝÝ ³ÏÝ³μáõÅáõÃÛ³Ý ³é³ç³ï³ñ Ï»ÝïñáÝ ¹³ñÓÝ»É áÕç ï³ñ³Í³ßñç³ÝáõÙ: §Î³ñáÕáõÃÛáõÝÝ»ñÇ ½³ñ·³óÙ³Ý¦ ³ÝÏÛáõÝ³ù³ñ»ñÝ »Ý ·Çï»ÉÇùÝ»ñÇ ÷áË³ÝóáõÙÁ ¨ Í³é³ÛáõÃÛáõÝÝ»ñÇ Ñ³Ù³Ï³ñ·³ÛÇÝ ÑÇÙÝáõÙÁ: 1992Ã. Ç í»ñ ³Ù»ñÇÏÛ³Ý Ù³ëÝ³·»ïÝ»ñÝ ³Ûó»ÉáõÙ »Ý Ð³Û³ëï³Ý` ÷áË³Ýó»Éáõ Ñ³Û ·áñÍÁÝÏ»ñÝ»ñÇÝ Çñ»Ýó ·Çï»ÉÇùÝ»ñÁ ¨ ÑÙïáõÃÛáõÝÝ»ñÁ ³ÏÝ³μáõÅáõÃÛ³Ý áÉáñïáõÙ: Æ ÉñáõÙÝ` 11 ÙÇç³½·³ÛÇÝ ³ÏÝ³μáõÅ³Ï³Ý Ñ³Ù³ÅáÕáíÝ»ñ »Ý Ï³½Ù³Ï»ñåí»É: Î³ñáÕáõÃÛáõÝÝ»ñÇ ½³ñ·³óÙ³ÝÝ ¿ ÙÇïí³Í Ø³É³Û³ÝÇ ³Ýí³Ý ³ÏÝ³μáõÅ³Ï³Ý ¨ ø³Ý³ù»é-¼»ÛÃáõÝ μÅßÏ³Ï³Ý Ï»ÝïñáÝÝ»ñáõÙ í»ó Ù³ëÝ³·Çï³óí³Í ÏÉÇÝÇÏ³Ý»ñÇ ëï»ÕÍáõÙÁ ¨ í»ñ³½ÇÝáõÙÁ: ¸ñ³Ýù »Ý` íÇïñ»á-é»ïÇÝ³É, ·É³áõÏáÙ³ÛÇ, »Õç»ñ³Ã³Õ³ÝÃÇ ¨ áõí»ÇïÇ, ÝÛ³ñ¹³-³ÏÝ³μáõÅáõÃÛ³Ý ¨ ûñμÇï³É íÇñ³Ñ³ïáõÃÛáõÝÝ»ñÇ, ³ãùÇ μ³ÝÏ ¨ ó³Íñ ï»ëáÕáõÃÛ³Ý ÏÉÇÝÇÏ³Ý»ñÁ: Ð²Ü-Ç ÏñÃ³Ï³Ý ÷áË³Ý³ÏÙ³Ý Íñ³·ñÇ ßÝáñÑÇí ²ØÜ-Ç ³ÏÝ³μáõÅ³Ï³Ý É³í³·áõÛÝ ÏÉÇÝÇÏ³Ý»ñáõÙ í»ñ³å³ïñ³ëïáõÙ ¿ ³Ýó»É Ñ³Û³ëï³ÝóÇ áõÃ ³ÏÝ³μáõÛÅ, áíù»ñ ³ÛÅÙ Õ»Ï³í³ñáõÙ »Ý í»ñáÑÇßÛ³É Ù³ëÝ³·Çï³Ï³Ý μ³Å³ÝÙáõÝùÝ»ñÁ ¨ ëï³óí³Í ÷áñÓÝ áõ ·Çï»ÉÇùÝ»ñÁ Ñ³Õáñ¹áõÙ Çñ»Ýó ·áñÍÁÝÏ»ñÝ»ñÇÝ ¨ áõë³ÝáÕÝ»ñÇÝ:

Ü»ñÏ³ÛáõÙë, áñå»ë ³é³ÝÓÇÝ áõÕÕáõÃÛáõÝ, Ð²Ü-Á ß³ñáõÝ³ÏáõÙ ¿ Ð³Û³ëï³ÝáõÙ Çñ ²ÝÑ³ëáõÃÛ³Ý é»ïÇÝáå³ÃÇ³ÛÇ (²è) ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñÇ ¨ μáõÅÙ³Ý Íñ³·ÇñÁ: ²ÛÝ Ù»ÏÝ³ñÏ»É ¿ 2010 Ã. ³Ùé³ÝÁ ²è Ï³ÝË³ñ·»ÉÙ³ÝÁ ¨ μáõÅÙ³ÝÁ ÝíÇñí³Í ÙÇç³½·³ÛÇÝ Ñ³Ù³ÅáÕáíÇ ¨ Ð²Ü-Ç Ñ³Ù³å³ï³ëË³Ý μÅßÏ³Ï³Ý ³é³ù»ÉáõÃÛ³Ý Ñ»ï ÙÇ³ëÇÝ: ÐÐ ³éáÕç³å³ÑáõÃÛ³Ý Ý³Ë³ñ³ñáõÃÛ³Ý Ñ³Ù³å³ï³ëË³Ý Ï³ñ·³¹ñáõÃÛ³Ùμª ³ÛëáõÑ»ï å³ñμ»ñ³Ï³Ý ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñ »Ý Çñ³Ï³Ý³óíáõÙ ºñ¨³ÝÇ` Ýáñ³ÍÇÝÝ»ñÇ í»ñ³Ï»Ý¹³Ý³óÙ³Ý ¨ ÇÝï»ÝëÇí Ã»ñ³åÇ³ÛÇ μáÉáñ μ³Å³ÝÙáõÝù»ñáõÙ: ²Ûë Íñ³·ñÇ ßÝáñÑÇí ï³ñ»Ï³Ý Ùáï 100 ³ÝÑ³ë Ýáñ³ÍÇÝ Ï÷ñÏíÇ ÏáõñáõÃÛáõÝÇó:

Þ³ñáõÝ³ÏíáõÙ ¿ Ý³¨ Ð²Ü-Ç ÏáÕÙÇó Ñ³Ù³Ï³ñ·íáÕ Ñ»é³μÅßÏáõÃÛ³Ý Íñ³·ÇñÁ: ²Ûë Ý³Ë³Ó»éÝáõÃ³Ý ßÝáñÑÇí Ñ³Û ¨ ³Ù»ñÇÏ³óÇ Ù³ëÝ³·»ïÝ»ñÁ Ùßï³Ï³Ý Ï³åÇ Ù»ç »Ý ¨ ËáñÑñ¹³ÏóáõÙ »Ý Ð³Û³ëï³ÝáõÙ Ñ³Ý¹ÇåáÕ ²è μáÉáñ ¹»åù»ñÇ ßáõñç:

20

3. 2003-2009 ÃÃ. ÐÐ ´Ü²ÎâàôÂÚ²ÜÀ Ð²Ü-Ç Ø²îàôò²Ì ²ÎÜ²´àôÄ²Î²Ü Ì²è²ÚàôÂÚàôÜÜºðÆ êºÔØ ÜÎ²ð²¶ÆðÀ

ÜÏ³ïÇ áõÝ»Ý³Éáí, áñ μÝ³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ É³ÛÝ³Í³í³É ½ÝÝáõÙÝ»ñÇ ¨ μáõÅû·ÝáõÃÛ³Ý μ³Õ³¹ñÇãÁ Ð²Ü-Ç §ÈáõÛë Ñ³ÛÇ ³ãù»ñÇÝ¦ Ý³Ë³Ó»éÝáõÃÛ³Ý ³é³í»É É³ÛÝ³ï³ñ³Í áõ Ù³ëë³Û³Ï³Ý μ³Õ³¹ñÇãÝ ¿, áñÇ Çñ³Ï³Ý³óáõÙÁ ÑÝ³ñ³íáñáõÃÛáõÝ ¿ ïí»É Ý³¨ Ï³ï³ñ»Éáõ í»ñÉáõÍáõÃÛáõÝÝ»ñ áõ ëï³Ý³Éáõ »ñÏñÇ μÝ³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ ³éáÕçáõÃÛáõÝÁ μÝáõÃ³·ñáÕ Ï³ñ¨áñ óáõó³ÝÇßÝ»ñ, ëïáñ¨ Ý»ñÏ³Û³óÝáõÙ »Ýù ³Û¹ μ³Õ³¹ñÇãÇ ßñç³Ý³ÏáõÙ Ð²Ü-Ç` 2003-2009 ÃÃ. Ð³Û³ëï³ÝÇ Ù³ñ½»ñáõÙ Ï³ï³ñ³Í »ñ»ù ßñç³Ûó»ñÇ ÁÝÃ³óùáõÙ Çñ³Ï³Ý³óñ³Í ³ßË³ï³ÝùÝ»ñÇ ë»ÕÙ ÝÏ³ñ³·ÇñÁ:

Ð²Ü-Ç í»ñçÝ³Ï³Ý Ýå³ï³ÏÁ ÏáõñáõÃÛ³Ý ¹»Ù å³Ûù³ñÁ ¨ Ð³Û³ëï³ÝÇ Ûáõñ³ù³ÝãÛáõñ μÝ³ÏãÇ Ñ³Ù³ñ Å³Ù³Ý³Ï³ÏÇó ³ÏÝ³μáõÅáõÃÛáõÝÁ Ñ³ë³Ý»ÉÇ áõ Ù³ïã»ÉÇ ¹³ñÓÝ»ÉÝ ¿: ²Û¹ Ýå³ï³ÏÇÝ Ñ³ëÝ»Éáõ Ñ³Ù³ñ Ð²Ü-Á, Ù³ëÝ³íáñ³å»ë, 2003 Ã, Ç í»ñ Çñ³Ï³Ý³óÝáõÙ ¿ §ÈáõÛë Ñ³ÛÇ ³ãù»ñÇÝ¦ Íñ³·ÇñÁ: ì»ñçÇÝë Ð³Û³ëï³ÝÇ ·ÛáõÕ³Ï³Ý áõ ù³Õ³ù³ÛÇÝ Ñ³Ù³ÛÝùÝ»ñÇ μÝ³ÏÇãÝ»ñÇ ßñç³ÝáõÙ ÁÝ¹Ñ³Ýáõñ ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñ, Ëáñ³óí³Í ³ÏÝ³ÛÇÝ Ñ»ï³½áïáõÃÛáõÝ, íÇñ³Ñ³ïáõÃÛáõÝ Ï³Ù É³½»ñ³ÛÇÝ μáõÅáõÙ ³ÝóÏ³óÝ»Éáõ ÙÇçáóáí Ýñ³Ýó Ñ³Ù³ñ Ñ³ë³Ý»ÉÇ ¿ ¹³ñÓÝáõÙ μ³ñÓñáñ³Ï ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñÁ:

§ÈáõÛë Ñ³ÛÇ ³ãù»ñÇÝ¦ Íñ³·ñÇ ßñç³Ý³ÏÝ»ñáõÙ 2003-2009 ÃÃ. Ð²Ü-Ç ÏáÕÙÇó ÐÐ Ù³ñ½»ñáõÙ Çñ³Ï³Ý³óí³Í ³ßË³ï³ÝùÝ»ñÇ ³Ù÷á÷ ÝÏ³ñ³·ÇñÁ, Ñ³ïÏ³å»ë Í³Ýñ³Ý³Éáí 2007-2009 ÃÃ. Ð²Ü-Ç Ï³ï³ñ³Í í»ñçÇÝ ßñç³ÛóÇ ³ñ¹ÛáõÝùÝ»ñÇ íñ³, μ»ñíáõÙ ¿ ëïáñ¨:

3.1. 2003-2009 ÃÃ. ºðºø Þðæ²ÚòºðÆ ÀÜÂ²òøàôØ Ð²Ü-Æ Ø²îàôò²Ì ²ÎÜ²´àôÄ²Î²Ü Ì²è²ÚàôÂÚàôÜÜºðÆ ²Øöàö ÜÎ²ð²¶ÆðÀ

´Ý³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñ Çñ³Ï³Ý³óÝ»Éáõ Ýå³ï³Ïáí 2003-2009 ÃÃ. ÁÝÃ³óùáõÙ Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÍÇ ³ÏÝ³μáõÛÅÝ»ñÝ áõ ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóÁ (²ÞÐ) »ñ»ù ßñç³Ûó »Ý Ï³ï³ñ»É ÐÐ 9 Ù³ñ½»ñáõÙ, ÁÝ¹·ñÏ»Éáí ¹ñ³Ýó ù³Õ³ù³ÛÇÝ áõ ·ÛáõÕ³Ï³Ý Ñ³Ù³ÛÝùÝ»ñÇ μÝ³ÏãáõÃÛ³Ý Ù»Í Ù³ëÁ1: âÝ³Û³Í áñáß ï³ñμ»ñáõÃÛáõÝÝ»ñÇÝ, μáÉáñ ßñç³Ûó»ñÇ Ï³½Ù³Ï»ñåã³Ï³Ý

1 ²Ûë μ³ÅÝáõÙ í»ñÉáõÍí»Éáõ »Ý ÙÇ³ÛÝ ÐÐ 9 Ù³ñ½»ñáõÙ (μ³óÇ ¶»Õ³ñùáõÝÇùÇó ¨ ºñ¨³Ý ù³Õ³ùÇó) 2003-2009 ÃÃ. Ð²Ü-Ç Ï³ï³ñ³Í ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñÇ ³ñ¹ÛáõÝùÝ»ñÁ:

21

·áñÍ»É³Ï»ñåÁ, μÅßÏ³Ï³Ý Ùáï»óáõÙÝ»ñÁ ¨ áõÕÕí³ÍáõÃÛáõÝÁ ÑÇÙÝ³Ï³ÝáõÙ ÝáõÛÝÝ »Ý:

²Û¹ ÁÝÃ³óùáõÙ Ð²Ü-Ç ³ÏÝ³μáõÛÅÝ»ñÇ ËÙμ»ñÁ ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ ³Ûó»É»É »Ý »ñÏñÇ 841 ·ÛáõÕ³Ï³Ý áõ ù³Õ³ù³ÛÇÝ Ñ³Ù³ÛÝùÝ»ñ (ÐÐ Ñ³Ù³ÛÝùÝ»ñÇ ßáõñç 90%-Á): Úáõñ³ù³ÝãÛáõñ Ù³ñ½áõÙ Ý³Ëù³Ý Ð²Ü-Ç ³ßË³ï³ÝùÝ»ñÁ ëÏë»ÉÁ ï»ÕÇ »Ý áõÝ»ó»É Ñ³Ý¹ÇåáõÙÝ»ñ Ù³ñ½Ç Õ»Ï³í³ñáõÃÛ³Ý Ñ»ï` Íñ³·ñÇ Çñ³Ï³Ý³óÙ³Ý ÑÇÙÝ³Ï³Ý ËÝ¹ÇñÝ»ñÁ Ñ³Ù³Ï³ñ·»Éáõ Ýå³ï³Ïáí: ´Ý³ÏãáõÃÛáõÝÁ É³ÛÝáñ»Ý ï»Õ»Ï³óí»É ¿ Ð²Ü-Ç ³Ýí×³ñ ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñÇ í»ñ³μ»ñÛ³É. Ñ³Ù³å³ï³ëË³Ý Ñ³Ûï³ñ³ñáõÃÛáõÝÝ»ñ »Ý ïåí»É ï»Õ³Ï³Ý Ã»ñÃ»ñáõÙ, Ñ»é³ñÓ³Ïí»É »Ý ï»Õ³Ï³Ý é³¹Çá- ¨ Ñ»éáõëï³Ï³Û³ÝÝ»ñáí, ÇÝãå»ë Ý³¨ ÷³Ïóí»É »Ý μáÉáñ Ñ³ë³ñ³Ï³Ï³Ý í³Ûñ»ñáõÙ (åáÉÇÏÉÇÝÇÏ³Ý»ñ, Ë³ÝáõÃÝ»ñ, ù³Õ³ù³å»ï³ñ³Ý, μ³ÝÏ»ñ, ¨ ³ÛÉÝ):

Ø³ñ½Ç μáõÅ³ßË³ïáÕÝ»ñÝ áõ ëáóÇ³É³Ï³Ý ³ßË³ïáÕÝ»ñÁ Ã»° ³ãùÇ ËÝ¹ÇñÝ»ñ áõÝ»óáÕ ÑÇí³Ý¹Ý»ñÇÝ, Ã»° ÁÝ¹Ñ³Ýáõñ μÝ³ÏãáõÃÛ³ÝÁ Ñáñ¹áñ»É »Ý ³Ûó»É»É Ð²Ü-Ç μÅÇßÏÝ»ñÇÝ: ²ÏÝ³μáõÅ³Ï³Ý ½ÝÝáõÙÝ»ñÝ Çñ³Ï³Ý³óÝáÕ μÅÇßÏÝ»ñÇ ËÙμ»ñÁ ï»Õ³Ï³Ûí»É »Ý ï»ÕÇ åáÉÇÏÉÇÝÇÏ³Ý»ñáõÙ, ³ÙμáõÉ³ïáñÇ³Ý»ñáõÙ ¨ ´ØÎ-Ý»ñáõÙ, ¨ μáÉáñ ó³ÝÏ³óáÕÝ»ñÝ ³Ýó»É »Ý ³Ýí×³ñ ³ÏÝ³μáõÅ³Ï³Ý ½ÝÝáõÙ: Ð²Ü-Ç ÏáÕÙÇó μÝ³ÏãáõÃÛ³ÝÁ ïñ³Ù³¹ñíáÕ Í³é³ÛáõÃÛáõÝÝ»ñÝ ³Ýí×³ñ »Ý μáÉáñÇ Ñ³Ù³ñ (Ý»ñ³éÛ³É ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñÁ, ³ÏÝáóÇ ¹áõñë·ñáõÙÝ áõ ÙÇç³ÙïáõÃÛáõÝÝ»ñÁ ²ÞÐ-áõÙ): ²ÏÝ³ÛÇÝ íÇñ³Ñ³ïáõÃÛáõÝÝ»ñ ³ñíáõÙ »Ý ÙÇ³ÛÝ μÝ³ÏãáõÃÛ³Ý ³Ù»Ý³³Õù³ï áõ Ëáó»ÉÇ Ë³í»ñÇÝ (Ý³Ë³å»ë ×ßï»Éáí ³Û¹ ÷³ëïÁ` ÐÐ ³ßË³ï³ÝùÇ áõ ëáóÇ³É³Ï³Ý Ñ³ñó»ñÇ Ý³Ë³ñ³ñáõÃÛ³Ý ïñ³Ù³¹ñ³Í ó³ÝÏ»ñÇ ÙÇçáóáí): ²Û¹ ËÙμ»ñÇÝ ãå³ïÏ³ÝáÕ ³ÝÓÇÝù, áñáÝù íÇñ³Ñ³ïáõÃÛ³Ý Ï³ñÇù áõÝ»Ý, áõÕ»·ñíáõÙ »Ý ³ÏÝ³μáõÅ³Ï³Ý ÏÉÇÝÇÏ³Ý»ñ:

²ãùÇ ½ÝÝáõÙÝ»ñÝ Çñ³Ï³Ý³óí»É »Ý ºñ¨³ÝÇ »ññáñ¹³ÛÇÝ ûÕ³ÏÇ ³ÏÝ³μáõÅ³Ï³Ý Ñ³ëï³ïáõÃÛáõÝÝ»ñÇ ³ÏÝ³μáõÛÅÝ»ñÇó, μáõÅùáõÛñ»ñÇó ¨ ÏÉÇÝÇÏ³Ï³Ý ûñ¹ÇÝ³ïáñÝ»ñÇó μ³ÕÏ³ó³Í ¨ Ñ³ïáõÏ ³Û¹ Ýå³ï³Ïáí í»ñ³å³ïñ³ëïí³Í ËÙμ»ñÇ ÏáÕÙÇó` û·ï³·áñÍ»Éáí ³ãùÇ ½ÝÝÙ³Ý ÙÇç³½·³ÛÝáñ»Ý ÁÝ¹áõÝí³Í ã³÷³ÝÇßÝ»ñÝ áõ ·áñÍÇùÝ»ñÁ: ¼ÝÝáõÙÁ Ý»ñ³é»É ¿ ÑÇí³Ý¹Ý»ñÇ ï»ëáÕáõÃÛ³Ý ëñáõÃÛ³Ý ëïáõ·áõÙÁ È³Ý¹áÉïÇ ¨ êÇíó¨-¶áÉáíÇÝÇ ³ÕÛáõë³ÏÝ»ñÇ û·ÝáõÃÛ³Ùμ: î»ëáÕáõÃÛ³Ý ó³Íñ ëñáõÃÛ³Ý ¹»åù»ñáõÙ, ¹ñ³ å³ï×³éÁ áñáß»Éáõ Ýå³ï³Ïáí, ½ÝÝáõÙÝ»ñÁ ß³ñáõÝ³ÏíáõÙ ¿ÇÝ ×»Õù³ÛÇÝ É³ÙåÇ ¨ ûýÃ³ÉÙáëÏáåÇ ÏÇñ³éÙ³Ùμ: â³÷í»É ¿ Ý»ñ³ÏÝ³ÛÇÝ ×ÝßáõÙÁ Ñ³Ù³å³ï³ëË³Ý ·áñÍÇùÇ` ïáÝáå»ÝÇ Ï³Ù Ø³ÏÉ³ÏáíÇ ÙÇçáóáí: ²ÝÑñ³Å»ßïáõÃÛ³Ý ¹»åùáõÙ ¹áõñë »Ý ·ñí»É ³ÏÝáóÝ»ñ:

22

²é³í»É μ³ñ¹ ¹»åù»ñáõÙ, »ñμ ÑÇí³Ý¹ÇÝ ³ÝÑñ³Å»ßï ¿ñ ³í»ÉÇ Ù³Ýñ³½ÝÝÇÝ Ñ»ï³½áïáõÙ Ï³Ù Ñ»ï³·³ μáõÅáõÙ (íÇñ³Ñ³ï³Ï³Ý Ï³Ù É³½»ñ³ÛÇÝ), Ý³ áõÕ»·ñíáõÙ ¿ñ ²ÞÐ` ³í»ÉÇ Ëáñ³óí³Í Ñ»ï³½áïáõÃÛáõÝÝ»ñÇ ¨ Ñ»ï³·³ μáõÅÙ³Ý ¨ áõÕ»·ñÙ³Ý Ýå³ï³Ïáí: ºñ»Ë³Ý»ñÝ ³Û¹åÇëÇ ¹»åù»ñáõÙ áõÕ»·ñíáõÙ ¿ÇÝ ºñ¨³ÝÇ ³ÏÝ³μáõÅ³Ï³Ý ÏÉÇÝÇÏ³Ý»ñ: ²ÛÝ ÑÇí³Ý¹Ý»ñÁ, áñáÝù ÙÇ³ÛÝ ß³ñáõÝ³Ï³Ï³Ý μáõÅáõÙ Ï³Ù ËÝ³ÙùÇ Ï³ñÇù áõÝ»ÇÝ, áõÕ»·ñíáõÙ ¿ÇÝ ï»ÕÇ ³ÏÝ³μáõÛÅÇ Ùáï:

²Ûë É³ÛÝ³Í³í³É ³ßË³ï³ÝùÝ»ñÇ ³ñ¹ÛáõÝùáõÙ 2003-2009 ÃÃ. ÁÝÃ³óùáõÙ Ð³Û³ëï³ÝáõÙ ³Ýí×³ñ ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñ ëï³Ý³Éáõ Ýå³ï³Ïáí Íñ³·ñÇÝ ¹ÇÙ»É ¨ ³ÏÝ³μáõÅ³Ï³Ý ½ÝÝáõÙ ¿ ³Ýó»É »ñÏñÇ 156,688 μÝ³ÏÇã (»ñÏñÇ μÝ³ÏãáõÃÛ³Ý ßáõñç 5%-Á), áñáÝó Ù»Í Ù³ëÁ` 61%-Á, Ù»Í³Ñ³ë³Ï μÝ³ÏãáõÃÛáõÝ ¿ (16 ¨ ³í»ÉÇ ï³ñ»Ï³Ý), ÇëÏ 39%-Á` »ñ»Ë³ (ÙÇÝã¨ 16 ï³ñ»Ï³Ý): ÀÝ¹ áñáõÙ, Ï³Ý³Ûù Ñ³Ýñ³å»ïáõÃÛáõÝáõÙ ½ÝÝí³Í μÝ³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ·»ñ³ÏßéáõÙ »Ý. Ýñ³Ýù Ï³½ÙáõÙ »Ý Ñ»ï³½áïí³ÍÝ»ñÇ ßáõñç 57%-Á:

ºñ»Ë³Ý»ñÇ ßñç³ÝáõÙ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ Ñ³ÛïÝ³μ»ñáõÙÝ áõ Å³Ù³Ý³ÏÇÝ Ï³ÝË³ñ·»ÉáõÙÁ Ù»Í³å»ë Ýå³ëïáõÙ ¿ μÝ³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ÏáõñáõÃÛ³Ý áõ ÃáõÛÉ ï»ëáÕáõÃÛ³Ý Ï³ÝË³ñ·»ÉÙ³ÝÁ, ³Û¹ ÇëÏ å³ï×³éáí Ð²Ü-Á Çñ »ñÏñáñ¹ ßñç³ÛóÇ Å³Ù³Ý³Ï ³í»ÉÇ Ù»Í áõß³¹ñáõÃÛáõÝ ¿ ¹³ñÓñ»É ¹åñáóÝ»ñáõÙ Ï³ï³ñíáÕ ³ÏÝ³ÛÇÝ Ñ»ï³½áïáõÃÛáõÝÝ»ñÇÝ: Æñ »ñÏñáñ¹ ßñç³ÛóÇ ÁÝÃ³óùáõÙ ÐÐ-áõÙ Ð²Ü-Ç ÏáÕÙÇó ½ÝÝí³Í μÝ³ÏãáõÃÛ³Ý Ï»ëÇó ³í»ÉÇÝ` 55%-Á ÑÇÙÝ³Ï³ÝáõÙ ·ÛáõÕ³Ï³Ý 245 Ñ³Ù³ÛÝùÝ»ñÇ 320 ¹åñáóÝ»ñÇ ³ß³Ï»ñïÝ»ñÝ »Ý »Õ»É: ÐÇÙÝ³Ï³ÝáõÙ ¹ñ³Ýáí ¿ å³ÛÙ³Ý³íáñí³Í Ð²Ü-Ç ÏáÕÙÇó Ñ»ï³½áïí³Í μÝ³ÏãáõÃÛ³Ý ßñç³ÝáõÙ »ñ»Ë³Ý»ñÇ μ³ñÓñ Ý»ñÏ³Û³óí³ÍáõÃÛáõÝÁ (39%)` »ñÏñÇ μÝ³ÏãáõÃÛ³Ý ÅáÕáíñ¹³·ñ³Ï³Ý Ï³éáõóí³ÍùÇ Ñ³Ù»Ù³ï (ßáõñç 24%):

Ð³ßíÇ ³éÝ»Éáí ·ÛáõÕ³Ï³Ý Ñ³Ù³ÛÝùÝ»ñÇ μÝ³ÏãáõÃÛ³Ý Ñ³Ù³ñ ³ÏÝ³μáõÅ³Ï³Ý ³é³çÝ³ÛÇÝ áõ »ñÏñáñ¹³ÛÇÝ Í³é³ÛáõÃÛáõÝÝ»ñÇ ³é³í»É ¹Åí³ñ³Ù³ïã»ÉÇáõÃÛáõÝÁ` Ð²Ü-Ç ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñÁ Ù»Í³å»ë áõÕÕí³Í »Ý »Õ»É ¹»åÇ ·ÛáõÕ³Ï³Ý μÝ³ÏãáõÃÛáõÝÁ. Ñ»ï³½áïí³ÍÝ»ñÇ ßáõñç 58%-Á ·ÛáõÕ³Ï³Ý μÝ³ÏãáõÃÛáõÝ ¿:

êáóÇ³É³å»ë ³Ý³å³Ñáí áõ Ëáó»ÉÇ ¨ ¹ñ³ Ï³ñÇùÝ áõÝ»óáÕ ½ÝÝí³Í μÝ³ÏãáõÃÛ³Ý Ñ³Ù³ñ Ð²Ü-Á å³ïñ³ëï»É áõ ³Ýí×³ñ ïñ³Ù³¹ñ»É ¿ ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ 29,546 ³ÏÝáó:

23

¼ÝÝáõÙÝ»ñ ³Ýó³Í μÝ³ÏãáõÃÛ³Ý Ù³ñ½³ÛÇÝ μ³ßËáõÙÁ íÏ³ÛáõÙ ¿, áñ ¹ñ³ ÁÝ¹Ñ³Ýáõñ ÃíáõÙ ³é³í»É Ù»Í Ý»ñÏ³Û³óí³ÍáõÃÛáõÝ áõÝ»Ý ²ñ³ñ³ïÇ, ²ñÙ³íÇñÇ, Îáï³ÛùÇ áõ Èáéáõ Ù³ñ½»ñÇ μÝ³ÏÇãÝ»ñÁ:

Ð²Ü-Ç ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóáõÙ (²ÞÐ) 2003-2009 ÃÃ. ÁÝÃ³óùáõÙ Ëáñ³óí³Í ³ÏÝ³ÛÇÝ Ñ»ï³½áïáõÃÛáõÝÝ»ñ ¿ ³Ýó»É ¹ñ³ Ï³ñÇùÝ áõÝ»óáÕ 16,518 μÝ³ÏÇã (½ÝÝí³Í Ù»Í³Ñ³ë³ÏÝ»ñÇ 17.3%-Á), áñáÝóÇó 7,939-Á (½ÝÝí³Í Ù»Í³Ñ³ë³ÏÝ»ñÇ 8.3%-Á) ³ÛÝáõÑ»ï¨ ²ÞÐ-áõÙ íÇñ³Ñ³ïí»É áõ É³½»ñ³ÛÇÝ μáõÅáõÙ »Ý ëï³ó»É:

24

ÀÝ¹Ñ³Ýáõñ ³éÙ³Ùμ 2003-2009 ÃÃ. ²ÞÐ-áõÙ ³ÝóÏ³óí»É ¿ 8,394 íÇñ³Ñ³ïáõÃÛáõÝ áõ É³½»ñ³ÛÇÝ ÙÇç³ÙïáõÃÛáõÝ, áñáÝó Ù»Í Ù³ëÁ (ßáõñç 70%-Á) Ï³ï³ñ³ÏïÇ ï³ñμ»ñ íÇñ³Ñ³ïáõÃÛáõÝÝ»ñÝ »Ý »Õ»É:

ÐÐ Ûáõñ³ù³ÝãÛáõñ Ù³ñ½áõÙ Ð²Ü-Ç Ù³ïáõó³Í ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñÇ ÝÏ³ñ³·ÇñÁ μ»ñí³Í ¿ μ³ÅÇÝ 5-áõÙ:

25

3.2. 2007-2009 ÃÃ. Ð²Ü-Ç ºððàð¸ Þðæ²ÚòÆ ÀÜÂ²òøàôØ Æð²Î²Ü²òì²Ì ²ÞÊ²î²ÜøÜºðÆ êºÔØ ÜÎ²ð²¶ÆðÀ

Ð²Ü-Ç ³ÏÝ³μáõÛÅÝ»ñÝ áõ ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóÁ 2007-2009 ÃÃ. ÁÝÃ³óùáõÙ »ññáñ¹ ßñç³ÛóÝ »Ý Ï³ï³ñ»É ÐÐ 9 Ù³ñ½»ñáõÙ (μ³ó³éáõÃÛ³Ùμ ºñ¨³ÝÇ, áñï»Õ ½ÝÝáõÙÝ»ñÁ Ï»ÝïñáÝ³óí³Í »Ý »Õ»É μÝ³ÏãáõÃÛ³Ý ³é³ÝÓÇÝ, Ñ³ïáõÏ ËÙμ»ñÇ ßñç³ÝáõÙ áõ ¹åñáóÝ»ñáõÙ, áõ ¶»Õ³ñùáõÝÇùÇ Ù³ñ½Ç)1:

ºññáñ¹ ßñç³ÛóÇ ÁÝÃ³óùáõÙ Ð²Ü-Ç ³ÏÝ³μáõÛÅÝ»ñÝ ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñ »Ý ³ÝóÏ³óñ»É Ð³Û³ëï³ÝÇ 490 Ñ³Ù³ÛÝùÝ»ñáõÙ Ï³Ù »ñÏñÇ Ñ³Ù³ÛÝùÝ»ñÇ ßáõñç 54%-áõÙ:

¼ÝÝáõÙÝ»ñÇ Ý»ñÏ³Û³ó»É »Ý »ñÏñÇ 615 ï³ñμ»ñ Ñ³Ù³ÛÝùÝ»ñÇ μÝ³ÏÇãÝ»ñ` ÑÇÙÝ³Ï³ÝáõÙ ·ÛáõÕ³Ï³Ý μÝ³Ï³í³Ûñ»ñÇó: ÀÝ¹Ñ³Ýáõñ ³éÙ³Ùμ, ½ÝÝí³ÍÝ»ñÇ ·»ñ³ÏßÇé Ù³ëÁ` 68%-Á, ·ÛáõÕ³Ï³Ý μÝ³ÏãáõÃÛáõÝÝ ¿, áñáÝó Ñ³Ù³ñ ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñÝ ³í»ÉÇ ¹Åí³ñ³Ù³ïã»ÉÇ »Ý:

Ð²Ü-Ç ÏáÕÙÇó ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñÇ ¿ »ÝÃ³ñÏí»É Ð³Û³ëï³ÝÇ 26,711 μÝ³ÏÇã (Ï³Ù »ñÏñÇ μÝ³ÏãáõÃÛ³Ý ßáõñç 0.9%-Á), áñáÝóÇó 16,837-Á Ï³Ù 63%-Á` Ï³Ý³Ûù, ÇëÏ 1,195-Á` »ñ»Ë³ (ÙÇÝã¨ 16 ï³ñ»Ï³Ý): Ð²Ü-Ç ÏáÕÙÇó ½ÝÝí³ÍÝ»ñÇ Ï»ëÇó ³í»ÉÇÝ` 52%-Á ëáóÇ³É³å»ë ³Ý³å³Ñáí ¨ ³é³ÝÓÇÝ (Ñ³ïáõÏ) Ëáó»ÉÇ ËÙμ»ñÇÝ å³ïÏ³ÝáÕ ³ÝÓÇÝù »Ý »Õ»É:

1 ՀԱՆ-ը իր աշխատանքները սահմանափակել է Գեղարքունիքի մարզում, քանի որ այնտեղ գործում է Հայաստանի ամերիկյան համալսարանի Կարո Մեղրիկյանի աչքի հիվանդությունների կանխարգելման կենտրոնի և “Արարատ-1 Լայոնս Քլաբ ինտերնեյշնլ” բարեգործական հասարական կազմակերպության և ՀՀ առողջապահության նախարարության համատեղ ջանքերով ստեղծված Սևանի ակնաբուժական կենտրոնը:

26

Ð²Ü-Ç ÏáÕÙÇó ³ÏÝ³ÛÇÝ ½ÝÝáõÙ ³Ýó³ÍÝ»ñÇ Ù»Í Ù³ëÁ (72.3%) í»ñ³ñï³¹ñáÕ³Ï³Ý ï³ñÇùÇó μ³ñÓñ ï³ñÇùÇ μÝ³ÏãáõÃÛáõÝÝ ¿` 49-Çó μ³ñÓñ ï³ñÇù áõÝ»óáÕÝ»ñÁ: 70 ¨ ³í»ÉÇ ï³ñ»Ï³ÝÝ»ñÁ Ï³½ÙáõÙ »Ý ½ÝÝí³Í μÝ³ÏãáõÃÛ³Ý Ù»Ï »ññáñ¹Çó ùÇã ³í»ÉÇÝ` 31%-Á: ¼ÝÝí³Í μÝ³ÏãáõÃÛ³Ý ï³ñÇù³ÛÇÝ μ³ßËáõÙÁ μ»ñí³Í ¿ ·Í³å³ïÏ»ñ 2-áõÙ:

²ÞÐ-Ý ÁÝ¹áõÝ»É, Ëáñ³óí³Í Ñ»ï³½áïÙ³Ý ¿ »ÝÃ³ñÏ»É ¨ ³Ëïáñáß»É ¹ñ³ Ï³ñÇùÝ áõÝ»óáÕ 3,943 ½ÝÝí³ÍÝ»ñÇ (½ÝÝí³Í Ù»Í³Ñ³ë³ÏÝ»ñÇ 15.5%-Á)` ³ßË³ï»Éáí ÑÇÙÝ³Ï³ÝáõÙ ÐÐ ÷áùñ áõ ÙÇçÇÝ ù³Õ³ùÝ»ñáõÙ ¨ ÁÝ¹áõÝ»Éáí Ý³¨ Ñ³ñ³ÏÇó ·ÛáõÕ»ñÇ μÝ³ÏãáõÃÛ³ÝÁ: ²Û¹ μÝ³ÏãáõÃÛ³Ý ßáõñç Ï»ëÁ` 48%-Á (Ï³Ù ½ÝÝí³Í Ù»Í³Ñ³ë³ÏÝ»ñÇ 7.4%-Á)` 1,893 Ù³ñ¹, ²ÞÐ-áõÙ íÇñ³Ñ³ïí»É Ï³Ù É³½»ñ³ÛÇÝ ÙÇç³ÙïáõÃÛ³Ý ¿ »ÝÃ³ñÏí»É:

Ð²Ü-Á ³ÏÝáó ¿ å³ïñ³ëï»É áõ ïñ³Ù³¹ñ»É ¹ñ³Ýó Ï³ñÇùÝ áõÝ»óáÕ ëáóÇ³É³å»ë ³Ý³å³Ñáí 9,793 Ù³ñ¹áõ Ñ³Ù³ñ:

27

4. Ð²Ü-Ç îìÚ²ÈÜºðÆ ÞîºØ²ð²ÜÆ ìºðÈàôÌàôÂÚ²Ü ²ð¸ÚàôÜøÜºðÆ ²ØöàöàôØÀ

´Ý³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ÁÝ¹Ñ³Ýáõñ ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñ Çñ³Ï³Ý³óÝ»ÉáõÝ ½áõ·ÁÝÃ³ó, 2003 Ã. Ç í»ñ Ð²Ü-Á Ñ³í³ù»É ¨ í»ñÉáõÍ»É ¿ Íñ³·ñÇ ßñç³Ý³ÏÝ»ñáõÙ ³ÏÝ³μáõÅ³Ï³Ý ½ÝÝáõÙ ³Ýó³Í ßáõñç 160 Ñ³½³ñ ß³Ñ³éáõÝ»ñÇ ïíÛ³ÉÝ»ñÁ ¨ ëï»ÕÍ»É ¿ ïíÛ³ÉÝ»ñÇ ßï»Ù³ñ³Ý, áñÇ í»ñÉáõÍáõÃÛ³Ý ÑÇÙ³Ý íñ³ ëï³óí»É »Ý Ð³Û³ëï³ÝáõÙ μÝ³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ ³éáÕçáõÃÛáõÝÝ áõ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ï³ñ³Íí³ÍáõÃÛáõÝÁ μÝáõÃ³·ñáÕ ÑÇÙÝ³Ï³Ý ÙÇç³½·³ÛÝáñ»Ý ÁÝ¹áõÝí³Í óáõó³ÝÇßÝ»ñÝ áõ ¹ñ³Ýó Ñ³Ù»Ù³ï³Ï³Ý å³ïÏ»ñÁ` »ñÏñÇ ¨ Ýñ³ Ù³ñ½»ñÇ Ïïñí³Íùáí:

êïáñ¨ Ý»ñÏ³Û³óÝáõÙ »Ýù ÐÐ μÝ³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ ³éáÕçáõÃÛ³Ý áõ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ï³ñ³Íí³ÍáõÃÛ³Ý ·Çï³Ï³Ý ·Ý³Ñ³ï³Ï³ÝÝ»ñ, áñáÝù áñáßáõÙ ÁÝ¹áõÝáÕÝ»ñÇÝ ÑÝ³ñ³íáñáõÃÛáõÝ Ïï³Ý ·Ý³Ñ³ï»Éáõ ÇÝãå»ë μÝ³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ ³éáÕçáõÃÛ³Ý íÇ×³ÏÁ, ³ÛÝå»ë ¿É ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñÇ å³Ñ³Ýç³ñÏÁ »ñÏñáõÙ: Üßí³Í ·Ý³Ñ³ï³Ï³ÝÝ»ñÁ ÑÇÙÝí³Í »Ý 2007-2009 ÃÃ. ÁÝÃ³óùáõÙ ÐÐ 9 Ù³ñ½»ñáõÙ Ð²Ü-Ç Ï³ï³ñ³Í »ññáñ¹ ßñç³ÛóÇ ïíÛ³ÉÝ»ñÇ í»ñÉáõÍáõÃÛ³Ý íñ³1 , ù³ÝÇ áñ ³ÛÝ å³ñáõÝ³Ï»É ¿ ³é³í»É Ã³ñÙ, Ñ³í³ëïÇ áõ É³ÛÝ ï»Õ»Ï³ïíáõÃÛáõÝ` ½ÝÝí³Í μÝ³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ ³éáÕçáõÃÛ³Ý í»ñ³μ»ñÛ³É: ´³óÇ ³Û¹, áñáß ÑÇÙÝ³Ï³Ý ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ·Íáí ÏÝ»ñÏ³Û³óí»Ý Ý³¨ Ð²Ü-Ç »ñ»ù ßñç³Ûó»ñÇ ¹ÇÝ³ÙÇÏ³ÛÇ í»ñÉáõÍáõÃÛáõÝÝ»ñ:

4.1. Ð²Ü-Ç ÎàÔØÆò ¼ÜÜì²Ì ´Ü²ÎâàôÂÚ²Ü ²ÎÜ²ÚÆÜ ²èàÔæàôÂÚ²Ü Ø²êÆÜ îìÚ²ÈÜºðÆ Ð²ì²ø²¶ðØ²Ü àô ØÞ²ÎØ²Ü ØºÂà¸²´²ÜàôÂÚàôÜÀ

Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÍÇ ³ÝóÏ³óñ³Í ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñÇÝ ½áõ·³Ñ»é Ñ³í³ùí»É »Ý ½ÝÝí³ÍÝ»ñÇ Ù³ëÇÝ áñáß³ÏÇ ïíÛ³ÉÝ»ñ: ²ÏÝ³ÛÇÝ Ñ»ï³½áïáõÃÛáõÝÝ»ñÇ Ñ³Ù³ñ ¹ÇÙ³Í Ûáõñ³ù³ÝãÛáõñ ³ÝÓÇ Ñ³Ù³ñ Éñ³óí»É ¿ Ñ³ñó³Ã»ñÃ, áñÁ Ý»ñ³éáõÙ ¿ Ýñ³ ³éáÕç³Ï³Ý ÁÝ¹Ñ³Ýáõñ íÇ×³ÏÇ (Ù³ëÝ³íáñ³å»ë áõß³¹ñáõÃÛáõÝ ¹³ñÓÝ»Éáí ³ÛÝ μÅßÏ³Ï³Ý ËÝ¹ÇñÝ»ñÇÝ, áñáÝù ³½¹áõÙ »Ý ï»ëáÕáõÃÛ³Ý íñ³,

1 ´³ó³éáõÃÛ³Ùμ ºñ¨³ÝÇ, áñï»Õ Ð²Ü-Á ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñ ¿ Ï³ï³ñ»É ÙÇ³ÛÝ ¹åñáóÝ»ñáõÙ ¨ ëáóÇ³É³Ï³Ý Ñ³ëï³ïáõÃÛáõÝÝ»ñáõÙ (Ù³ÝÏ³ïÝ»ñ, Í»ñ»ñÇ ïáõÝ ÇÝï»ñÝ³ïÝ»ñ, μ³ñ»·áñÍ³Ï³Ý ×³ß³ñ³ÝÝ»ñ, ³½³ï³½ñÏÙ³Ý í³Ûñ»ñ ¨ ³ÛÉÝ) áõ ¶»Õ³ñùáõÝÇùÇ Ù³ñ½Ç, áñï»Õ Ð²Ü-Ç ½ÝÝáõÙÝ»ñÁ ÷áùñ ï³ñ³ÍáõÙ »Ý áõÝ»ó»É, ù³ÝÇ áñ Ù³ñ½áõÙ ³ÏÝ³ÛÇÝ Í³é³ÛáõÃÛáõÝÝ»ñÝ ³é³í»É Ù³ïã»ÉÇ »Ý:

28

ÇÝãå»ë, ûñÇÝ³Ï` ß³ù³ñ³ÛÇÝ ¹Ç³μ»ïÁ, μ³ñÓñ ×ÝßáõÙÁ ¨ μáñμáù³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÁ), ³éáÕç³å³Ñ³Ï³Ý áõ ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñÇÝ ¹ÇÙ»Éáõ Ñ³×³Ë³Ï³ÝáõÃÛ³Ý, ÇÝãå»ë Ý³¨ ³éáÕç ³åñ»É³Ï»ñåÇ å³ïÏ»ñ³óáõÙÝ»ñÇ í»ñ³μ»ñÛ³É Ñ³ñó»ñ: Ð²Ü-Ç μÅßÏ³Ï³Ý ³ÝÓÝ³Ï³½ÙÁ Ñ³ñó³Ã»ñÃÇ í»ñçÝ³Ù³ëáõÙ ½»ï»Õ»É ¿ ïíÛ³É ³ÝÓÇ ³ÏÝ³ÛÇÝ ½ÝÝÙ³Ý áõ ³ËïáñáßÙ³Ý, ÇÝãå»ë Ý³¨ μÅßÏ³Ï³Ý ÙÇç³ÙïáõÃÛ³Ý μÝáõÃ³·ÇñÝ áõ ³ñ¹ÛáõÝùÝ»ñÁ: Èñ³óí³Í Ñ³ñó³Ã»ñÃ»ñÁ Ùáõïù³·ñí»É »Ý, áñÇ ³ñ¹ÛáõÝùáõÙ ëï»ÕÍí»É ¿ Ð²Ü-Ç ½ÝÝáõÙÝ»ñÝ ³Ýó³Í μÝ³ÏãáõÃÛ³Ý ïíÛ³ÉÝ»ñÇ ßï»Ù³ñ³Ý, áñÝ ³ÛÝáõÑ»ï¨ íÇ×³Ï³·ñ³Ï³Ý í»ñÉáõÍáõÃÛ³Ý ¿ »ÝÃ³ñÏí»É (h³ñó³Ã»ñÃÇ 2007-2009 ¨ 2010 ÃÃ. ßñç³Ûó»ñÇ ÁÝÃ³óùáõÙ û·ï³·áñÍí³Í ï³ñμ»ñ³ÏÁ ½»ï»Õí³Í ¿ Ð³í»Éí³Í 1-áõÙ):

¶Ý³Ñ³ïÙ³Ý ¨ ÙáÝÇÃáñÇÝ·Ç Ñ»ï¨áÕ³Ï³Ý ³ßË³ï³ÝùÁ, ÇÝãå»ë Ý³¨ Ùßï³Ï³Ý Ñ»ï³¹³ñÓ Ï³åÁ Ð²Ü-Ç μÅßÏ³Ï³Ý ËÙμ»ñÇ ¨ ²ÞÐ-Ç ³ÝÓÝ³Ï³½ÙÇ Ñ»ï ÑÝ³ñ³íáñáõÃÛáõÝ »Ý ïí»É ßñç³Ûó»ñÇ Ï³½Ù³Ï»ñåã³Ï³Ý ·áñÍ»É³Ï»ñåÇ, μÅßÏ³Ï³Ý Ùáï»óáõÙÝ»ñÇ ¨ μáí³Ý¹³Ï³ÛÇÝ μ³ñ»É³íÙ³Ý ï»ë³ÝÏÛáõÝÇó ³í»ÉÇ ³ñ¹ÛáõÝ³í»ï ¹³ñÓÝ»Éáõ Ð²Ü-Ç ³ÙμáÕç ·áñÍáõÝ»áõÃÛáõÝÁ ÐÐ-Ç Ù³ñ½»ñáõÙ: Ð²Ü-Ç ÏáÕÙÇó ëï»ÕÍí»É ¨ ·áñÍÇ »Ý ¹ñí»É ëùñÇÝÇÝ·Ç Ù»Ãá¹³μ³ÝáõÃÛáõÝÁ, Ñ³ñó³Ã»ñÃ»ñÁ, μ³½Ù³ÃÇí áõÕ»óáõÛó»ñ, Çñ³Ï³Ý³óÙ³Ý Ï³ñ·»ñ, Ñ³ßí»ïíáõÃÛ³Ý Ã»ñÃÇÏÝ»ñ ¨ ³ÛÉÝ: ¸ñ³Ýù ¨ Ù³ëÝ³íáñ³å»ë Ð²Ü-Ç Ñ³ñó³Ã»ñÃÇ Ýáñ³óí³Í ï³ñμ»ñ³ÏÁ ÑÝ³ñ³íáñáõÃÛáõÝ »Ý ïí»É Ð²Ü-Ç »ññáñ¹ ÷áõÉáõÙ ëï³Ý³Éáõ ³í»ÉÇ Ù³Ýñ³Ù³ëÝ ï»Õ»ÏáõÃÛáõÝÝ»ñ ÐÐ-áõÙ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ í»ñ³μ»ñÛ³É` ÙÇ³Å³Ù³Ý³Ï å³Ñå³Ý»Éáí Ý³Ëáñ¹ ßñç³Ûó»ñÇ ïíÛ³ÉÝ»ñÇ Ñ»ï Ñ³Ù»Ù³ïáõÃÛ³Ý ÑÝ³ñ³íáñáõÃÛáõÝÁ: àõëïÇ ïíÛ³ÉÝ»ñÇ í»ñÉáõÍáõÃÛáõÝÁ ÑÇí³Ý¹³óáõÃÛ³Ý ï»ë³ÝÏÛáõÝÇó Ý»ñÏ³Û³óíáõÙ ¿ ³é³í»É³å»ë »ññáñ¹ ÷áõÉÇ ûñÇÝ³Ïáí:

Ð³ñÏ ¿ Ýß»É, áñ Ð²Ü-Ç ïíÛ³ÉÝ»ñÇ ßï»Ù³ñ³ÝÁ ÁÝïñ³Ýù³ÛÇÝ Ñ»ï³½áïáõÃÛ³Ý ³ñ¹ÛáõÝù ã¿, ù³ÝÇ áñ μÝ³ÏãáõÃÛ³Ý Ù³ëÝ³ÏóáõÃÛáõÝÁ Ï³ï³ñíáÕ Ñ»ï³½áïáõÃÛáõÝÝ»ñÇÝ Ï³Ù³íáñ μÝáõÛÃ ¿ áõÝ»ó»É, ½ÝÝáõÙÝ»ñÝ Çñ³Ï³Ý³óÝáÕ ËÙμ»ñÝ ÁÝ¹áõÝ»É »Ý μáÉáñ ³ÛÝ Ù³ñ¹Ï³Ýó, áíù»ñ ¹ÇÙ»É »Ý Ð²Ü-ÇÝ: ²Û¹ ÇëÏ å³ï×³éáí, ½ÝÝí³Í μÝ³ÏãáõÃÛ³Ý ë»é³-ï³ñÇù³ÛÇÝ, ÇÝãå»ë Ý³¨ ï³ñ³Íù³ÛÇÝ (ù³Õ³ù-·ÛáõÕ ¨ Ù³ñ½»ñ) Ñ³Ù³Ù³ëÝáõÃÛáõÝÝ»ñÁ ã»Ý Ñ³Ù³å³ï³ëË³Ý»É »ñÏñÇ ÅáÕáíñ¹³·ñ³Ï³Ý áõ ï³ñ³Íù³ÛÇÝ μÝáõÃ³·ñÇãÝ»ñÇÝ: ²Ûë Ñ³Ý·³Ù³ÝùÁ Ñ³ßíÇ ³éÝ»Éáí` ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ï³ñ³Íí³ÍáõÃÛ³Ý ·Ý³Ñ³ï³Ï³ÝÝ»ñÁ ëï³Ý³Éáõ Ñ³Ù³ñ ïíÛ³ÉÝ»ñÁ Ïßéí»É »Ý` Ýßí³Í Ñ³Ù³Ù³ëÝáõÃÛáõÝÝ»ñÁ ßïÏ»Éáõ ¨ »ñÏñÇ ÅáÕáíñ¹³·ñ³Ï³Ý áõ Ù³ñ½³ÛÇÝ μÝáõÃ³·ñÇãÝ»ñÇÝ Ñ³Ù³å³ï³ëË³Ý»óÝ»Éáõ Ýå³ï³Ïáí ¨ ï³ñ³Íí»É »Ý:

29

²Ûë Ñ»ï³½áïáõÃÛ³Ý ßñç³Ý³ÏÝ»ñáõÙ ³ÏÝ³ÛÇÝ ³éáÕçáõÃÛ³Ý ·Ý³Ñ³ï³Ï³ÝÝ»ñÝ áõ óáõó³ÝÇßÝ»ñÁ Ñ³ßí³ñÏí»É »Ý ÑÇÙÝ³Ï³ÝáõÙ Ù»Í³Ñ³ë³Ï (16 ¨ ³í»ÉÇ ï³ñ»Ï³Ý) ¨ Ù³ëÝ³íáñ³å»ë 50-Çó μ³ñÓñ ï³ñÇùÇ μÝ³ÏãáõÃÛ³Ý Ñ³Ù³ñ` Ñ³ßíÇ ³éÝ»Éáí í»ñçÇÝÝ»ñÇë ³é³í»É μ³ñÓñ éÇëÏ³ÛÇÝ ·áñÍáÝÁ ÑÝ³ñ³íáñ ÏáõñáõÃÛ³Ý ³éáõÙáí:

´³óÇ ³Û¹, ßï»Ù³ñ³ÝÁ å³ñáõÝ³ÏáõÙ ¿ ¹ÇÝ³ÙÇÏ ß³ñù»ñ, áñáÝù Ñ³Ù³å³ï³ëË³ÝáõÙ »Ý »ñÏáõ ï³ñí³ ÁÝÃ³óùáõÙ ÐÐ 9 Ù³ñ½»ñáõÙ Ð²Ü-Ç Çñ³Ï³Ý³óñ³Í »ñ»ù ßñç³Ûó»ñÇÝ` 2003-2005, 2005-2007 ¨ 2007-2009 Ãí³Ï³ÝÝ»ñÇÝ: àõëïÇ, ëï³óí³Í ³ñ¹ÛáõÝùÝ»ñÇ Ñ³Ù»Ù³ïáõÃÛáõÝÝ»ñÁ ¹ÇÝ³ÙÇÏ³ÛáõÙ áõÝ»Ý áñáß³ÏÇ ³é³ÝÓÝ³Ñ³ïÏáõÃÛáõÝÝ»ñ, áñáÝó ÁÝÃ»ñóáÕÁ å»ïù ¿ áñáß í»ñ³å³ÑáõÙáí Ùáï»Ý³:

4.2. Ð²Ü-Ç 2003-2009 ÃÃ. ºðºø Þðæ²ÚòºðÆ ÀÜÂ²òøàôØ ÐÐ ´Ü²ÎâàôÂÚ²Ü Þðæ²ÜàôØ ¶ð²Üòì²Ì ²ÎÜ²ÚÆÜ ÐÆì²Ü¸àôÂÚàôÜÜºðÀ

ÐÐ ²éáÕç³å³ÑáõÃÛ³Ý Ý³Ë³ñ³ñáõÃÛáõÝÝ Çñ íÇ×³Ï³·ñ³Ï³Ý ï³ñ»·ñù»ñáõÙ å³ßïáÝ³å»ë Ññ³å³ñ³ÏáõÙ ¿ »ñÏñÇ μÝ³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ ³éáÕçáõÃÛáõÝÁ μÝáõÃ³·ñáÕ »ñÏáõ ÑÇÙÝ³Ï³Ý óáõó³ÝÇß` ³ãùÇ ¨ Ýñ³ Ñ³í»ÉÛ³É ³å³ñ³ïÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ áõ ·É³áõÏáÙ³ÛÇ ³é³çÇÝ ³Ý·³Ù ³Ëïáñáßí³Í ¹»åù»ñÇ ù³Ý³ÏÁ ¨ μÝ³ÏãáõÃÛ³Ý ÁÝ¹Ñ³Ýáõñ ÑÇí³Ý¹³óáõÃÛáõÝÝ ³Û¹ ÑÇí³Ý¹áõÃÛáõÝÝ»ñáí: Àëï áñáõÙ, μÝ³ÏãáõÃÛ³Ý ÑÇí³Ý¹³óáõÃÛ³Ý ¹»åù»ñÁ ·ñ³ÝóíáõÙ »Ý μáõÅû·ÝáõÃÛáõÝ ëï³Ý³Éáõ Ñ³Ù³ñ ¹ÇÙ»ÉÇë ¨ å³ñï³¹Çñ Ï³ÝË³ñ·»ÉÇã ùÝÝáõÃÛáõÝÝ»ñ ³ÝóÝ»ÉÇë1: ²Û¹ óáõó³ÝÇßÝ»ñÇ ¹ÇÝ³ÙÇÏ³Ý íÏ³ÛáõÙ ¿, áñ ³ãùÇ áõ Ýñ³ Ñ³í»ÉÛ³É ³å³ñ³ïÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñáí ·ñ³Ýóí³Í μÝ³ÏãáõÃÛ³Ý ÃÇíÁ Ù»ñ »ñÏñáõÙ 2004-2008 ÃÃ. ³×»É ¿ ßáõñç »ñÏáõ ³Ý·³Ù` 2008Ã-ÇÝ Ï³½Ù»Éáí 2,610 Ù³ñ¹` 100,000 μÝ³ÏãÇ Ñ³ßíáí (Ï³Ù ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ 68,544 Ù³ñ¹): ÀÝ¹ áñáõÙ, 2005 Ã-Çó ëÏë³Í, Ýßí³Í ÑÇí³Ý¹áõÃÛáõÝÝ»ñáí ÑÇí³Ý¹Ý»ñÇ ÁÝ¹Ñ³Ýáõñ ÃíÇ ßáõñç 47%-Á, ³Ëïáñáßí»É ¿ Çñ ÏÛ³ÝùáõÙ ³é³çÇÝ ³Ý·³Ù:

²ãùÇ áõ Ýñ³ Ñ³í»ÉÛ³É ³å³ñ³ïÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ÃíáõÙ, ë³Ï³ÛÝ, å³ßïáÝ³Ï³Ý íÇ×³Ï³·ñáõÃÛáõÝÁ Ù³Ýñ³Ù³ëÝáõÙ ¿ ÙÇ³ÛÝ ·É³áõÏáÙ³ÛÇ ¹»åù»ñÁ: Àëï ÐÐ ³éáÕç³å³ÑáõÃÛ³Ý Ý³Ë³ñ³ñáõÃÛ³Ý ïíÛ³ÉÝ»ñÇ` 2008 Ã. ¹ñáõÃÛ³Ùμ Ù»ñ »ñÏñáõÙ ·ñ³Ýóí³Í ¿ »Õ»É ·É³áõÏáÙ³Ûáí ³Ëïáñáßí³Í 5,320 Ù³ñ¹, áñáÝóÇó 1,274-Á 2008 Ã. ³Ëïáñáßí»É ¿ ÏÛ³ÝùáõÙ ³é³çÇÝ

1 î»°ë ÐÐ ²Ü ²²Æ ï»Õ»Ï³ïí³Ï³Ý í»ñÉáõÍ³Ï³Ý Ñ³Ýñ³å»ï³Ï³Ý Ï»ÝïñáÝ. ìÇ×³Ï³·ñ³Ï³Ý ï»Õ»Ï³·Çñù 2008:

30

³Ý·³Ù: ²ãùÇ áõ Ýñ³ Ñ³í»ÉÛ³É ³å³ñ³ïÇ ³ÛÉ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ·Íáí å³ßïáÝ³Ï³Ý íÇ×³Ï³·ñáõÃÛáõÝÁ μ³ó³Ï³ÛáõÙ ¿:

¶Í³å³ïÏ»ñ 4-Á Ý»ñÏ³Û³óÝáõÙ ¿ Ð²Ü-Ç ³ÏÝ³μáõÅ³Ï³Ý ËÙμ»ñÇ ÏáÕÙÇó 2003-2009 ÃÃ. »ñ»ù ßñç³Ûó»ñÇ ÁÝÃ³óùáõÙ Ù»Í³Ñ³ë³ÏÝ»ñÇ (16 ¨ ³í»ÉÇ ï³ñ»Ï³Ý) ßñç³ÝáõÙ ³Ëïáñáßí³Í ³ãùÇ áõ Ýñ³ Ñ³í»ÉÛ³É ³å³ñ³ïÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ¹»åù»ñÇ ÃÇíÁ` ÑÇÙÝ³Ï³Ý ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ áñáß³ÏÇ ËÙμ»ñÇ Ïïñí³Íùáí: ²ÛÝ íÏ³ÛáõÙ ¿, áñ Ð²Ü-ÇÝ ³Û¹ ³ÙμáÕç ÁÝÃ³óùáõÙ ³Ûó»É³Í ÐÐ μÝ³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ³Ëïáñáßí»É ¿ ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ Ï³ï³ñ³ÏïÇ 27,032 ¹»åù, áñáÝó Ù»Í Ù³ëÁ` 60%-Á Ñ³ÛïÝ³μ»ñí»É ¿ ÑÇí³Ý¹Ç ÏÛ³ÝùáõÙ ³é³çÇÝ ³Ý·³Ù: Ð²Ü-Ç ³ÏÝ³μáõÅ³Ï³Ý ËÙμ»ñÝ ³Û¹ Å³Ù³Ý³Ï³Ñ³ïí³ÍáõÙ Ñ³ÛïÝ³μ»ñ»É »Ý ³ÏÝ³Ñ³ï³ÏÇ ï³ñμ»ñ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ 14,437 ¹»åù, áñáÝóÇó 62%-Á` ÑÇí³Ý¹Ý»ñÇ ÏÛ³ÝùáõÙ ³é³çÇÝ ³Ý·³Ù, »Õç»ñ³Ã³Õ³ÝÃÇ ï³ñμ»ñ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ` 6,877 ¹»åù, áñáÝóÇó 62%-Á ³é³çÇÝ ³Ý·³Ù ¨ ·É³áõÏáÙ³ÛÇ 5,411 ¹»åù, áñáÝóÇó 54.5%-Á` ³é³çÇÝ ³Ý·³Ù:

ÀÝ¹Ñ³Ýáõñ ³éÙ³Ùμ Ð²Ü ³ßË³ï³ÝùÇ 6 ï³ñÇÝ»ñÇ ÁÝÃ³óùáõÙ »ñÏñáõÙ Ñ³ÛïÝ³μ»ñí»É ¿ ³Ûë ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ 53,757 ¹»åù (ÁÝ¹ áñáõÙ, Ù»Ï Ù³ñ¹Á Ï³ñáÕ ¿ñ áõÝ»Ý³É ÙÇ ù³ÝÇ ï³ñμ»ñ ÑÇí³Ý¹áõÃÛáõÝÝ»ñ), áñáÝóÇó 32,465-Á Ï³Ù 60.4%-Á ÑÇí³Ý¹áõÃÛáõÝÝ áõÝ»óáÕÝ»ñÇ Ùáï Ñ³ÛïÝ³μ»ñí»É ¿ ÏÛ³ÝùáõÙ ³é³çÇÝ ³Ý·³Ù: ÎáõñáõÃÛ³Ý Ñ³Ý·»óÝáÕ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ Ñ³ÛïÝ³μ»ñáõÙÁ Ï³Ù, áñ ÝáõÛÝÝ ¿, ³é³çÇÝ ³Ý·³Ù ³ËïáñáßáõÙÁ ÑÇí³Ý¹Ý»ñÇÝ ÑÝ³ñ³íáñáõÃÛáõÝ ¿ ï³ÉÇë Å³Ù³Ý³ÏÇÝ ¹ÇÙ»Éáõ μÅßÏÇ` ³ÏÝ³μáõÅ³Ï³Ý »ñÏñáñ¹³ÛÇÝ áõ »ññáñ¹³ÛÇÝ Í³é³ÛáõÃÛáõÝÝ»ñ ëï³Ý³Éáõ ÙÇçáóáí ÑÝ³ñ³íáñ ÏáõñáõÃÛáõÝÁ Ï³ÝË³ñ·»É»Éáõ Ýå³ï³Ïáí:

áõ

31

àõëïÇ Ð²Ü-Ç ·áñÍáõÝ»áõÃÛáõÝÁ ÏáõñáõÃÛ³Ý Ñ³Ý·»óÝáÕ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ μ³ó³Ñ³ÛïÙ³Ý ³éáõÙáí Ù»Í³å»ë Ýå³ëïáõÙ ¿ ÏáõñáõÃÛ³Ý Ï³ÝË³ñ·»ÉÙ³ÝÁ »ñÏñáõÙ:

ì»ñÁ Ýßí³Í ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ` Ð²Ü-Ç ÏáÕÙÇó 2003-2009 ÃÃ. Ð³Û³ëï³ÝáõÙ ·ñ³Ýóí³Í ¹»åù»ñÇ μ³ßËáõÙÁ Ù³ñ½³ÛÇÝ Ïïñí³Íùáí μ»ñí³Í ¿ ëïáñ¨:

32

2003-2009 ÃÃ. Ð²Ü-Ç ³ÏÝ³μáõÛÅÝ»ñÇ ÏáÕÙÇó ³ÏÝ³ÛÇÝ ½ÝÝáõÙ ³Ýó³Í ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ 95,607 Ù»Í³Ñ³ë³ÏÝ»ñÇó (16 ¨ ³í»ÉÇ ï³ñ»Ï³Ý) ßáõñç 40,000-Ç ßñç³ÝáõÙ ·ñ³Ýóí»É ¿ ³ãùÇ áõ Ýñ³ Ñ³í»ÉÛ³É ³å³ñ³ïÇ ³éÝí³½Ý Ù»Ï ÑÇí³Ý¹áõÃÛáõÝ: ê³ Ï³½ÙáõÙ ¿ ½ÝÝí³ÍÝ»ñÇ ßáõñç 42%-Á: ê³Ï³ÛÝ, ÝÏ³ïÇ áõÝ»Ý³Éáí ½ÝÝí³Í μÝ³ÏãáõÃÛ³Ý ÅáÕáíñ¹³·ñ³Ï³Ý ³é³ÝÓÝ³Ñ³ïÏáõÃÛáõÝÝ»ñÁ, ³Ûë óáõó³ÝÇßÁ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ï³ñ³Íí³ÍáõÃÛ³Ý óáõó³ÝÇß ãÇ Ñ³Ù³ñíáõÙ: ²ÏÝ³ÛÇÝ ï³ñμ»ñ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ï³ñ³Íí³ÍáõÃÛ³Ý ·Ý³Ñ³ï³Ï³ÝÝ»ñÁ Ñ³ßí³ñÏí»É »Ý ïíÛ³ÉÝ»ñÇ ßï»Ù³ñ³ÝÁ Ïßé»Éáõó Ñ»ïá ¨ μ»ñí³Í »Ý »ÝÃ³·ÉáõË 4.3-áõÙ: Ð²Ü-Ç ÏáÕÙÇó Çñ³Ï³Ý³óíáÕ ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñÇ ³ÙμáÕç ÁÝÃ³óùáõÙ ³éÝí³½Ý Ù»Ï ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛ³Ùμ ·ñ³Ýóí³Í μÝ³ÏãáõÃÛ³Ý Ù³ñ½³ÛÇÝ μ³ßËáõÙÁ μ»ñíáõÙ ¿ ëïáñ¨:

33

Ð²Ü-Á 2003-2009 ÃÃ. »ñ»ù ßñç³Ûó»ñÇ ÁÝÃ³óùáõÙ Ñ³ÛïÝ³μ»ñ»É ¿ ï»ëáÕáõÃÛ³Ý Ë³Ã³ñáõÙáí ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ 16,520 Ù³ñ¹, áñáÝóÇó 3,173-Á` ÏáõÛñ, ÇëÏ ¨ë 13,347-Á` ÃáõÛÉ ï»ëáÕáõÃÛ³Ùμ1:

î»ëáÕáõÃÛ³Ý Ë³Ã³ñáõÙÝ»ñÇ ¹»åù»ñÁ ÑÇÙÝ³Ï³ÝáõÙ å³ÛÙ³Ý³íáñí³Í »Ý »Õ»É Ï³ï³ñ³Ïï ÑÇí³Ý¹áõÃÛ³Ùμ: Ð²Ü-Ç Ñ»ï³½áïáõÃÛáõÝÝ»ñÝ ³Ýó³Í ¨ ï»ëáÕáõÃÛ³Ý Ë³Ã³ñÙ³Ùμ ³Ëïáñáßí³Í Ù»Í³Ñ³ë³Ï μÝ³ÏãáõÃÛ³Ý ³í»ÉÇ ù³Ý 50%-Ç ßñç³ÝáõÙ Ñ³ÛïÝ³μ»ñí»É ¿ Ï³ï³ñ³Ïï, ßáõñç 8%-Ç ßñç³ÝáõÙ` ·É³áõÏáÙ³, 22%-Ç ßñç³ÝáõÙ ³ÏÝ³Ñ³ï³ÏÇ ËÝ¹ÇñÝ»ñ »Ý Ñ³ÛïÝ³μ»ñí»É, ÇëÏ ¨ë 15%-Ç Ùáï` »Õç»ñ³Ã³Õ³ÝÃÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñ:

Î³ï³ñ³ÏïÇó ³é³ç³óáÕ ÏáõñáõÃÛáõÝÇó, ÇÝãå»ë Ñ³ÛïÝÇ ¿, Ï³ñ»ÉÇ ¿ Ëáõë³÷»É Å³Ù³Ý³ÏÇÝ íÇñ³Ñ³ï³Ï³Ý ÙÇç³ÙïáõÃÛáõÝ Ï³ï³ñ»Éáõ ¹»åùáõÙ:

Àëï Ð²Ü-Ç »ññáñ¹ ßñç³ÛóÇ ïíÛ³ÉÝ»ñÇ` ÐÐ-áõÙ 16 ¨ ³í»ÉÇ ï³ñ»Ï³ÝÝ»ñÇ 2.3%-Á ï³ñ»É ¿ Ï³ï³ñ³ÏïÇ íÇñ³Ñ³ïáõÃÛáõÝ Ù»Ï ¨ ¨ë 0.7%-Á` »ñÏáõ ³ãùáõÙ: ØÇÝã¹»é, Ï³ï³ñ³ÏïÇ íÇñ³Ñ³ï³Ï³Ý Í³ÍÏáõÛÃÁ (»ñÏáõ ³ãùáõÙ Ï³ï³ñ³Ïï áõÝ»óáÕ μÝ³ÏãáõÃÛ³Ý ÃíáõÙ ³éÝí³½Ý Ù»Ï ³ãùáõÙ

1 Àëï ²éáÕç³å³ÑáõÃÛ³Ý Ñ³Ù³ßË³ñÑ³ÛÇÝ Ï³½Ù³Ï»ñåáõÃÛ³Ý ë³ÑÙ³ÝÙ³Ý` ÏáõÛñ ¿ Ñ³Ù³ñíáõÙ ³ÛÝ ³ÝÓÁ, áñÇ ï»ëáÕáõÃÛ³Ý ëñáõÃÛáõÝÁ É³í³·áõÛÝ ï»ëÝáÕ ³ãùáõÙ, ³é³í»É³·áõÛÝ ×ß·ñïÙ³Ý å³ÛÙ³ÝÝ»ñáõÙ 3/60-Çó (0.05-Çó) å³Ï³ë ¿: ÂáõÛÉ ï»ëáÕáõÃÛáõÝ áõÝ»óáÕ ¿ Ñ³Ù³ñíáõÙ ³ÛÝ ³ÝÓÁ, áñÇ ï»ëáÕáõÃÛ³Ý ëñáõÃÛáõÝÁ É³í³·áõÛÝ ï»ëÝáÕ ³ãùáõÙ, ³é³í»É³·áõÛÝ ×ß·ñïÙ³Ý å³ÛÙ³ÝÝ»ñáõÙ ·ïÝíáõÙ ¿ 3/60-6/18 ÙÇç³Ï³ÛùáõÙ (0.05-0.33), ÇëÏ ï»ëáÕáõÃÛ³Ý Ë³Ã³ñáõÙ áõÝ»óáÕÝ»ñÝ ³Ûë »ñÏáõ ËÙμ»ñÇó áñ¨¿ Ù»ÏÇÝ å³ïÏ³ÝáÕÝ»ñÝ »Ý (ï»ëáÕáõÃÛ³Ý ëñáõÃÛáõÝÁ 0.0- 0.33)

34

Ï³ï³ñ³ÏïÇ íÇñ³Ñ³ïáõÃÛáõÝ áõÝ»ó³ÍÝ»ñÇ Ù³ëÝ³μ³ÅÇÝÁ) Ï³½ÙáõÙ ¿ ÁÝ¹³Ù»ÝÁ 23.8%2: ê³ Ýß³Ý³ÏáõÙ ¿, áñ »ñÏáõ ³ãùáõÙ Ï³ï³ñ³Ïï áõÝ»óáÕÝ»ñÇ ÁÝ¹³Ù»ÝÁ Ùáï 24%- ¿, áñ íÇñ³Ñ³ï»É ¿ ·áÝ» Ù»Ï ³ãùÇ Ï³ï³ñ³ÏïÁ:

2 Ð³Ù»Ù³ïáõÃÛ³Ý Ñ³Ù³ñ Ýß»Ýù, áñ ÝáõÛÝÇëÏ ½³ñ·³óáÕ »ñÏñÝ»ñáõÙ ³Ûë óáõó³ÝÇßÁ ÑÇÙÝ³Ï³ÝáõÙ ß³ï ³í»ÉÇ μ³ñÓñ ¿: úñÇÝ³Ï` ÐÝ¹Ï³ëï³ÝáõÙ ³ÛÝ Ï³½ÙáõÙ ¿ 63%, ä³ÏÇëï³ÝáõÙ` 44%:

4.3. ÐÐ ´Ü²ÎâàôÂÚ²Ü Þðæ²ÜàôØ ²ÎÜ²ÚÆÜ ÐÆì²Ü¸àôÂÚàôÜÜºðÆ î²ð²Ìì²ÌàôÂÚ²Ü ¶Ü²Ð²î²Î²ÜÜºðÀ` Àêî Ð²Ü-Ç îìÚ²ÈÜºðÆ

Ð²Ü-Ç ïíÛ³ÉÝ»ñÁ Ïßé»Éáõó, »ñÏñÇ μÝ³ÏãáõÃÛ³Ý ë»é³ï³ñÇù³ÛÇÝ áõ ï³ñ³Íù³ÛÇÝ Ñ³Ù³Ù³ëÝáõÃÛáõÝÝ»ñÇÝ Ñ³Ù³å³ï³ëË³Ý»óÝ»Éáõó ¨ ï³ñ³Í»Éáõó Ñ»ïá ëï³óí»É »Ý Ð³Û³ëï³ÝáõÙ ï»ëáÕáõÃÛ³Ý Ë³Ã³ñÙ³Ý, ³Û¹ ÃíáõÙ` ÏáõñáõÃÛ³Ý áõ ÃáõÛÉ ï»ëáÕáõÃÛ³Ý ï³ñ³Íí³ÍáõÃÛ³Ý ÙÇçÇÝ ·Ý³Ñ³ï³Ï³ÝÝ»ñÁ` »ñÏ³ÙÛ³ Å³Ù³Ý³Ï³Ñ³ïí³ÍáõÙ` 2003-2005, 2005-2007 ¨ 2007-2009 ÃÃ. Ñ³Ù³ñ:

Àëï ³Û¹ ·Ý³Ñ³ï³Ï³ÝÝ»ñÇ` ÐÐ-áõÙ 2007-2009 ÃÃ. ¹ñáõÃÛ³Ùμ ÏáõÛñ ¿ »Õ»É μÝ³ÏãáõÃÛ³Ý ÙÇçÇÝ Ñ³ßíáí 0.7%-Á, ÇëÏ ÃáõÛÉ ï»ëáÕáõÃÛáõÝ ¿ áõÝ»ó»É` 4.1%-Á: ÀÝ¹Ñ³Ýáõñ ³éÙ³Ùμ »ñÏñÇ μÝ³ÏãáõÃÛ³Ý 4.8%-Ý áõÝ»ó»É ¿ ï»ëáÕáõÃÛ³Ý Ë³Ã³ñáõÙ: Àëï áñáõÙ, ÏáõñáõÃÛ³Ý ï³ñ³Íí³ÍáõÃÛ³Ý ·Ý³Ñ³ï³Ï³ÝÝ»ñÁ Å³Ù³Ý³ÏÇ Ù»ç μ³ñ»É³íí»É »Ý` 2003-2005 ÃÃ. 1.3%-Çó 2007-2009 ÃÃ. Ñ³ëÝ»Éáí ÙÇçÇÝÁ 0.7%-Ç, ÇëÏ ÃáõÛÉ ï»ëáÕáõÃÛ³Ý ï³ñ³Íí³ÍáõÃÛ³Ý ·Ý³Ñ³ï³Ï³ÝÝ»ñÁ í³ï³ó»É »Ý: ê³ ¿ å³ï×³éÁ, áñ ï»ëáÕáõÃÛ³Ý Ë³Ã³ñÙ³Ý ï³ñ³Íí³ÍáõÃÛ³Ý ·Ý³Ñ³ï³Ï³ÝÝ»ñÁ

35

»ñÏñáõÙ ³×»É »Ý: ²ÛÝáõ³Ù»Ý³ÛÝÇí, 2007-2009 ÃÃ. Ñ³Ù³ñ Ð³Û³ëï³ÝáõÙ ÏáõñáõÃÛ³Ý ï³ñ³Íí³ÍáõÃÛ³Ý ·Ý³Ñ³ï³Ï³ÝÝ»ñÁ ²éáÕç³å³ÑáõÃÛ³Ý Ñ³Ù³ßË³ñÑ³ÛÇÝ Ï³½Ù³Ï»ñåáõÃÛ³Ý` ÎáíÏ³ëÇ Ñ³Ù³ñ ³ñí³Í ëïáñÇÝ ¨ í»ñÇÝ ·Ý³Ñ³ï³Ï³ÝÝ»ñÇ ÙÇç³Ï³ÛùáõÙ ¿, ÇëÏ ÃáõÛÉ ï»ëáÕáõÃÛ³Ý ·Ý³Ñ³ï³Ï³ÝÝ»ñÁ ·»ñ³½³ÝóáõÙ »Ý ¹ñ³ í»ñÇÝ »½ñÁ 1.2 ïáÏáë³ÛÇÝ Ï»ïáí: î»ëáÕáõÃÛ³Ý Ë³Ã³ñáõÙÝ ³é³í»É³å»ë Ù»Í ï³ñ³Íí³ÍáõÃÛáõÝ áõÝÇ »ñÏñÇ 50 ¨ ³í»ÉÇ ï³ñ»Ï³Ý μÝ³ÏãáõÃÛ³Ý ßñç³ÝáõÙ: î»ëáÕáõÃÛ³Ý Ë³Ã³ñÙ³Ùμ ³Ëïáñáßí³Í ½ÝÝí³ÍÝ»ñÇ ½·³ÉÇ Ù³ëÁ` ßáõñç Ï»ëÁ, 50 ¨ ³í»ÉÇ ï³ñ»Ï³Ý »Ý: ÎáõñáõÃÛ³Ý ï³ñ³Íí³ÍáõÃÛáõÝÁ 50 ¨ ³í»ÉÇ ï³ñ»Ï³ÝÝ»ñÇ ßñç³ÝáõÙ ¿³å»ë μ³ñÓñ ¿: ²Ûëå»ë` 2007-2009 ÃÃ. Ð²Ü-Ç ïíÛ³ÉÝ»ñÇ Ñ³Ù³Ó³ÛÝ` 2.7 ³Ý·³Ù, ÇëÏ ÃáõÛÉ ï»ëáÕáõÃÛ³Ý ï³ñ³Íí³ÍáõÃÛáõÝÁ` 1.6 ³Ý·³Ù μ³ñÓñ ¿ »Õ»É »ñÏñÇ ÁÝ¹Ñ³Ýáõñ ÙÇçÇÝÇó (ï»°ë ·Í³å³ïÏ»ñ 7):

36

Ð²Ü-Ç Ñ³í³ù³Í ïíÛ³ÉÝ»ñÇ ÏßéáõÙÁ (Ñ³Ù³å³ï³ëË³Ý»óáõÙÁ ÐÐ μÝ³ÏãáõÃÛ³Ý ë»é³-ï³ñÇù³ÛÇÝ Ï³éáõóí³ÍùÇÝ) ¨ ï³ñ³ÍáõÙÁ ÑÝ³ñ³íáñáõÃÛáõÝ »Ý ïí»É ëï³Ý³Éáõ Ý³¨ »ñÏñáõÙ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ï³ñ³Íí³ÍáõÃÛ³Ý ·Ý³Ñ³ï³Ï³ÝÝ»ñ (ï»°ë ³ÕÛáõë³Ï 6): ê³Ï³ÛÝ ¹ñ³Ýù Ñ³ßí³ñÏí»É »Ý Ð²Ü-Ç »ññáñ¹` 2007-2009 ÃÃ. ßñç³ÛóÇ ïíÛ³ÉÝ»ñÇ ÑÇÙ³Ý íñ³` ÝÏ³ïÇ áõÝ»Ý³Éáí ³ÛÝ, áñ Ð²Ü-Ç Ñ»ï³½áïáõÃÛáõÝÝ»ñÇ Ñ³ñó³Ã»ñÃÁ ß³ñáõÝ³Ï³μ³ñ μ³ñ»É³íí»É áõ »ññáñ¹ ßñç³ÛóÇ ÁÝÃ³óùáõÙ ÑÝ³ñ³íáñáõÃÛáõÝ ¿ ïí»É ëï³Ý³É ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ³é³í»É μ³ñ»É³íí³Í ó³ÝÏ, ÇÝãå»ë Ý³¨ ³ÛÝ, áñ ³Ûë ßñç³ÛóÇ ïíÛ³ÉÝ»ñÇÁ ³é³í»É Ã³ñÙ »Ý:

Àëï ³Û¹ ·Ý³Ñ³ï³Ï³ÝÝ»ñÇ` ÐÐ μÝ³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ³é³í»É ï³ñ³Íí³Í ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÝ »Ý Ï³ï³ñ³ÏïÁ (8.4%) ¨ ³ÏÝ³Ñ³ï³ÏÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÁ (7.9%):

Ð³ïÏ³å»ë Ï³ñ¨áñ »Ý ÏáõñáõÃÛ³Ý Ñ³Ý·»óÝáÕ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ (·É³áõÏáÙ³, Ï³ï³ñ³Ïï, »Õç»ñ³Ã³Õ³ÝÃÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñ, ¹Ç³μ»ïÇÏ é»ïÇÝáå³ÃÇ³ ¨ Ù³ÏáõÉÛ³ñ ¹»·»Ý»ñ³óÇ³) ï³ñ³Íí³ÍáõÃÛ³Ý ·Ý³Ñ³ï³Ï³ÝÝ»ñÁ:

²ÕÛáõë³Ï 6-Çó »ñ¨áõÙ ¿, áñ ÏáõñáõÃÛ³Ý Ñ³Ý·»óÝáÕ ³éÝí³½Ý Ù»Ï ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝ áõÝ»óáÕ μÝ³ÏãáõÃÛ³Ý ï»ë³Ï³ñ³ñ ÏßÇéÁ »ñÏñÇ μÝ³ÏãáõÃÛ³Ý ßñç³ÝáõÙ Ï³½ÙáõÙ ¿ 13.3%, ¨ ¹ñ³ÝóÇó ³Ù»Ý³ï³ñ³Íí³ÍÁ Ï³ï³ñ³ÏïÝ ¿ (8.4%):

é»ïÇÝáå³ÃÇ³


37

ÎáõñáõÃÛ³Ý Ñ³Ý·»óÝáÕ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ï³ñ³Íí³ÍáõÃÛ³Ý ·Ý³Ñ³ï³Ï³ÝÝ»ñÇ Ù³ñ½³ÛÇÝ å³ïÏ»ñÁ μ»ñí³Í ¿ ù³ñï»½ 6-áõÙ, áñÇó »ñ¨áõÙ ¿, áñ ÏáõñáõÃÛ³Ý Ñ³Ý·»óÝáÕ ³éÝí³½Ý Ù»Ï ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝ áõÝ»óáÕ μÝ³ÏãáõÃÛ³Ý ï»ë³Ï³ñ³ñ ÏßÇéÝ ³é³í»É Ù»Í ¿ î³íáõßÇ, ²ñ³ñ³ïÇ áõ ²ñÙ³íÇñÇ Ù³ñ½»ñáõÙ (16.3, 16 ¨ 15.5 %` Ñ³Ù³å³ï³ëË³Ý³μ³ñ), ÇëÏ ³Ù»Ý³ó³ÍñÁ` êÛáõÝÇùáõÙ áõ ì³Ûáó ÓáñáõÙ:

ÎáõñáõÃÛ³Ý Ñ³Ý·»óÝáÕ ³é³ÝÓÇÝ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ï³ñ³Íí³ÍáõÃÛ³Ý ·Ý³Ñ³ï³Ï³ÝÝ»ñÇ Ù³ñ½³ÛÇÝ Ñ³Ù»Ù³ï³Ï³Ý å³ïÏ»ñÁ μ»ñí³Í ¿ ³ÕÛáõë³Ï 7-áõÙ:


38

ÆÝãå»ë Ñ³ÛïÝÇ ¿, 50 ¨ ³í»ÉÇ ï³ñ»Ï³Ý μÝ³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÁ ³í»ÉÇ ï³ñ³Íí³Í »Ý: ÆÝãå»ë »ñ¨áõÙ ¿ ²ÕÛáõë³Ï 8-Çó, ÏáõñáõÃÛ³Ý Ñ³Ý·»óÝáÕ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ï³ñ³Íí³ÍáõÃÛáõÝÁ ÐÐ 50 ¨ ³í»ÉÇ ï³ñ»Ï³Ý μÝ³ÏãáõÃÛ³Ý ÃíáõÙ ¿³å»ë ³í»ÉÇ μ³ñÓñ ¿ ù³Ý ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ μÝ³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ¨ Ï³½ÙáõÙ ¿ 37% (μÝ³ÏãáõÃÛ³Ý` 13.3%-Ç ¹ÇÙ³ó):

Ð²Ü-Ç ÏáÕÙÇó Ùß³Ïí»É áõ Ñ³ßí³ñÏí»É ¿ ½ÝÝí³Í 50 ¨ ³í»ÉÇ ï³ñ»Ï³Ý μÝ³ÏãáõÃÛ³Ý ³ÏÝ³ÛÇÝ ³éáÕçáõÃÛ³Ý Ëáó»ÉÇáõÃÛ³Ý Ñ³Ù³ÃÇíÁ (²²ÊÐ): Ð²Ü-Ç ÏáÕÙÇó ½ÝÝí³Í 50 ¨ ³í»ÉÇ ï³ñ»Ï³Ý ³ÛÝ Ù³ñ¹ÇÏ, áñáÝù ³Ëïáñáßí»É »Ý ÏáõñáõÃÛ³Ý Ñ³Ý·»óÝáÕ ³éÝí³½Ý Ù»Ï ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛ³Ùμ (·É³áõÏáÙ³, Ï³ï³ñ³Ïï, »Õç»ñ³Ã³Õ³ÝÃÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñ, ¹Ç³μ»ïÇÏ é»ïÇÝáå³ïÇ³ ¨ Ù³ÏáõÉÛ³ñ ¹»·»Ý»ñ³óÇ³), Ñ³Ù³ñí»É »Ý Ëáó»ÉÇ` ³ÏÝ³ÛÇÝ ³éáÕçáõÃÛ³Ý ï»ë³ÝÏÛáõÝÇó: ²²ÊÐ-Ý ³Û¹åÇëÇ μÝ³ÏãáõÃÛ³Ý ï»ë³Ï³ñ³ñ ÏßÇéÝ ¿ 50 ¨ ³í»ÉÇ ï³ñ»Ï³Ý μÝ³ÏãáõÃÛ³Ý ÁÝ¹Ñ³Ýáõñ ÃíáõÙ:

Ð²Ü-Ç ïíÛ³ÉÝ»ñÁ íÏ³ÛáõÙ »Ý, áñ ÐÐ 50 ¨ ³í»ÉÇ ï³ñ»Ï³ÝÝ»ñÇ 37%-Ý áõÝÇ Ëáó»ÉÇ ³ÏÝ³ÛÇÝ ³éáÕçáõÃÛáõÝ: ê³ Ýß³Ý³ÏáõÙ ¿, áñ ÐÐ-Ç ³Û¹ ï³ñÇùÇ Ñ³Ù³ñÛ³ Ûáõñ³ù³ÝãÛáõñ ãáññáñ¹ μÝ³ÏÇã ÏáõñáõÃÛ³Ý Ñ³Ý·»óÝáÕ ³éÝí³½Ý Ù»Ï ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝ áõÝÇ: ÀÝ¹ áñáõÙ, ÐÐ Ù³ñ½³ÛÇÝ Ïïñí³Íùáí ³Ù»Ý³μ³ñÓñ ³ÏÝ³ÛÇÝ ³éáÕçáõÃÛ³Ý Ëáó»ÉÇáõÃÛ³Ý Ñ³Ù³Ãí»ñÁ ëï³óí»É »Ý ²ñ³ñ³ïÇ, ²ñÙ³íÇñÇ áõ ²ñ³·³ÍáïÝÇ Ù³ñ½»ñáõÙ (ï»°ë ù³ñï»½ 7):


ÑÇí³Ý¹áõÃÛáõÝÝ»ñ

39

5. 2003-2009 ÃÃ. Ð²Ü-Ç ºðºø Þðæ²ÚòºðÆ ÀÜÂ²òøàôØ ÐÐ ´Ü²ÎâàôÂÚ²ÜÀ îð²Ø²¸ð²Ì ²ÎÜ²´àôÄ²Î²Ü Ì²è²ÚàôÂÚàôÜÜºðÀ` Ø²ð¼²ÚÆÜ Îîðì²Ìàì

²Ûë μ³ÅÇÝÁ Ý»ñÏ³Û³óÝáõÙ ¿ Ð²Ü-Ç §ÈáõÛë Ñ³ÛÇ ³ãù»ñÇÝ¦ Ý³Ë³Ó»éÝáõÃÛ³Ý ßñç³Ý³ÏÝ»ñáõÙ 2003-2009 ÃÃ ÐÐ Ù³ñ½»ñáõÙ Çñ³Ï³Ý³óí³Í ³ÏÝ³ÛÇÝ Ñ»ï³½áïáõÃÛáõÝÝ»ñÇ áõ μáõÅû·ÝáõÃÛ³Ý ³ßË³ï³ÝùÝ»ñÇ ³Ù÷á÷ å³ïÏ»ñÁ` Ûáõñ³ù³ÝãÛáõñ Ù³ñ½Ç Ïïñí³Íùáí:

5.1. ²ð²¶²ÌàîÜÆ Ø²ð¼

´Ý³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñ Çñ³Ï³Ý³óÝ»Éáõ Ýå³ï³Ïáí 2003, 2005 ¨ 2007 Ãí³Ï³ÝÝ»ñÇÝ §Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÍÇ¦ ³ÏÝ³μáõÛÅÝ»ñÝ áõ ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóÁ »ñ»ù ßñç³Ûó »Ý Ï³ï³ñ»É ²ñ³·³ÍáïÝÇ Ù³ñ½Ç ù³Õ³ù³ÛÇÝ áõ ·ÛáõÕ³Ï³Ý Ñ³Ù³ÛÝùÝ»ñáõÙ: ²Û¹ ÁÝÃ³óùáõÙ Ð²Ü-Á ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ Ñ»ï³½áï»É ¿ Ù³ñ½Ç 20,750 μÝ³ÏãÇ, áñáÝó Ï»ëÇó ùÇã ³í»ÉÇÝ` 52.8%-Á, ã³÷³Ñ³ë μÝ³ÏãáõÃÛáõÝ ¿ »Õ»É, ÇëÏ 47.2%-Á` »ñ»Ë³:

40

Ð²Ü-Ç ³ßË³ï³ÝùÝ»ñÝ áõ Ù³ïáõó³Í Í³é³ÛáõÃÛáõÝÝ»ñÁ áõÕÕí³Í »Ý »Õ»É ·ÛáõÕ³Ï³Ý μÝ³ÏãáõÃÛ³ÝÁ, áñÇ Ñ³Ù³ñ ³ÏÝ³μáõÅ³Ï³Ý ËáñÁ Ñ»ï³½áïáõÃÛáõÝÝ»ñÝ ³é³í»É³å»ë ¹Åí³ñ Ñ³ë³Ý»ÉÇ »Ý: ¶ÛáõÕ³μÝ³ÏÝ»ñÁ Ï³½ÙáõÙ »Ý Ù³ñ½áõÙ ½ÝÝí³Í μÝ³ÏãáõÃÛ³Ý 68.2%-Á:

Ð²Ü-Ç ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóáõÙ 2003-2007 ÃÃ. ÁÝÃ³óùáõÙ Ëáñ³óí³Í ³ÏÝ³ÛÇÝ Ñ»ï³½áïáõÃÛáõÝÝ»ñ ¿ ³Ýó»É Ù³ñ½Ç 1,319 μÝ³ÏÇã, áñáÝóÇó 552-Á íÇñ³Ñ³ïí»É áõ É³½»ñ³ÛÇÝ μáõÅáõÙ »Ý ëï³ó»É:

Ð²Ü-Á 1,924 ³Ýí×³ñ ³ÏÝáó ¿ ïñ³Ù³¹ñ»É Ù³ñ½Ç` ¹ñ³ Ï³ñÇùÝ áõÝ»óáÕ ¨ ëáóÇ³É³å»ë Ëáó»ÉÇ ËÙμ»ñÇÝ å³ïÏ³ÝáÕ μÝ³ÏãáõÃÛ³ÝÁ:

41

5.2. ²ð²ð²îÆ Ø²ð¼

´Ý³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñ Çñ³Ï³Ý³óÝ»Éáõ Ýå³ï³Ïáí 2004, 2006 ¨ 2008 ÃÃ. Ð²Ü-Ç ³ÏÝ³μáõÛÅÝ»ñÝ áõ ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóÁ »ñ»ù ßñç³Ûó »Ý Ï³ï³ñ»É ²ñ³ñ³ïÇ Ù³ñ½Ç ù³Õ³ù³ÛÇÝ áõ ·ÛáõÕ³Ï³Ý Ñ³Ù³ÛÝùÝ»ñáõÙ: ²Û¹ ÁÝÃ³óùáõÙ Ð²Ü-Á Ñ»ï³½áï»É ¿ ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ Ù³ñ½Ç 23,870 μÝ³ÏãÇ, áñáÝó ßáõñç 51%-Á ã³÷³Ñ³ë μÝ³ÏãáõÃÛáõÝ ¿ »Õ»É, ÇëÏ 49%-Á` »ñ»Ë³:



42

5.3. ²ðØ²ìÆðÆ Ø²ð¼

´Ý³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñ Çñ³Ï³Ý³óÝ»Éáõ Ýå³ï³Ïáí 2003, 2006 ¨ 2008 ÃÃ, Ð²Ü-Ç ³ÏÝ³μáõÛÅÝ»ñÝ áõ ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóÁ »ñ»ù ßñç³Ûó »Ý Ï³ï³ñ»É ²ñÙ³íÇñÇ Ù³ñ½Ç ù³Õ³ù³ÛÇÝ áõ ·ÛáõÕ³Ï³Ý Ñ³Ù³ÛÝùÝ»ñáõÙ: ²Û¹ ÁÝÃ³óùáõÙ Ð²Ü-Á Ñ»ï³½áï»É ¿ ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ Ù³ñ½Ç 25,115 μÝ³ÏãÇ, áñáÝó ßáõñç 53%-Á ã³÷³Ñ³ë μÝ³ÏãáõÃÛáõÝ ¿ »Õ»É, ÇëÏ 47%-Á` »ñ»Ë³:

Ð²Ü-Ç ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóáõÙ 2003-2008 ÃÃ. ÁÝÃ³óùáõÙ Ëáñ³óí³Í ³ÏÝ³ÛÇÝ Ñ»ï³½áïáõÃÛáõÝÝ»ñ ¿³Ýó»É Ù³ñ½Ç 2,405 μÝ³ÏÇã, áñáÝóÇó 1,084-Á íÇñ³Ñ³ïí»É áõ É³½»ñ³ÛÇÝ μáõÅáõÙ »Ý ëï³ó»É:


43

5.4. Îàî²ÚøÆ Ø²ð¼

´Ý³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñ Çñ³Ï³Ý³óÝ»Éáõ Ýå³ï³Ïáí 2005, 2007 ¨ 2009 ÃÃ. Ð²Ü-Ç ³ÏÝ³μáõÛÅÝ»ñÝ áõ ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóÁ »ñ»ù ßñç³Ûó »Ý Ï³ï³ñ»É Îáï³ÛùÇ Ù³ñ½Ç ù³Õ³ù³ÛÇÝ áõ ·ÛáõÕ³Ï³Ý Ñ³Ù³ÛÝùÝ»ñáõÙ: ²Û¹ ÁÝÃ³óùáõÙ Ð²Ü-Á Ñ»ï³½áï»É ¿ ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ Ù³ñ½Ç 18,949 μÝ³ÏãÇ, áñáÝó ßáõñç 50%-Á ã³÷³Ñ³ë μÝ³ÏãáõÃÛáõÝ ¿ »Õ»É:



44

5.5. Èàèàô Ø²ð¼

´Ý³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñ Çñ³Ï³Ý³óÝ»Éáõ Ýå³ï³Ïáí 2005-2009 ÃÃ. ÁÝÃ³óùáõÙ §Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÍÇ¦ ³ÏÝ³μáõÛÅÝ»ñÝ áõ ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóÁ »ñ»ù ßñç³Ûó »Ý Ï³ï³ñ»É Èáéáõ Ù³ñ½Ç ù³Õ³ù³ÛÇÝ áõ ·ÛáõÕ³Ï³Ý Ñ³Ù³ÛÝùÝ»ñáõÙ: ²Û¹ ÁÝÃ³óùáõÙ Ð²Ü-Á Ñ»ï³½áï»É ¿ ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ Ù³ñ½Ç 18,569 μÝ³ÏãÇ, áñáÝó ßáõñç 68%-Á ã³÷³Ñ³ë μÝ³ÏãáõÃÛáõÝ ¿ »Õ»É, ÇëÏ 32%-Á` »ñ»Ë³:

Ð²Ü-Ç ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóáõÙ 2005-2009 ÃÃ. ÁÝÃ³óùáõÙ Ëáñ³óí³Í ³ÏÝ³ÛÇÝ Ñ»ï³½áïáõÃÛáõÝÝ»ñ ¿ ³Ýó»É Ù³ñ½Ç 2,815 μÝ³ÏÇã, áñáÝóÇó 1,165-Á íÇñ³Ñ³ïí»É áõ É³½»ñ³ÛÇÝ μáõÅáõÙ »Ý ëï³ó»É:


45

5.6. ÞÆð²ÎÆ Ø²ð¼

´Ý³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñ Çñ³Ï³Ý³óÝ»Éáõ Ýå³ï³Ïáí 2005-2009 ÃÃ. ÁÝÃ³óùáõÙ §Ð³ÛÏ³Ï³Ý ²ÏÝ³μáõÅáõÃÛ³Ý Ü³Ë³·ÍÇ ³ÏÝ³μáõÛÅÝ»ñÝ áõ ²ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóÁ »ñ»ù ßñç³Ûó »Ý Ï³ï³ñ»É ÞÇñ³ÏÇ Ù³ñ½Ç ù³Õ³ù³ÛÇÝ áõ ·ÛáõÕ³Ï³Ý Ñ³Ù³ÛÝùÝ»ñáõÙ: ²Û¹ ÁÝÃ³óùáõÙ Ð²Ü-Á ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ Ñ»ï³½áï»É ¿ Ù³ñ½Ç 16,834 μÝ³ÏãÇ, áñáÝó ßáõñç 86%-Á ã³÷³Ñ³ë μÝ³ÏãáõÃÛáõÝ ¿ »Õ»É, ÇëÏ 14%-Á` »ñ»Ë³Ý»ñ:

âÝ³Û³Í Ýñ³Ý, áñ Ù³ñ½Ç μÝ³ÏãáõÃÛáõÝÁ ÑÇÙÝ³Ï³ÝáõÙ ù³Õ³ù³μÝ³Ï ¿, Ð²Ü-Ç ³ßË³ï³ÝùÝ»ñÝ áõ Ù³ïáõó³Í Í³é³ÛáõÃÛáõÝÝ»ñÁ Ù»Í³å»ë áõÕÕí³Í »Ý »Õ»É ¹»åÇ ·ÛáõÕ³Ï³Ý μÝ³ÏãáõÃÛáõÝÁ, áñÇ Ñ³Ù³ñ ³ÏÝ³μáõÅ³Ï³Ý ËáñÁ Ñ»ï³½áïáõÃÛáõÝÝ»ñÝ ³é³í»É³å»ë ¹Åí³ñ Ñ³ë³Ý»ÉÇ »Ý: Ð³ßíÇ ³éÝ»Éáí, áñ ¶ÛáõÙñÇáõÙ Ã»° ³é³çÝ³ÛÇÝ ¨ Ã»° »ñÏñáñ¹³ÛÇÝ Ù³Ï³ñ¹³ÏÇ ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñÝ ³éÏ³ »Ý, Ð²Ü-Ç »ññáñ¹ ßñç³ÛóÇ ÁÝÃ³óùáõÙ ¶ÛáõÙñÇ ù³Õ³ùÁ ÁÝ¹·ñÏí³Í ãÇ »Õ»É: ²ÛëåÇëáí, Ù³ñ½Ç ù³Õ³ù³ÛÇÝ áõ ·ÛáõÕ³Ï³Ý μÝ³ÏãáõÃÛ³Ý ÁÝ¹·ñÏí³ÍáõÃÛáõÝÁ Ð²Ü-Ç ïñ³Ù³¹ñ³Í ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñáí ß³ï ãÇ ï³ñμ»ñíáõÙ` Ñ³Ù³å³ï³ëË³Ý³μ³ñ Ùáï 53 ¨ 47% (ÙÇÝã¹»é Áëï ²ìÌ ïíÛ³ÉÝ»ñÇ` Ù³ñ½Ç ù³Õ³ù³μÝ³Ï μÝ³ÏãáõÃÛ³Ý Ù³ëÝ³μ³ÅÇÝÁ Ï³½ÙáõÙ ¿ ßáõñç 63%):

Ð²Ü-Ç ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóáõÙ 2005-2009 ÃÃ. ÁÝÃ³óùáõÙ Ëáñ³óí³Í ³ÏÝ³ÛÇÝ Ñ»ï³½áïáõÃÛáõÝÝ»ñ ¿ ³Ýó»É Ù³ñ½Ç 2,724 μÝ³ÏÇã, áñáÝóÇó 1,153-Á íÇñ³Ñ³ïí»É áõ É³½»ñ³ÛÇÝ μáõÅáõÙ »Ý ëï³ó»É:

46

Æñ »ñÏñáñ¹ ¨ »ññáñ¹ ßñç³Ûó»ñÇ ÁÝÃ³óùáõÙ Ð²Ü-Á ³Ýí×³ñ ³ÏÝáó ¿ ïñ³Ù³¹ñ»É ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ ¹ñ³ Ï³ñÇùÝ áõÝ»óáÕ ¨ ëáóÇ³É³å»ë Ëáó»ÉÇ ËÙμ»ñÇÝ å³ïÏ³ÝáÕ 3,948 Ù³ñ¹áõ:

5.7. êÚàôÜÆøÆ Ø²ð¼

´Ý³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñ Çñ³Ï³Ý³óÝ»Éáõ Ýå³ï³Ïáí 2004, 2006 ¨ 2008 ÃÃ. ÁÝÃ³óùáõÙ Ð²Ü-Ç ³ÏÝ³μáõÛÅÝ»ñÝ áõ ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóÁ »ñ»ù ßñç³Ûó »Ý Ï³ï³ñ»É êÛáõÝÇùÇ Ù³ñ½Ç ù³Õ³ù³ÛÇÝ áõ ·ÛáõÕ³Ï³Ý Ñ³Ù³ÛÝùÝ»ñáõÙ: ²Û¹ ÁÝÃ³óùáõÙ Ð²Ü-Á Ñ»ï³½áï»É ¿ ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ Ù³ñ½Ç 12,928 μÝ³ÏãÇ, áñáÝó ßáõñç 56%-Á ã³÷³Ñ³ë μÝ³ÏãáõÃÛáõÝ ¿ »Õ»É, ÇëÏ 44%-Á` »ñ»Ë³:


47


5.8. î²ìàôÞÆ Ø²ð¼

´Ý³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñ Çñ³Ï³Ý³óÝ»Éáõ Ýå³ï³Ïáí 2004, 2007 ¨ 2009 ÃÃ. ÁÝÃ³óùáõÙ Ð²Ü-Ç ³ÏÝ³μáõÛÅÝ»ñÝ áõ ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóÁ »ñ»ù ßñç³Ûó »Ý Ï³ï³ñ»É î³íáõßÇ Ù³ñ½Ç ù³Õ³ù³ÛÇÝ áõ ·ÛáõÕ³Ï³Ý Ñ³Ù³ÛÝùÝ»ñáõÙ: ²Û¹ ÁÝÃ³óùáõÙ Ð²Ü-Á Ñ»ï³½áï»É ¿ ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ Ù³ñ½Ç 14,210 μÝ³ÏãÇ, áñáÝó ßáõñç 65%-Á ã³÷³Ñ³ë μÝ³ÏãáõÃÛáõÝ ¿ »Õ»É, ÇëÏ 35%-Á` »ñ»Ë³:

48



5.9. ì²Úàò ÒàðÆ Ø²ð¼

´Ý³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ³ÏÝ³ÛÇÝ ½ÝÝáõÙÝ»ñ Çñ³Ï³Ý³óÝ»Éáõ Ýå³ï³Ïáí 2003, 2006 ¨ 2008 ÃÃ. ÁÝÃ³óùáõÙ Ð²Ü-Ç ³ÏÝ³μáõÛÅÝ»ñÝ áõ ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóÁ »ñ»ù ßñç³Ûó »Ý Ï³ï³ñ»É ì³Ûáó ÓáñÇ Ù³ñ½Ç ù³Õ³ù³ÛÇÝ áõ ·ÛáõÕ³Ï³Ý Ñ³Ù³ÛÝùÝ»ñáõÙ: ²Û¹ ÁÝÃ³óùáõÙ Ð²Ü-Á Ñ»ï³½áï»É ¿ ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ Ù³ñ½Ç 10,047 μÝ³ÏãÇ, áñáÝó ßáõñç 62%-Á ã³÷³Ñ³ë μÝ³ÏãáõÃÛáõÝ ¿ »Õ»É, ÇëÏ 38%-Á` »ñ»Ë³:

49

Ð²Ü-Ç ³ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóáõÙ 2003-2008ÃÃ. ÁÝÃ³óùáõÙ Ëáñ³óí³Í ³ÏÝ³ÛÇÝ Ñ»ï³½áïáõÃÛáõÝÝ»ñ ¿ ³Ýó»É Ù³ñ½Ç 1,071 μÝ³ÏÇã, áñáÝóÇó 452-Á íÇñ³Ñ³ïí»É áõ É³½»ñ³ÛÇÝ μáõÅáõÙ »Ý ëï³ó»É:

Ð²Ü-Á 549 ³Ýí×³ñ ³ÏÝáó ¿ ïñ³Ù³¹ñ»É Ù³ñ½Ç` ¹ñ³ Ï³ñÇùÝ áõÝ»óáÕ ¨ ëáóÇ³É³å»ë Ëáó»ÉÇ ËÙμ»ñÇÝ å³ïÏ³ÝáÕ μÝ³ÏãáõÃÛ³ÝÁ:

50

Ð²ìºÈì²ÌÜºð

1

------------------------------------------------------------------------------------- ´Ý³ÏãáõÃÛ³Ý ï»ëáÕáõÃÛ³Ý ÁÝ¹Ñ³Ýáõñ Ñ»ï³½áïáõÃÛ³Ý

Ñ³ñó³Ã»ñÃ

Ð³ñó³Ã»ñÃÇ Ñ³Ù³ñÁ Ð»ï³½áïáõÃÛ³Ý ³Ùë³ÃÇíÁ ûñ ³ÙÇë ï³ñ»ÃÇí Ð»ï³½áïáõÃÛ³Ý ³ÝóÏ³óÙ³Ý í³ÛñÁ` 1. Ø³ñ½ ___________________________________(³ÝáõÝÁ)

2. Ð³Ù³ÛÝù_________________________________(³ÝáõÝÁ)

3. Ð³Ù³ÛÝùÇ ïÇåÁ ø³Õ³ù ¶ÛáõÕ

Ð»ï³½áïíáÕÇ` ²ÝáõÝÁ_____________________________________ Ð³Ûñ³ÝáõÝÁ_________________________________ ²½·³ÝáõÝÁ__________________________________ ê»éÁ ³ñ³Ï³Ý Ç·³Ï³Ý ÌÝÝ¹Û³Ý ï³ñ»ÃÇíÁ ²ÝÓÝ³·ñÇ ë»ñÇ³Ý ¨ Ñ³Ù³ñÁ ´Ý³ÏáõÃÛ³Ý í³ÛñÁ` 1. Ø³ñ½ _________________ 2. Ð³Ù³ÛÝù________________ 3. Ð³ëó»________________________ ³ÝáõÝÁ ³ÝáõÝÁ ÷áÕáó, ïáõÝ, Ý³Ï.

Ð»é³ËáëÁ_____________________________

Ð³ßí³éí³±Í ¿ ÁÝï³Ý»Ï³Ý Ýå³ëïÝ»ñÇ Ñ³Ù³Ï³ñ·áõÙ (Ýß»ù §³Ûá¦ å³ï³ëË³ÝÁ)

ä³ïÏ³Ýáõ±Ù ¿ å»ïå³ïí»ñÇó û·ïíáÕ Ëáó»ÉÇ ËÙ »ñÇó áñ¨¿ Ù»ÏÇÝ (Ýß»ù §³Ûá¦ å³ï³ëË³ÝÁ)

Ü³ËÏÇÝáõÙ ³Ûó»É»±É ¿ Ð²Ü ÅÇßÏÝ»ñÇÝ ._____________________________

ºÃ» ³Ûá, Ç±Ýã û·ÝáõÃÛáõÝ ¿ ëï³ó»É Ýñ³ÝóÇó (Ýß»ù §³Ûá¦ å³ï³ëË³ÝÝ»ñÁ).

§Ð³ÛÏ³Ï³Ý ²ÏÝ³ áõÅáõÃÛ³Ý Ý³Ë³·ÇÍ¦ ³ñ»·áñÍ³Ï³Ý ÑÇÙÝ³¹ñ³Ù

AECP /Ð²Ü/

1. ²Ûá 2. àã

1. î»ëáÕáõÃÛ³Ý ëïáõ·áõÙ

2. ²ÏÝáóÇ Ýß³Ý³ÏáõÙ

3. ²ÏÝáó

4. êïáõ·áõÙ ²ÞÐ-áõÙ

5. È³½»ñ³ÛÇÝ ÙÇç³ÙïáõÃÛáõÝ ²ÞÐ-áõÙ

6. ìÇñ³Ñ³ïáõÃÛáõÝ ²ÞÐ-áõÙ

Ð²ìºÈì²Ì 1

51

2

´³ÅÇÝ A. ²ÝÓÝ³Ï³Ý ³éáÕçáõÃÛáõÝ ¨ ¹ñ³ å³Ñå³ÝáõÙ

A_1. ì»ñçÇÝ 12 ³ÙÇëÝ»ñÇ ÁÝÃ³óùáõÙ áñ¨¿ ÅßÏÇ ³Ûó»É»É Ï³Ù ÅßÏ³Ï³Ý ËáñÑñ¹³ïíáõÃÛáõÝ ëï³ó»±É »ù.______________________________ A_2. ºÃ» áã, ³å³ í»ñçÇÝ ³Ý·³Ù »±ñ »ù ³Ûó»É»É áñ¨¿ ÅßÏÇ, Ï³Ù ËáñÑñ¹³ïíáõÃÛáõÝ ëï³ó»É. _______________________________________

A_3. Ò»½ Ùáï »ñ ¨¿ ³Ëïáñáßí»±É »Ý Ñ»ï¨Û³É ÑÇí³Ý¹áõÃÛáõÝÝ»ñÁ (Ýß»É “³Ûá” å³ï³ëË³ÝÝ»ñÁ).

A_4. ¸áõù áõÝ»±ù ³ñÛ³Ý ³ñÓñ ×ÝßáõÙ/ÑÇå»ñïáÝÇ³.__________________________

A_5. ºÃ» ³Ûá, ù³ÝÇ± ï³ñÇ ¿ áñ áõÝ»ù ³ñÛ³Ý ³ñÓñ ×ÝßáõÙ. (ï³ñÇÝ»ñÇ ÃÇíÁ)

A_6. ºÃ» áõÝ»ù ³ñÛ³Ý ³ñÓñ ×ÝßáõÙ , ³ñ¹Ûá±ù ³ÛÝ ³Ëïáñáß»É ¿ ÅÇßÁ._______

A_7. ºÃ» ³Ûá, ³ËïáñáßáÕ ÅÇßÏÁ áõÕ»·ñ»±É ¿ Ò»½ ³ÏÝ³ áõÛÅÇ Ùáï._________

A_8. ÆëÏ ¸áõù ³Û¹ áõÕ»·ñÙ³Ù ¹ÇÙ»±É »ù ³ÏÝ³ áõÛÅÇ.______________________

A_9. ºñ ¨¿ ÅÇßÏÁ Ò»½ Ùáï ³Ëïáñáß»±É ¿ ß³ù³ñ³Ëï________________________

A_10. ºÃ» ³Ûá, ³å³ ù³ÝÇ± ï³ñÇ ³é³ç (ï³ñÇÝ»ñÇ ÃÇíÁ).________________

A_11. ºÃ» ³Ûá, ³ËïáñáßáÕ ÅÇßÏÁ áõÕ»·ñ»±É ¿ Ò»½ ³ÏÝ³ áõÛÅÇ Ùáï._______

A_12. ÆëÏ ¸áõù ³Û¹ áõÕ»·ñÙ³Ù ¹ÇÙ»±É »ù ³ÏÝ³ áõÛÅÇ.____________________

A_13. ¸áõù ÝÏ³ïáõ±Ù »ù áñ áõÝ»ù Ñ»ï¨Û³É »ñ¨áõÛÃÝ»ñÁ (Ýß»É “³Ûá” å³ï³ëË³ÝÝ»ñÁ).

A_14. àõÝ»±ù ³ñÛáõÝ³ÏÇó Ñ³ñ³½³ïÝ»ñ, áñáÝó Ùáï ³Ëïáñáßí»É ¿ Ýßí³ÍÁ (Ýß»É “³Ûá” å³ï³ëË³ÝÝ»ñÁ). ÀÝ¹Ñ³Ýáõñ ÑÇí³Ý¹áõÃÛáõÝÝ»ñ ²ãùÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñ

Þ³ù³ñ³Ëï ¶É³áõÏáÙ³ Î³ï³ñ³Ïï

1 àã, ãáõÝ»Ù ³Û¹åÇëÇ Ñ³ñ³½³ï 2 ²Ûá, ÍÝáÕÝ»ñë/ÍÝáÕë 3 ²Ûá, Ñ³ñ³½³ï ùáõÛñë/»Õ ³Ûñë 4 ²Ûá, ï³ïë/å³åë 5 ²Ûá, ³ÛÉ ÙáïÇÏ Ñ³ñ³½³ï

A_15. ÆÝãå»±ë Ï·Ý³Ñ³ï»ù Ò»ñ ÁÝ¹Ñ³Ýáõñ ³éáÕç³Ï³Ý íÇ×³ÏÁ Ý»ñÏ³ÛáõÙë.______

1. ²Ûá A_3 2. àã

1. Ø»ÏÇó 1,5 ï³ñÇ ³é³ç 2. 2-2,5 ï³ñÇ ³é³ç 3. 3-4 ï³ñÇ ³é³ç 4. 5 ¨ ³í»ÉÇ ï³ñÇÝ»ñ ³é³ç 5. ºñ »ù

1. ²Ûá 2. àã A_13

1.Þ³ï í³ï 2.ì³ï 3.´³í³ñ³ñ 4.È³í 5.Þ³ï É³í

1. êñï³ÝáÃ³ÛÇÝ 2. ²ñÛ³Ý 3. ì³Ñ³Ý³·»ÕÓÇ 4. ²Õ»-ëï³Ùáùë³ÛÇÝ

5 ºñÇÏ³ÙÝ»ñÇ 6. Âáù»ñÇ ¨/Ï³Ù ßÝãáõÕÇÝ»ñÇ 7. Ðá¹»ñÇ/³ñÃñÇï 8. ²ÛÉ________________________(Ýß»É)

1. ²Ûá 2. àã A 9

1. ²Ûá 2. àã A 9

1. ²Ûá 2. àã

1. ²Ûá 2. àã A 13

1. ²Ûá 2. àã

1. êáíáñ³Ï³ÝÇó ³í»ÉÇ Ñ³×³Ë³ÏÇ Í³ñ³íÇ ½·³óáõÙ 2. êáíáñ³Ï³ÝÇó ³í»ÉÇ Ñ³×³Ë³ÏÇ ÙÇ½»Éáõ å³Ñ³Ýç 3. ø³ßÇ ÏïñáõÏ ¨ ½·³ÉÇ ³í»É³óáõÙ Ï³Ù Ïáñáõëï

4. Ì³ÏÍÏáóÝ»ñ ¨ ÃÙñ³ÍáõÃÛáõÝ í»ñçáõÛÃÝ»ñáõÙ 5. ²ÝÁÝ¹Ñ³ï Ñá·Ý³ÍáõÃÛ³Ý ½·³óáõÙ 6. â»Ù ÝÏ³ï»É ëñ³ÝóÇó áã Ù»ÏÁ

1. ²Ûá 2. àã A 9

52

3

A_16. ¸áõù ÍËáõ±Ù »ù._______________________________________________________

A_17. ¸áõù ³ÉÏáÑáÉ Ñ³×³Ë (ß³ ³ÃÁ 4-5 ³Ý·³Ù) û·ï³·áñÍáõ±Ù »ù._______________

´³ÅÇÝ B. ²ÏÝ³ÛÇÝ ³éáÕçáõÃÛáõÝ ¨ ¹ñ³ å³Ñå³ÝáõÙ

B_1. ì»ñçÇÝ 12 ³ÙÇëÝ»ñÇ ÁÝÃ³óùáõÙ ³ãù»ñÇ Ï³Ù ï»ëáÕáõÃÛ³Ý Ñ»ï Ï³åí³Í ËÝ¹ÇñÝ»ñ/·³Ý·³ïÝ»ñ áõÝ»ó»±É »ù._____________________________

B_2. ºÃ» ³Ûá, ¹ÇÙ»±É »ù ³ÏÝ³ áõÛÅÇ._________________________________________

B_3. ºÃ» ·³Ý·³ï »ù áõÝ»ó»É ¨ ã»ù ¹ÇÙ»É ³ÏÝ³ áõÛÅÇ, ³å³ á±ñÝ ¿ ¹ñ³ å³ï×³éÁ.

B_4. ì»ñçÇÝ ³Ý·³Ù »±ñ »ù ³Ûó»É»É ³ÏÝ³ áõÛÅÇ. _______________________________

B _5. ì»ñçÇÝ ³Ý·³Ù Ç±Ýã Ýå³ï³Ïáí »ù ³Ûó»É»É ³ãùÇ ÅßÏÇ._________________

B _6. Ò»½ Ùáï »ñ ¨¿ ³ÏÝ³ÛÇÝ ÑÇí³Ý¹áõÃÛáõÝ Ï³Ù ï»ëáÕáõÃÛ³Ý åñá É»Ù ³Ëïáñáßí»±É ¿ ._________

B _7. ºÃ» ³Ûá, ³å³ ÇÝãåÇëÇ± (Ýß»É “³Ûá” å³ï³ëË³ÝÝ»ñÁ).

B _8. ¸áõù ³ãùÇ íÇñ³Ñ³ïáõÃÛáõÝ »ñ ¨¿ áõÝ»ó»±É »ù.___________________________

B _9. Ò»½ »ñ ¨¿ ³ÏÝáó Ýß³Ý³Ïí»±É ¿._____________________________________

B _10. ¸áõù ³ÏÝáó Ïñáõ±Ù »ù._____________________________________________

B _11. ºÃ» Ò»½ ³ÏÝáó »Ý Ýß³Ý³Ï»É ¨ ¹áõù ã»ù ÏñáõÙ, ³å³ ÇÝãáõ± ._____________

B _12. ÆÝãá±í ¿ å³ÛÙ³Ý³íáñí³Í Ð²Ü Ò»ñ ³Ûó»ÉáõÃÛáõÝÝ ³Ûëûñ .______________

B _13. ºÃ» áõÝ»ù ·³Ý·³ïÝ»ñ ³ãù»ñÇ Ñ»ï Ï³åí³Í, ³å³ ÇÝãåÇëÇ± (Ýß»ù §³Ûá¦ å³ï³ëË³ÝÝ»ñÁ).

1. ì»ñçÇÝ 12 ³ÙÇëÝ»ñÇ ÁÝÃ³óùáõÙ 2. Ø»ÏÇó 1,5 ï³ñÇ ³é³ç 3. 2-2.5 ï³ñÇ ³é³ç 4. 3-4 ï³ñÇ ³é³ç 5. 5 ¨ ³í»ÉÇ ï³ñÇÝ»ñ ³é³ç 6. ºñ »ù ã»Ù »Õ»É ³ÏÝ³ áõÛÅÇ Ùáï B _6

1. Î³ÝË³ñ·»ÉÇã ëïáõ·Ù³Ý 2. ´áõÅÙ³Ý/ËáñÑñ¹³ïíáõÃÛ³Ý 3. ìÇñ³Ñ³ïáõÃÛ³Ý/ÙÇç³ÙïáõÃÛ³Ý 4. ²ÏÝáóÇ ¹»Õ³ïáÙëÇ 5. ²ÛÉ____________________________/Ýß»É/

1. ²Ûá 2. àã B 8

1. ²Ûá 2. àã

1. ²Ûá, Ñ»éáõÝ ï»ëÝ»Éáõ 2. ²Ûá, ÙáïÇÏÁ ï»ëÝ»Éáõ 3. ²Ûá, »ñÏáõëÝ ¿É 4. àã

1. ²Ûá 2. àã

1. ²Ûá 2. àã

1. ²Ûá 2. àã B_4

1. ²Ûá B_5 2. àã

1. Øáï³Ï³ ³ÏÝ³ áõÅÁ ß³ï Ñ»éáõ ¿ 2. Ä³Ù³Ý³Ï ãáõÝ»Ù 3. ÜÛáõÃ³Ï³Ý ÙÇçáóÝ»ñ ãáõÝ»Ù 4. â»Ù íëï³ÑáõÙ ï»ÕÇ Ù³ëÝ³·»ïÇÝ 5. ²ÛÉ_______________________/Ýß»É/

1. ²Ûá 2. àã

1. ¶É³áõÏáÙ³ /³ãùÇ ×ÝßáõÙ/ 2. Î³ï³ñ³Ïï /÷³é/ 3. ²ãùÇ áñ áùáõÙ 4. Øë³ÙáÉ /¹ñëÇ ÷³é/ 5. ²ÏÝ³Ñ³ï³ÏÇ ÑÇí./³ãùÇ Ý»ñëÇ ÑÇí./

6. ò³Íñ ï»ëáÕáõÃÛáõÝ 7. Î³ñ×³ï»ëáõÃÛáõÝ 8. Ð»é³ï»ëáõÃÛáõÝ 9. ÞÉáõÃÛáõÝ 10. ²ÛÉ___________________/Ýß»É/

1. Î³ñ¹³Éáõ ¹Åí³ñáõÃÛáõÝÝ»ñ 2. î»ëáÕáõÃÛ³Ý í³ï³óáõÙ 3. ´áñ áùí³ÍáõÃÛáõÝ 4. øáñ 5. ²ñï³¹ñáõÃÛáõÝ ³ãùÇó

6. ²ãùÇ ó³í 7. ²ñóáõÝù³ÑáëáõÃÛáõÝ 8. ²ÏÝáóÇ Ï³Ù ¹ñ³ ¹»Õ³ïáÙëÇ Ï³ñÇù 9. úï³ñ Ù³ñÙÝÇ (³í³½Ç) ½·³óáÕáõÃÛáõÝ 10. îÑ³× ½·³óáõÙ ³ãù»ñáõÙ 11. ²ÛÉ ·³Ý·³ï_________________/Ýß»É/

1. âÇ û·ÝáõÙ 2. ²ÝÑ³ñÙ³ñ³í»ï ¿ 3. ²Ù³ãáõÙ »Ù 4. ØÇçáóÝ»ñ ãáõÝ»Ù 5. ²ÛÉ

1. ¶³Ý·³ï ãáõÝ»Ù, áõ½áõÙ »Ù Ï³ÝË³ñ·»ÉÇã ëïáõ·í»É ³í³ñï 2. àõÝ»Ù ·³Ý·³ïÝ»ñ ³ãù»ñÇó/ï»ëáÕáõÃÛáõÝÇó

53

4

Ð²Ü-Ç ´ÄÞÎ²Î²Ü ¶ð²èàôØÜºð

Î³Û³Ý 1: î»ëáÕáõÃÛáõÝ OD OS ²ÏÝ³·Ý¹Ç ³ó³Ï³ÛáõÃÛáõÝ No Globe/Anophtalm OD OS OD OS OD OS î»ëáÕáõÃÛáõÝÝ ³é³Ýó ³ÏÝáóÇ

î»ëáÕáõÃÛáõÝÁ ÷ÇÝÑáÉáí

î»ëáÕáõÃÛáõÝÝ ³ÏÝáóáí

------------------------------------------------------------------------------------------------------------------------------------------------ OD OS è»ýñ³ÏóÇ³ÛÇ Ë³Ý·³ñáõÙ R

------------------------------------------------------------------------------------------------------------------------------------------------ Î³Û³Ý 2: ²ãùÇ ×ÝßáõÙ OD OS OD OS ä³Éå³óÇ³Ý ÝáñÙ³ÛÇó ³ñÓñ ¿ PN îáÝáå»ÝÇ ã³÷áõÙÁ IOP ¶É³áõÏáÙ³ÛÇ Ï³ëÏ³Í G1 ------------------------------------------------------------------------------------------------------------------------------------------------ Î³Û³Ý 3: OD OS ÎáåÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñ E ÞÉáõÃÛáõÝ S ²ÏÝ³·Ý¹Ç ³å³×, ÷á÷áËáõÃÛáõÝ Gl ÎáÝÛáõÏïÇíÇï Con äï»ñÇ·ÇáõÙ P ºÕç»ñ³Ã³Õ³ÝÃÇ ³Ëï³Ñ³ñáõÙ/ÑÇí³Ý¹áõÃÛáõÝ K Î³ï³ñ³Ïï, ³Û¹ ÃíáõÙ` C Ð³ëáõÝ Ï³ï³ñ³Ïï CC ----------------------------------------------------------------------------------------------------------------------------------------------- Î³Û³Ý 4: Ü³ËÏÇÝ íÇñ³Ñ³ïáõÃÛáõÝÝ»ñ OD OS ²ÏÝ³ÛÇÝ Ý³ËÏÇÝ íÇñ³Ñ³ïáõÃÛáõÝ, ³Û¹ ÃíáõÙ` SP

ìÇñ³Ñ³ïí³Í Ï³ï³ñ³Ïï, ³Û¹ ÃíáõÙ` Cp ²ý³ÏÇ³ A öë»í¹á³ý³ÏÇ³/²ñïÇý³ÏÇ³ PA Ð»ïÇÝ å³ïÇ×Ç ýÇ ñá½ Fib

ìÇñ³Ñ³ïí³Í ·É³áõÏáÙ³ Gp ìÇñ³Ñ³ïí³Í »Õç»ñ³Ã³Õ³ÝÃ Kp

Î³Û³Ý 4: OD OS ¶É³áõÏáÙ³ G î»ë³ÝÛ³ñ¹Ç áã ·É³áõÏáÙ³ïá½ ³Ëï³Ñ³ñáõÙ N ²ÏÝ³Ñ³ï³ÏÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñ, ³Û¹ ÃíáõÙ` F

¸Ç³ »ïÇÏ é»ïÇÝáå³ïÇ³ DR ÐÇå»ñïáÝÇÏ é»ïÇÏáå³ïÇ³ HR ´³ñÓñ Ï³ñ×³ï»ëáõÃÛáõÝ M Ø³ÏáõÉÛ³ñ ¹»·»Ý»ñ³óÇ³ MD

²ÛÉ_________________________________________Ýß»É

´áõÅáõÙ` Üß³Ý³Ïí»É ¿ áõÅáõÙ___________________________________________________________

àõÕ»·ñáõÙ`

Ð»ï³½áï³Ï³Ý ËáõÙ ÅÇßÏ /³½·³ÝáõÝ/ ÏÉ.ûñ¹/³½·³ÝáõÝ/ ùáõÛñ/³½·³ÝáõÝ/

àôÕ»·Çñ ²ÞÐ ¸ÇÙ»É ºñ¨³Ý` ³ÏÝ³ÛÇÝ ÏÉÇÝÇÏ³

¸ÇÙ»É ï³ñ³Íù. ³ÏÝ³ áõÛÅÇÝ ¸ÇÙ»É ï³ñ³Íù. ¿Ý¹áÏñÇÝáÉá·ÇÝ

¸ÇÙ»É ï³ñ³Íù. ÝÛ³ñ¹³ ³ÝÇÝ ¸ÇÙ»É ï³ñ³Íù. Ã»ñ³å»íïÇÝ

Ð²Ü-ÇÝ å³ïíÇñí³Í ³ÏÝáóÇ ¹»Õ³ïáÙë

²ç ³ãù

êý. òÇÉ. ²é.

Ò³Ë ³ãù

êý. òÇÉ. ²é.

DPP ÙÙ

54

Ð²ìºÈì²Ì 2

§ìÇÅÁÝ-2020¦-Á, áñÝ ²éáÕç³å³ÑáõÃÛ³Ý Ñ³Ù³ßË³ñÑ³ÛÇÝ Ï³½Ù³Ï»ñåáõÃÛ³Ý (World Health Organization/WHO) ¨ ÎáõñáõÃÛ³Ý Ï³ÝË³ñ·»ÉÙ³Ý ÙÇç³½·³ÛÇÝ ·áñÍ³Ï³ÉáõÃÛ³Ý (International Agency for the Prevention of Blindness /IAPB) Ý³Ë³Ó»éÝáõÃÛáõÝÝ ¿, Ïáã ¿ ³ÝáõÙ ÙÇÝã¨ 2020 Ãí³Ï³ÝÁ ½·³ÉÇáñ»Ý Ýí³½»óÝ»É Ï³ÝË³ñ·»ÉÇ ÏáõñáõÃÛáõÝÁ ³ßË³ñÑáõÙ: ²ÛÝ Ñáñ¹áñáõÙ ¿ »ñÏñÝ»ñÇ Ï³é³í³ñáõÃÛáõÝÝ»ñÇÝ Ùß³Ï»É ÏáõñáõÃÛ³Ý Ï³ÝË³ñ·»ÉÙ³Ý ³½·³ÛÇÝ é³½Ù³í³ñáõÃÛáõÝÝ»ñ ¨ Ó»éÝ³ÙáõË ÉÇÝ»É ¹ñ³Ýó Çñ³Ï³Ý³óÙ³ÝÁ:

Æ å³ï³ëË³Ý §ìÇÅÁÝ-2020¦-Ç ÏáãÇÝ, ÐÐ ³éáÕç³å³ÑáõÃÛ³Ý Ý³Ë³ñ³ñáõÃÛáõÝÁ, Ð³Û³ëï³ÝÇ ³Ù»ñÇÏÛ³Ý Ñ³Ù³Éë³ñ³ÝÇ Î³ñá Ø»ÕñÇÏÛ³ÝÇ ³ãùÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ Ï³ÝË³ñ·»ÉÙ³Ý Ï»ÝïñáÝÇ Ý³Ë³Ó»éÝáõÃÛ³Ùμ, ëÏë»ó Ð³Û³ëï³ÝÇ ÏáõñáõÃÛ³Ý Ï³ÝË³ñ·»ÉÙ³Ý ³½·³ÛÇÝ Íñ³·ñÇ /ÐÎÎ²Ì/ Ùß³ÏÙ³Ý ³ßË³ï³ÝùÝ»ñÁ:

ÎáõñáõÃÛ³Ý Ï³ÝË³ñ·»ÉÙ³Ý ³½·³ÛÇÝ ÏáÙÇï»Ý ëï»ÕÍí»ó 2004 Ã.:

Ð³Û³ëï³ÝÇ ÏáõñáõÃÛ³Ý Ï³ÝË³ñ·»ÉÙ³Ý ³½·³ÛÇÝ Íñ³·ÇñÝ ³Ý¹ñ³¹³éÝáõÙ ¿ §ìÇÅÁÝ-2020¦-Ç ÑÇÙÝ³Ï³Ý Ýå³ï³ÏÝ»ñÇÝ ¨ ³é³çÝ³ÛÝáõÃÛáõÝÝ»ñÇÝ` ï»Õ³ÛÝ³óÝ»Éáí ¹ñ³Ýù Ñ³ÛÏ³Ï³Ý Çñ³Ï³ÝáõÃÛ³ÝÁ: ÐÎÎ²Ì-Á áõÕÕí³Í ¿ Ñ³Ù³Ï³ñ·»Éáõ ÐÐ-áõÙ å»ï³Ï³Ý ¨ Ñ³ë³ñ³Ï³Ï³Ý Ù³ñÙÇÝÝ»ñÇ ·áñÍáõÝ»áõÃÛáõÝÁ, ÇÝãÇ ßÝáñÑÇí ÑÝ³ñ³íáñ ÏÉÇÝÇ ½³ñ·³óÝ»É ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñÁ ¨ ³ñ¹ÛáõÝ³í»ï Ï»ñåáí Ýí³½»óÝ»É ÏáõñáõÃÛáõÝÁ Ñ³Ýñ³å»ïáõÃÛáõÝáõÙ: Ð³Û³ëï³ÝÇ ÏáõñáõÃÛ³Ý Ï³ÝË³ñ·»ÉÙ³Ý ³½·³ÛÇÝ Íñ³·ÇñÝ Ñ³ëï³ïí»ó ÐÐ Ï³é³í³ñáõÃÛ³Ý ÏáÕÙÇó 02/11/2006 Ã. /N-43-Ü áñáßáõÙ/: Ìñ³·ÇñÁ Ý»ñ³éáõÙ ¿ ÙÇ³ÛÝ 2006-2010 ÃÃ. Å³Ù³Ý³Ï³Ñ³ïí³ÍÁ:

Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÇÍÁ ³ÛÝ Ï³½Ù³Ï»ñåáõÃÛáõÝÝ»ñÇ ÃíáõÙ ¿, áñáÝù Ù³ëÝ³Ïó»É »Ý ÐÎÎ²Ì-Ç Çñ³Ï³Ý³óÙ³ÝÁ: Ð²Ü-Ç Ñ³Ù³å³ñ÷³Ï Íñ³·ñÇ ·áñÍáõÝ»áõÃÛáõÝÁ Ù»Í³å»ë Ýå³ëï»É ¿ ÐÎÎ²Ì-Ç Ûáõñ³ù³ÝãÛáõñ ¨ μáÉáñ Ýå³ï³ÏÝ»ñÇ Çñ³Ï³Ý³óÙ³ÝÁ: ¸ñ³ Ù³ëÇÝ ¿ íÏ³ÛáõÙ ¿ ÐÎÎ²Ì-Ç ³í³ñïÇ Ï³å³ÏóáõÃÛ³Ùμ ÐÐ ³éáÕç³å³ÑáõÃÛ³Ý Ý³Ë³ñ³ñáõÃÛ³Ý å³ïñ³ëï³Í ï»Õ»Ï³ÝùÁ:

Տ Ե Ղ Ե Կ Ա Ն ՔÐÐ Ï³é³í³ñáõÃÛ³Ý 2006 Ãí³Ï³ÝÇ

02.11.2006 Ãí³Ï³ÝÇ N 43 -Ü áñáßÙ³Ý կատարման վերաբերյալ

ԸՆԴՀԱՆՈՒՐ ԱՌՄԱՄԲ

2007-2010ÃÃ. ²ØÜ Ø¼¶ Հայկական ակնաբուժության նախագծի (ՀԱՆ) և ՀՀ ԱՆ համագործակցության շրջանակներում տարվել է ծավալուն ³ßË³ï³ÝùÝ»ñ ÐÐ Ù³ñ½»ñáõÙ ¨ ÈÐÔ-áõÙ, áñոնց ³ñ¹ÛáõÝùÝ»ñÁ Ñ»ï¨Û³ÉÝ »Ý.

- Կատարվել են ըÝ¹Ñ³Ýáõñ ³ÏÝ³ÛÇÝ Ñ»ï³½áïáõÃÛáõÝÝ»ñ, որոնցում ընդգրկվել է 131790 մարդ, այդ թվում 72147 »ñ»Ë³

55

- Հայտնաբերված հիվանդներից աãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³Ýáó են áõÕ»·ñí»É 11026 ÑÇí³Ý¹

- ²ãùÇ ß³ñÅ³Ï³Ý ÑÇí³Ý¹³ÝáóáõÙ íÇñ³Ñ³ïí»É »Ý 4961 ÑÇí³Ý¹, որոնցից É³½»ñ³ÛÇÝ ÙÇç³ÙïáõÃÛ³Ý »Ý »ÝÃ³ñÏí»É 1434 –ը

- Անվճար տրամադրվել ¿ 24106 ³ÏÝáó

- ì»ñ³å³ïñ³ëïí»É ¿ 326 ÁÝï³Ý»Ï³Ý μÅÇßÏ

- ì»ñ³å³ïñ³ëïí»É ¿ 773 ÁÝï³Ý»Ï³Ý/գյուղական և 133 դպրոցական բուժքույր

- ÎñÏÝ³ÏÇ í»ñ³å³ïñ³ëïáõÙ »Ý ³Ýó»É 57 ÁÝï³Ý»Ï³Ý μÅÇßÏ

- Ø³ëÝ³·Çï³Ï³Ý í»ñ³å³ïñ³ëïáõÙ ¿ ³Ýó»É 61 Ù³ñ½³ÛÇÝ ³ÏÝ³μáõõÛÅ

- Ø³ëÝ³·Çï³Ï³Ý í»ñ³å³ïñ³ëïáõÙ ¿ ³Ýó»É 37 Ù³ñ½³ÛÇÝ ³ÏÝ³μáõÅ³Ï³Ý բուժùáõÛñ

- ²ÝóÏ³óí»É ¿ Ñ³Ýñ³ÛÇÝ ÏñÃáõÃÛ³Ý 349 ¹³ëÁÝÃ³ó

- Ð³Ýñ³ÛÇÝ ÏñÃáõÃÛ³Ý ¹³ëÁÝÃ³óÝ»ñÇÝ Ù³ëÝ³Ïó»É ¿ 8814 ¹åñáó³Ï³Ý

- Ð²Ü-Ç μÅßÏ³Ï³Ý ËÙμ»ñÁ ³Ûó»É»É »Ý 841 Ñ³Ù³ÛÝù

- ÀÝ¹Ñ³Ýáõñ ³éÙ³Ùμ Ù³ñ½»ñáõÙ ³ßË³ï»É »Ý 903 ûñ

- Նախաձեռնվել է մշակել և ներդնել Անհաս ռետինոպատիայի ազգային ծրագիրը, որի նպատակով 2010 թ. հáõÝÇëÇ 28-29-ÇÝ,

Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÇÍÁ, ÐÐ ³éáÕç³å³ÑáõÃÛ³Ý Ý³Ë³ñ³ñáõÃÛ³Ý ¨ ²ØÜ ØÇç³½·³ÛÇÝ ½³ñ·³óÙ³Ý ·áñÍ³Ï³ÉáõÃÛ³Ý Ñ»ï Ñ³Ù³ï»Õ, ³Ýó ¿ Ï³óնելու ÙÇç³½·³ÛÇÝ ÏáÝý»ñ³Ýë` §²ÝÑ³ëáõÃÛ³Ý é»ïÇÝáå³ÃÇ³ÛÇ Ï³ÝË³ñ·»ÉáõÙÁ Ð³Û³ëï³ÝáõÙ¦ Ã»Ù³Ûáí: ²Ûë ÙÇç³½·³ÛÇÝ ÏáÝý»ñ³ÝëÁ ëÏÇ½μ ¿ Ñ³Ý¹Çë³ÝáõÙ ³ÝÑ³ëáõÃÛ³Ý é»ïÇÝáå³ÃÇ³ÛÇ Ï³ÝË³ñ·»ÉÙ³Ý ¨ μáõÅÙ³Ý Íñ³·ñÇ Ñ³Ù³ñ: ²ñ¹»Ý ÇëÏ Ó»éù »Ý μ»ñí»É ³ÝÑñ³Å»ßï ë³ñù³íáñáõÙÝ»ñÁ: ØÇç³½·³ÛÇÝ ÏáÝý»ñ³ÝëÇ ÁÝÃ³óùáõÙ ÏÇñ³Ï³Ý³óíÇ Ñ³Û Ù³ëÝ³·»ïÝ»ñÇ í»ñ³å³ïñ³ëïáõÙ: àÉáñïÇ ³ñï³ë³ÑÙ³ÝÛ³Ý ÷áñÓ³·»ïÝ»ñÁ ³ßË³ï»Éáõ »Ý Ñ³Û Ù³ëÝ³·»ïÝ»ñÇ Ñ»ï ³éÝí³½Ý í»ó ³ÙÇë Ñ»é³μÅßÏáõÃÛ³Ý (telemedicine) ÙÇçáóáí: Ìñ³·ÇñÁ ÃáõÛÉ Ïï³ ³Ù»Ý ï³ñÇ Ùáï 100 ³ÝÑ³ë Ýáñ³ÍÝÇ ÷ñÏ»É ÏáõñáõÃÛ³Ý íï³Ý·Çó:-ՀՀ ԱՆ ԱԱԻ բազան հանդիսացող Քանաքեռ – Զեյթուն ԲԿ –ում բացվել է ò³Íñ ï»ëáÕáõÃÛ³Ý Ï»ÝïñáÝ, որը համապատասխանում է ÙÇç³½·³ÛÇÝ ã³÷áñáßÇãÝ»ñÇն և հնարավորություն է ընձեռում անվճար սպասարկել նման խնդիրներ ունեցող բազմաթիվ ՀՀ քաղաքացիների:

56

- Ստեղծվել է վիրահատական հմտությունների զարգացման կենտրոն (Վետ-լաբ):

- Պատրաստվել և հրատարակվել է ուսումնական ձեռնարկներ և կլինիկական ուղեցույցեր ակնաբույժների, ընտանեկան բժիշկների և համայնքային բուժքույրերի համար:

- Իրականացվել է կատարակտի վիրահատության մոնիտորինգ Աչքի շարժական հիվանդանոցում: Կատարակտի վիրահատության մոնիտորինգի փորձնական ծրագիր ներդրվում է Մալայանի անվան ակնաբուժական կենտրոնում:

Ըստ ՀՀ կառավարության որոշմամբ սահմանված նպատակների կատարված աշխատանքներն են.

Üå³ï³Ï I. 50-Çó μ³ñÓñ ï³ñÇùÇ μÝ³ÏãáõÃÛ³Ý Ùáï »ñÏÏáÕÙ³ÝÇ ÏáõñáõÃÛ³Ý ï³ñ³Íí³ÍáõÃÛáõÝÁ 0.5%-Çó Ñ³ëóÝ»É 0.2 %-Ç:

ºÝÃ³Ýå³ï³ÏÝ»ñ:

Î³ï³ñ³Ïï: Ð³Û³ëï³ÝÇ Ð³Ýñ³å»ïáõÃÛáõÝáõÙ Ï³ï³ñ³ÏïÇ íÇñ³Ñ³ï³Ï³Ý óáõó³ÝÇßÁ 1000-Çó μ³ñÓñ³óÝ»É ÙÇÝã¨ 3000-Ç` Ù»Ï ÙÇÉÇáÝ μÝ³ÏãáõÃÛ³Ý Ñ³ßíáíØ³ñ½³ÛÇÝ ³ÏÝ³μáõÅ³Ï³Ý Ï»ÝïñáÝÝ»ñáõÙ Ý»ñ³ÏÝ³ÛÇÝ áëåÝÛ³ÏÇ ï»Õ³¹ñÙ³Ùμ Ï³ï³ñ³ÏïÇ ¿ùëïñ³Ï³åëáõÉÛ³ñ íÇñ³Ñ³ïáõÃÛáõÝÝ»ñÇ ÁÝ¹Ñ³Ýáõñ ÃÇíÁ 0.03%-Çó Ñ³ëóÝ»É 80%-Ç:Àëï ²éáÕç³å³ÑáõÃÛ³Ý Ð³Ù³ßË³ñÑ³ÛÇÝ Î³½Ù³Ï»ñåáõÃÛ³Ý ÎáõñáõÃÛ³Ý Ï³ÝË³ñ·»ÉÙ³Ý ÏáÙÇï»Ç ã³÷áñáßÇãÝ»ñÇ, μáõÅÙ³Ý ³ÝÑ³çáÕ »Éù»ñÇ ÃÇíÁ 23% -Çó Ñ³ëóÝ»É 5%-Ç:

¶É³áõÏáÙ³: ÎñÏÝ³å³ïÏ»É ÑÇí³Ý¹áõÃÛ³Ý í³Õ ÷áõÉ»ñáõÙ Ñ³ÛïÝ³μ»ñí³Í ·É³áõÏáÙ³Ûáí ÑÇí³Ý¹Ý»ñÇ ã³÷³μ³ÅÇÝÁ:¶É³áõÏáÙ³ÛÇ ï³ñ»Ï³Ý íÇñ³Ñ³ïáõÃÛáõÝÝ»ñÇ ÃÇíÁ ³í»É³óÝ»É 30%-áí¸Ç³μ»ïÇÏ é»ïÇÝáå³ïÇ³: È³½»ñ³ÛÇÝ μáõÅáõÙ ëï³óáÕ ¹Ç³μ»ïÇÏ é»ïÇÝáå³ÃÇ³Ûáí ÑÇí³Ý¹Ý»ñÇ ÃÇíÁ ï³ñ»Ï³Ý 120-Çó Ñ³ëóÝ»É 500-Ç:Þ³ù³ñ³ÛÇÝ ¹Ç³μ»ïáí ·ñ³Ýóí³Í μáÉáñ ÑÇí³Ý¹Ý»ñÇÝ ³å³Ñáí»É ³Ýí×³ñ ³ÏÝ³μáõÅ³Ï³Ý Ñ»ï³½áïáõÃÛáõÝÝ»ñ` ÏÛ³ÝùÇ Ñ³Ù³ñ íï³Ý· ëå³éÝ³óáÕ é»ïÇÝáå³¬ÃÇ³ÛÇ í³Õ Ñ³ÛïÝ³μ»ñÙ³Ý Ñ³Ù³ñ:

1. ÐÐ Ù³ñ½»ñÇ ³ÏÝ³μáõÅ³Ï³Ý Ï»ÝïñáÝÝ»ñÇ ½³ñ·³óÙ³ÝÝ աջակցելու պարտավորությունը հանձն է առել ²ØÜ Ø¼¶ Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅության Ý³Ë³·ÇÍÁ, áñÁ ÙÇÝã ûñë ß³ñáõÝ³ÏáõÙ է Çñ ·áñÍáõÝ»áõÃÛáõÝÁ:

2. Î³ï³ñ³ÏïÇ μáõÅÙ³Ý ¨ ÑëÏáÕáõÃÛ³Ý ³ñ¹ÛáõÝ³í»ï Ùáï»óáõÙÝ»ñÇ ÏÇñ³éÙ³Ý Ýå³ï³Ïáí Ï³ï³ñ³ÏïÇ íÇñ³Ñ³ïáõÃÛáõÝÁ Ï³ï³ñíáõÙ ¿ ³ÏÝ³μáõÅ³Ï³Ý ÏÉÇÝÇÏ³Ý»ñáõÙ Ï³Ù ³ÛÝ μ³½Ù³åñáýÇÉ ÑÇí³Ý¹³ÝáóÝ»ñÇ ³ÏÝ³μáõÅ³Ï³Ý μ³Å³ÝÙáõÝùÝ»ñáõÙ, áñáÝù áõÝ»Ý Ñ³Ù³å³ï³ëË³Ý ÉÇó»Ý½³íáñáõÙ, ³Û¹åÇëáí

57

³å³Ñáí»Éáí íÇñ³Ñ³ïáõÃÛ³Ý ¨ ÑëÏáÕáõÃÛ³Ý Ù³ëÝ³·Çï³Ï³Ý áñ³ÏÁ: ÐÇßÛ³É Ñ³ëï³ïáõÃÛáõÝÝ»ñáõÙ Ï³ï³ñ³ÏïÇ íÇñ³Ñ³ïáõÃÛáõÝÝ»ñÁ Ï³ï³ñíáõÙ »Ý ³Ýí×³ñ` §ëáóÇ³É³å»ë ³Ý³å³Ñáí ¨ Ñ³ïáõÏ ËÙμ»ñում¦ ÁÝ¹·ñÏí³Í ³ÝÓ³Ýó Ñ³Ù³ñ: Ընտանեկան նպաստի 30 և բարձր միավոր ունեցող ընտանիքների անդամները, ինչպես նաև պետպատվերի համակարգով նախատեսված կատեգորիաների ներկայացուցիչների ինչպես նաև հատուկ խմբերում չընդգրկված բայց սոցիալապես խոցելի անձանց ³Ýí×³ñ íÇñ³Ñ³ïáõÃÛáõÝÝ»ñÁ ՀՀ մարզերում Ï³ï³ñíáõÙ են նաև ²ØÜ Ø¼¶ §Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅության Ý³Ë³·ÍÇ¦ աչքի շարժական հիվանդանոցում, ÇÝãå»ë Ý³¨ §Ø³É³Û³ÝÇ ³Ýí³Ý¦ ÏÉÇÝÇÏ³ÛÇ ÏáÕÙÇó` μ³ñ»·áñÍ³Ï³Ý ³ÏóÇ³ÛÇ ßñç³Ý³ÏÝ»ñáõÙ: ²é³ÝÓÇÝ ¹»åù»ñáõÙ /μ³ó³éáõÃÛ³Ý Ï³ñ·áí/, ëáóÇ³É³Ï³Ý ËÙμ»ñáõÙ ãÁÝ¹·ñÏí³Í ³ÝÓ³Ýó ³Ýí×³ñ íÇñ³Ñ³ïáõÃÛáõÝÁ Ï³ï³ñíáõÙ ¿ ÐÐ ³éáÕç³å³ÑáõÃÛ³Ý Ý³Ë³ñ³ñÇ ÃáõÛÉïíáõÃÛ³Ùμ` ÐÐ ²Ü áõÕ»·ñÙ³Ùμ:

3. ÐÐ Ù³ñ½³ÛÇÝ Ï»ÝïñáÝÝ»ñÇ Ù³ëÝ³·»ïÝ»ñÇ ÏáÕÙÇó å³ñï³¹Çñ ³Ûó»ñ ÐÐ Ù³ñ½»ñÇ ·ÛáõÕ³Ï³Ý μÝ³Ï³í³Ûñ»ñ (Ýí³½³·áõÛÝÁ ³ÙÇëÁ 1 ³Ý·³Ù) ¨ §μ³ó ¹éÝ»ñÇ ûñ»ñ¦ (ï³ñ»Ï³Ý ³éÝí³½Ý 2 ³Ý·³Ù) Ï³½Ù³Ï»ñå»Éáõ Ýå³ï³Ïáí, ëÏë³Í 2007Ã. – Çó /ÐÐ ²Ü 29.12.2006Ã. ÃÇí 1565-² Ññ³Ù³Ýáí/, ë³ÑÙ³Ýí»É ¿ å³ñï³¹Çñ ³Ûó»ÉáõÃÛáõÝÝ»ñ ·ÛáõÕ³Ï³Ý í³Ûñ»ñ /ãÑ³ßí³Í μ³ó ¹éÝ»ñÇ ûñ»ñÁ/: ´³óÇ ¹ñ³ÝÇó, ëÏë³Í 2006 Ãí³Ï³ÝÇó, ÐÐ Ù³ñ½»ñÇ åáÉÇÏÉÇÝÇÏ³Ý»ñÇ ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÁ ¹³ñÓ»É ¿ ³Ýí×³ñ` μÝ³ÏãáõÃÛ³Ý μáÉáñ ËÙμ»ñÇ Ñ³Ù³ñ:

4. 2007-2010ÃÃ. ÁÝÃ³óùáõÙ ²ØÜ Ø¼¶ <<Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÍÇ>> ÏáÕÙÇó ³Ûó»ñ են Ï³ï³ñվ»É ÐÐ μáÉáñ Ù³ñ½»ñÇ ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ 850 ·ÛáõÕ³Ï³Ý μÝ³Ï³í³Ûñ»ñ, áñï»Õ Ð²Ü ³ÏÝ³μáõÛÅÝ»ñÁ μ³ó ÁÝ¹áõÝ»ÉáõÃÛ³Ý Å³Ù³Ý³Ï ½ÝÝ»É »Ý ÁÝ¹Ñ³Ýáõñ ³éÙ³Ùμ 41000 ·ÛáõÕ³Ï³Ý μÝ³ÏãÇ: ÐÐ μáÉáñ Ù³ñ½»ñáõÙ ²ØÜ Ø¼¶ Ð²Ü ²ÞÐ-áõÙ /աչքի շարժական հիվանդանոց/ Ï³ï³ñí»É ¿ 3612 Ï³ï³ñ³ÏïÇ íիրահատáõÃÛáõÝ ¨/կամ լազերային միջամտությáõÝ : ՄÇ¨ÝáõÛÝ Å³Ù³Ý³Ï Ï³ï³ñí»É ¿ ï»ÕÇ Ù³ëÝ³·»ïÝ»ñÇ áõëáõóáõÙ` ÏÉÇÝÇÏ³Ï³Ý ÑÙïáõÃÛáõÝÝ»ñÇ ³éáõÙáí, Ù³ëÝ³ÏÇó ¹³ñÓÝ»Éáí μáõÅÙ³ÝÁ ¨ íÇñ³Ñ³ïáõÃÛáõÝÝ»ñÇÝ:

5. Ü»ñ³ÏÝ³ÛÇÝ áëåÝÛ³ÏÇ ï»Õ³¹ñÙ³Ùμ Ï³ï³ñ³ÏïÇ ¿ùëïñ³Ï³åëáõÉÛ³ñ íÇñ³Ñ³ïáõÃÛáõÝÝ»ñÁ Ù³ñ½³ÛÇÝ ³ÏÝ³μáõÅ³Ï³Ý Ï»ÝïñáÝÝ»ñáõÙ ¹³ñÓ»É է å³ñï³¹Çñ, »Ã» ¹³ Ñ³Ï³óáõóí³Í ã¿ ³ÛÉ ÑÇí³Ý¹áõÃÛ³Ý ³éÏ³ÛáõÃÛ³Ý ¹»åùáõÙ: Ներակնային ոëåÝÛ³ÏÝ»ñÁ ïñ³Ù³¹ñíáõÙ »Ý ëáóÇ³É³å»ë ³Ý³å³Ñáí ¨ Ñ³ïáõÏ ËÙμ»ñáõÙ ÁÝ¹·ñÏí³Í ³ÝÓ³Ýó, ÐÐ ²Ü կողմից բարեգործական խողովակներով ստացված, ինչպես նաև ԱՄՆ ՄԶԳ Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÍÇ կողմից` բարեգործական հիմունքներով: Ü»ñ³ÏÝ³ÛÇÝ áëåÝÛ³ÏÇ ï»Õ³¹ñÙ³Ùμ Ï³ï³ñ³ÏïÇ ¿ùëïñ³Ï³åëáõÉÛ³ñ íÇñ³Ñ³ïáõÃÛáõÝÝ»ñÁ Ñ³Ýñ³å»ïáõÃÛáõÝáõÙ ÏÇñ³éíáõÙ ¿ ողջ հանրապետությունում ³Û¹ ÃíáõÙ Ý³¨ ÐÐ Ù³ñ½»ñáõÙ: Տեղադրման տոկոսը մոտ է 100-ի:

58

6. Որակի ապահովում: Համաձայն ÐÐ Ï³é³í³ñáõÃÛ³Ý 18.09.2009Ã. ÃÇí 35 ³ñÓ³Ý³·ñ³ÛÇÝ áñáßÙ³ն, Ùß³Ïí»Éáõ ¨ ՀՀ կառավարության հաստատմանն է ներկայացվել Ոñ³ÏÇ ·Ý³Ñ³ïÙ³Ý Ñ³յեցակարգը, áñÁ ÑÝ³ñ³íáñáõÃÛáõÝ ÏÁÝÓ»éÇ í»ñ³ÑëÏ»É μáõÅû·ÝáõÃÛ³Ý ¨ Ù³ïáõóíáÕ Í³é³ÛáõÃÛáõÝÝ»ñÇ áñ³ÏÁ` բուժօգնության բոլոր մակարդակներում /³Û¹ ÃíáõÙ ³ÏÝ³μáõÅáõÃÛ³Ý μÝ³·³í³éáõÙ/:

Մասնագետների գիտելիքների բարձրացման նպատակով, ԱՄՆ ՄԶԳ Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÍÇ կողմից պատրաստվել է հրատարակվել է ուսումնական ձեռնարկ Ակնաբուժության ընտրանի:

Որակի ապահովմանն է ուղղված նաև ÐÐ Ï³é³í³ñáõÃÛ³Ý 05.12.2002Ã. ÃÇí 1936-Ü áñáßÙ³Ý å³Ñ³Ýçը, ըստ որի` Ûáõñ³ù³ÝãÛáõñ 5 ï³ñÇÝ Ù»Ï μÅÇßÏÝ»ñÇ Ù³ëÝ³·Çï³Ï³Ý í»ñ³å³ïñ³ëïáõÙÁ պարտադիր է: ՈõëïÇ, ³ÏÝ³μáõÛÅÝ»ñÁ ¨ë ³ÝóÝáõÙ »Ý ß³ñáõÝ³Ï³Ï³Ý ÏñÃáõÃÛáõÝ í»ñ³Ý³Ûí³Í ÏñÃ³Ï³Ý Íñ³·ñáí: ´áÉáñ åáÉÇÏÉÇÝÇÏ³Ý»ñÇ ³ÏÝ³μáõÅ³Ï³Ý Ï³μÇÝ»ïÝ»ñÝ áõÝ»Ý Ý»ñ³ÏÝ³ÛÇÝ ×ÝßáõÙÁ ã³÷»Éáõ ¨ ³ÏÝ³Ñ³ï³ÏÁ ½ÝÝ»Éáõ ÑÝ³ñ³íáñáõÃÛáõÝ:

ԱՄՆ ՄԶԳ Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÍÇ կողմից իրականացվել է կատարակտի վիրահատության մոնիտորինգ Աչքի շարժական հիվանդանոցում: Կատարակտի վիրահատության մոնիտորինգի փորձնական ծրագիր ներդրվում է Մալայանի անվան ակնաբուժական կենտրոնում:

7. Գլաուկոմա: êÏë³Í 2008Ã.-ից, ÐÐ ²Ü Ññ³Ù³Ýáí Ñ³ëï³տí³Í ã³÷áñáßիãáí /áñÁ å»ï³Ï³Ý å³ïí»ñÇ ï»Õ³¹ñÙ³Ý Ý³Ë³å³ÛÙ³Ý ¿/, ë³ÑÙ³Ýí»É ¿, áñ å³ñï³¹Çñ Ï³ÝË³ñ·»ÉÇã ³ÛóÇ ßñç³Ý³ÏÝ»ñáõÙ Çñ³Ï³Ý³óí»Éáõ ¿ ·É³áõÏáÙ³ÛÇ í³Õ Ñ³ÛïÝ³μ»ñÙ³Ý ëÏñÇÝÇÝ·:2007-2010ÃÃ. ÁÝÃ³óùáõÙ ԱՄՆ ՄԶԳ – ՀԱՆ-ի կողմից Çñ»Ý ¹ÇÙ³Í μÝ³ÏãáõÃÛ³Ý ßñç³ÝáõÙ ¹Çïí»É ¿ ·É³áõÏáÙ³ÛÇ 1,653 ¹»åù, áñÇó 622-Á հայտնաբերվել է ³é³çÇÝ ³Ý·³Ù:

ԲáÉáñ μÅßÏ³Ï³Ý ³ÙμáõÉ³ïáñÇ³Ý»ñÁ, ÁÝï³Ý»Ï³Ý μÅßÏÇ ·ñ³ë»ÝÛ³ÏÝ»ñÁ ¨ åáÉÇÏÉÇÝÇÏ³Ý»ñÇ ³ÏÝ³μáõÅ³Ï³Ý Ï³μÇÝ»ïÝ»ñÁ áõÝ»Ý ûýï³ÉÙáëÏáå/ տոնոմետր, Ù³ëÝ³·»ïÝ»ñÁ í»ñ³å³ïñ³ëïí»É ¨ ß³ñáõÝ³ÏáõÙ »Ý í»ñ³å³ïñ³ëïí»É ²ØÜ Ø¼¶ Ð²Ü-Ç ÏáÕÙÇó, áñáÝó ÁÝ¹Ñ³Ýáõñ ÃÇíÁ Ï³½ÙáõÙ ¿ -1600 մասնագետ:

¸Ç³μ»ïÇÏ é»ïÇÝáå³ïÇ³: ԱՄՆ ՄԶԳ Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÍÇ կողմից իրականացվել է դիաբետիկ ռետինոպատիայի 400 լազերային միջամտություն: 2008 Ã.Ï³½Ù³Ï»ñåí»É ¿ ë»ÙÇÝ³ñ §¸Ç³μ»ïÁ ¨ ÏáõñáõÃÛáõÝÁ¦ Ã»Ù³Ûáí, áñÇÝ Ù³ëÝ³Ïó»É »Ý ³ÏÝ³μáõÛÅÝ»ñÁ ¨ Ý»ñ½³ï³μ³ÝÝ»ñÁ:

Øß³Ïí»É ¨ å³ñμ»ñ³μ³ñ í»ñ³Ý³Ûí»É »Ý ¹Ç³μ»ïÇ í³ñÙ³Ý áõÕ»óáõÛóÝ»ñÁ ³é³çÝ³ÛÇÝ ûÕ³ÏÇ Ù³ëÝ³·»ïÝ»ñÇ Ñ³Ù³ñ: ì»ñçÇÝ í»ñ³Ý³Ûí³Í ¨ Éñ³Ùß³Ïí³Í ï³ñμ»ñ³ÏÁ Ñ³ëï³ïí»É ¿ ÐÐ ²Ü Ññ³Ù³Ýáí:

59

Üå³ï³Ï II. Üí³½»óÝ»É Ù³ÝÏ³Ï³Ý ÏáõñáõÃÛ³Ý ¹»åù»ñÇ ù³Ý³ÏÁ ¨ μ³ñ»É³í»É »ñ»Ë³Ý»ñÇ ³ãù»ñÇ ³éáÕçáõÃÛáõÝÁ:


´áÉáñ ¹åñáó³Ñ³ë³Ï »ñ»Ë³Ý»ñÇÝ ³å³Ñáí»É ³Ýí×³ñ ³ÏÝ³μáõÅ³Ï³Ý Ñ»ï³½áïáõÃÛáõÝÝ»ñ` é»ýñ³ÏóÇáÝ Ë³Ý·³ñáõÙ¬Ý»ñÇ Ñ³ÛïÝ³μ»ñÙ³Ý ¨ ³é³í»É Ï³ñÇù³íáñÝ»ñÇÝ ³ÏÝáóÝ»ñáí ³å³ÑáíÙ³Ý Ýå³ï³Ïáí:Ð³Ýñ³å»ïáõÃÛáõÝáõÙ ëï»ÕÍ»É ³ÝÑ³ë Ýáñ³ÍÇÝÝ»ñÇ é»ïÇÝáå³ÃÇ³ÛÇ ÑëÏáÕáõÃÛ³Ý ³ñ¹ÛáõÝ³í»ï Ñ³Ù³Ï³ñ·:

1. ՀՀ մարզերում, կապված մասնագիտական ներուժի դիֆիցիտի հետ, երեխաների ակնաբուժական խնդիրներով զբաղվում եմ մեծերի մասնագետները, որոնց հետ, մանկության խնդիրների վերաբերյալ ուսուցման աշխատանք է տանում Հայկական ակնաբուժական նախագիծը:

2. ¸åñáó³Ñ³ë³Ï »ñ»Ë³Ý»ñÇ ßñç³ÝáõÙ Ï³ï³ñíáõÙ »Ý Ï³ÝË³ñ·»ÉÇã μÅßÏ³Ï³Ý ùÝÝáõÃÛáõÝÝ»ñ, áñÇ Å³Ù³Ý³Ï Ñ³ÛïÝ³μ»ñí³Í é»ýñ³ÏóÇáÝ Ë³Ý·³ñáõÙÝ»ñÇ ¹»åùáõÙ ³é³ç³ñÏíáõÙ ¿ Ù³ëÝ³·Çï³Ï³Ý μáõÅáõÙ, ïñ³Ù³¹ñíáõÙ »Ý ³ÏÝáóÝ»ñ /Ù³ñ¹³ëÇñ³Ï³Ý ×³Ý³å³ñÑáí ëï³óí³Í, ÇÝãå»ë Ý³¨ Ô³ñ³·Ûá½Û³Ý ÑÇÙÝ³¹ñ³ÙÇ ÏáÕÙÇó ºñ¨³ÝáõÙ, êÛáõÝÇùÇ, Èáéáõ ¨ ÞÇñ³ÏÇ Ù³ñ½»ñáõÙ/:

3. Երեխաների մասնագիտական աÏÝ³μáõÅ³Ï³Ý Ñ»ï³½áïáõÃÛáõÝÝ»ñը ¨ μáõÅáõÙը Ù³ÝÏ³Ï³Ý ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñ ãáõÝ»óáÕ Ù³ñ½»ñÇ Ñ»é³íáñ μÝ³Ï³í³Ûñ»ñáõÙ ³åñáÕ é»ýñ³ÏóÇáÝ Ë³Ý·³ñáõÙÝ»ñáí ¹åñáó³Ñ³ë³Ï »ñ»Ë³Ý»ñÇÝ իñ³Ï³Ý³óí»É ¿ ²ØÜ Ø¼¶ Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÍÇ ÏáÕÙÇց: Կ³ï³ñí»É »Ý ³Ûó»ñ ÐÐ Ù³ñ½»ñ` ßñçÇÏ ³ÏÝ³μáõÅ³Ï³Ý խմբերի ÏáÕÙÇó ստուգվել է 72147 երեխա` ՀՀ մարզերում և Երևանում:

4. è»ýñ³ÏóÇáÝ Ë³Ý·³ñáõÙÝ»ñ áõÝ»óáÕ »ñ»Ë³Ý»ñÇ ÍÝáÕÝ»ñÇÝ ïñ³Ù³¹ñ»É Ñ³Ù³å³ï³ëË³Ý ÏñÃ³Ï³Ý ÝÛáõÃ»ñ, ÇëÏ ³Û¹åÇëÇ »ñ»Ë³Ý»ñÇÝ` ËáñÑñ¹³ïíáõÃÛáõÝ Æñ³Ï³Ý³óí»É ¿ ²ØÜ Ø¼¶ Ð²Ü ÏáÕÙÇó – ծնողների համար կազմակերպած հանրային կրթության դասերում մասնակցել է 843 ծնող, նաև տարածվել են 4 անուն բրյոշյուր, ներառյալ ռեֆրակցիոն խանգարումների մասին` ծնողների համար:

5. Նախատեսվում է կ³½Ù³Ï»ñå»É Ûáõñ³ù³ÝãÛáõñ Ù³ñ½Çó Ù»Ï ³ÏÝ³μáõÛÅÇ í»ñ³å³ïñ³ëïáõÙ ³ÝÑ³ë Ýáñ³ÍÇÝÝ»ñÇ é»ïÇÝáå³ÃÇ³ÛÇ í³Õ ³ËïáñáßÙ³Ý ¨ μáõÅÙ³Ý í»ñ³μ»ñÛ³É` Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÍÇ աջակցությամբ:

6. ²ÝÑ³ë Ýáñ³ÍÇÝÝ»ñÇ é»ïÇÝáå³ÃÇ³ÛÇ μáõÅÙ³Ý Ýå³ï³Ïáí ºñ¨³ÝÇ ØËÇÃ³ñ Ð»ñ³óáõ ³Ýí³Ý å»ï³Ï³Ý μÅßÏ³Ï³Ý Ñ³Ù³Éë³ñ³Ý äà²Î-Ç Ð³Ù³Éë³ñ³Ý³Ï³Ý ³ÏÝ³μáõÅ³Ï³Ý ÏÉÇÝÇÏ³Ï³Ý ÑÇí³Ý¹³ÝáóÇÝ ïñ³Ù³¹ñ»É É³½»ñ³ÛÇÝ ë³ñù³íáñáõÙÝ»ñ: Ð³Ýñ³å»ïáõÃÛ³Ý μáÉáñ åáÉÇÏÉÇÝÇÏ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñÇ Ù³ÝÏ³Ï³Ý ³ÏÝ³μáõÛÅÝ»ñÇ Ñ³Ù³ñ Ùß³Ï»É ¨ Çñ³Ï³Ý³óÝ»É í»ñ³å³ïñ³ëïÙ³Ý

60

¹³ëÁÝÃ³ó` ³ÝÑ³ë Ýáñ³ÍÇÝÝ»ñÇ é»ïÇÝáå³ÃÇ³ÛÇ í³Õ ³ËïáñáßÙ³Ý ¨ μáõÅÙ³Ý, ÇÝãå»ë Ý³¨ é»ýñ³ÏóÇáÝ Ë³Ý·³ñáõÙÝ»ñÇ í»ñ³μ»ñÛ³É:

ՀԱՆ-ը ձեռք է բերել երկու ռետինալ ֆոտոխցիկ և դիոդային լազեր` անհաս ռետինոպաթիայի ախտորոշման և բուժման համար: 7. Անհաս Ï³Ù ó³Íñ ù³ßáí »ñ»Ë³Ý»ñÇ ³ÏÝ³μáõÅ³Ï³Ý Ñ»ï³½áïáõÃÛ³Ý ¨ μáõÅÙ³Ý Ñ³ÙÁÝ¹Ñ³Ýáõñ ÁÝÃ³ó³Ï³ñ·»ñը և դրա իրականացման ²½·³ÛÇÝ Íñ³·ñÇ Ý³Ë³·ÇÍÁ նախաå³ïñ³ëïí»É ¿ Հայկական ակնաբուժության նախագծի ÏáÕÙÇó, հաստատվել է ÐÐ ²Ü-ի կողմից: È³ÛÝ³Í³í³É ³ßË³ï³ÝùÝ»ñÁ »ÝÃ³¹ñíáõÙ ¿ ëÏë»É 2010 ë»åï»Ùμ»ñÇó:

Üå³ï³Ï III. Ð³Ýñ³å»ïáõÃÛáõÝáõÙ ½³ñ·³óÝ»É ÏáõñáõÃÛ³Ý Ï³ÝË³ñ·»ÉÙ³ÝÁ Ýå³ëïáÕ »ÝÃ³Ï³éáõóí³ÍùÝ»ñÁ:


¼³ñ·³óÝ»É ³ÏÝ³μáõÅáõÃÛ³Ý ³é³çÝ³ÛÇÝ ûÕ³ÏÁ ·ÛáõÕ³Ï³Ý μÝ³Ï³í³Ûñ»ñáõÙ:

´³ñ»É³í»É ³ÏÝ³μáõÅáõÃÛ³Ý ³é³çÝ³ÛÇÝ ûÕ³ÏÁ åáÉÇÏÉÇÝÇÏ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñáõÙ:

²ñ¹Ç³Ï³Ý³óÝ»É ¨ ë³ñù³íáñáõÙÝ»ñáí Ñ³Ù³Éñ»É ·áÛáõÃÛáõÝ áõÝ»óáÕ Ù³ñ½³ÛÇÝ ³ÏÝ³μáõÅ³Ï³Ý Ï»ÝïñáÝÝ»ñÁ:

²ñ¹Ç³Ï³Ý³óÝ»É Ð³Û³ëï³ÝáõÙ ³ÏÝ³μáõÅáõÃÛ³Ý »ññáñ¹³ÛÇÝ ûÕ³ÏÁ:

1. Նախատեսվել էր ըÝïñí³Í ·ÛáõÕ³Ï³Ý ³ÙμáõÉ³ïáñÇ³Ý»ñáõÙ Ï³Ù ÁÝï³Ý»Ï³Ý μÅßÏÇ ·ñ³ë»ÝÛ³ÏÝ»ñáõÙ ëï»ÕÍ»É ·ÛáõÕ³Ï³Ý μáõÅÏ»ï»ñ (20,000 μÝ³ÏãÇ Ñ³ßíáí Ù»Ï Ï»ÝïñáÝ), áñáÝù ÏÍ³é³Û»Ý áñå»ë ³é³çÝ³ÛÇÝ ³ÏÝ³μáõÅ³Ï³Ý Ï»ÝïñáÝÝ»ñ:

Üáñ Ï»ÝïñáÝÝ»ñÇ ëï»ÕÍÙ³Ý Ñ»ï Ï³åí³Í é»ëáõñëÝ»ñÇ ËÝ³ÛáÕáõÃÛ³Ý Ýå³ï³Ïáí áñå»ë ³Û¹åÇëÇù ¹Çï³ñÏíáõÙ ¿ ï³ñ³Í³ßñջ³Ý³ÛÇÝ åáÉÇÏÉÇÝÇÏ³Ý»ñÇ Ï³Ù μáõÅÙÇ³íáñáõÙÝ»ñÇ åáÉÇÏÉÇÝÇÏ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñÇ ³ÏÝ³μáõÅ³Ï³Ý Ï³μÇÝ»ïÝ»ñÁ, որոնք հագեցվել են սարքավորումներով ՀԲ առողջապահական վարկային ծրագրի շրջանակներում կամ ëï³ó»É »Ý ³ç³ÏóáõÃÛáõÝ ÙÇç³½·³ÛÇÝ Ï³½Ù³Ï»ñåáõÃÛáõÝÝ»ñÇ /մասնավորապես ԱՄՆ ՄԶԳ/ ÏáÕÙÇó:

2. Գլաուկոմայի կանխարգելման նպատակով, սÏë³Í 2008Ã. –ից, ÐÐ ²Ü Ññ³Ù³Ýáí Ñ³ëï³տí³Í ã³÷áñáßիãáí /áñÁ å»ï³Ï³Ý å³ïí»ñÇ ï»Õ³¹ñÙ³Ý Ý³Ë³å³ÛÙ³Ý ¿/, ë³ÑÙ³Ýí»É ¿, áñ å³ñï³¹Çñ Ï³ÝË³ñ·»ÉÇã ³ÛóÇ ßñç³Ý³ÏÝ»ñáõÙ Çñ³Ï³Ý³óí»Éáõ ¿ ·É³áõÏáÙ³ÛÇ í³Õ Ñ³ÛïÝ³μ»ñÙ³Ý ëÏñÇÝÇÝ·, áñÁ »ÝÃ³¹ñáõÙ ¿ Ý³¨ Ý»ñ³ÏÝ³ÛÇÝ ×ÝßÙ³Ý ã³÷áõÙ: Պոլիկլինիկաների և ԱՄՆ ՄԶԳ Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÍÇ կողմից ընդհանուր ստուգումների

61

ժամանակ վեր է հանվել ակնային ճնշման կասկած ունեցող 1730 հիվանդ: 3. Ø³ñ½³ÛÇÝ ³ÏÝ³μáõÅ³Ï³Ý Ï»ÝïñáÝÝ»ñÇ հագեցումը ակնաբուժական սարքավորումներով /այդ թվում լազերային/, նախատեսվել և իրականացվում է ՀԲ առողջապահական ՎԾ շրջանակներում <<Մարզային հիվանդանոցների արդիականացման ծրագրի ենթատեքստում:

4. ì»ñ³Ýáñá·»É ¨ ³ñ¹Ç³Ï³Ý ë³ñù³íáñáõÙÝ»ñáí Ñ³·»óÝ»É ì³Ý³ÓáñÇ ³ÏÝ³μáõÅ³Ï³Ý Ï»ÝïñáÝÁ:

Վանաձորում կենտրոնի ստեղծումը չի իրականացվել, դրա փոխարեն ստեղծվել է Գեղարքունիքի մարզի Սևան քաղաքում Հայաստանի Ամերիկյան համալսարանի և Լայոնս Ակումբի աջակցությամբ: Կենտրոնը ունի լավ շենքային պայմաններ, հագեցված է ժամանակակից սարքավորումներով: 2008թ. լիցենզավորվել է ՀՀ ԱՆ կողմից:

5. §²Ï³¹»ÙÇÏáë ê.²í¹³Éμ»ÏÛ³ÝÇ ³Ýí³Ý ³éáÕç³å³ÑáõÃÛ³Ý ³½·³ÛÇÝ ÇÝëïÇïáõï¦ ö´À-Ç ³ãùÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ³ÙμÇáÝÇÝ ÏÇó ëï»ÕÍվել է ò³Íñ ï»ëáÕáõÃÛ³Ý Ï»ÝïñáÝ, որը համապատասխանում է ÙÇç³½·³ÛÇÝ ã³÷áñáßÇãÝ»ñÇն: Այն ստեղծված է ԱՄՆ ՄԶԳ Հայկական ակնաբուժության նախագծի աջակցությամբ` Քանաքեռ-Զեյթուն ԲԿ-ի կազմում, որը հանդիսանում է §²Ï³¹»ÙÇÏáë ê.²í¹³Éμ»ÏÛ³ÝÇ ³Ýí³Ý ³éáÕç³å³ÑáõÃÛ³Ý ³½·³ÛÇÝ ÇÝëïÇïáõï¦ ö´À-Ç ³ãùÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ ³ÙμÇáÝÇ բազան:

Üå³ï³Ï IV. ´Ý³ÏãáõÃÛ³ÝÁ å³ïß³× ³ÏÝ³μáõÅ³Ï³Ý Í³é³ÛáõÃÛáõÝÝ»ñÇ Ù³ïáõóÙ³Ý Ñ³Ù³ñ ½³ñ·³óÝ»É Ù³ñ¹Ï³ÛÇÝ/կադրային/ é»ëáõñëÝ»ñÁ:


´³ñÓñ³óÝ»É Ñ³Ýñ³å»ïáõÃÛáõÝáõÙ ³ÏÝ³μáõÅáõÃÛ³Ý ³é³çÝ³ÛÇÝ ûÕ³ÏÇ μáõÅ³ßË³ïáÕÝ»ñÇ ÏñÃáõÃÛ³Ý Ù³Ï³ñ¹³ÏÁ:

´³ñÓñ³óÝ»É Ù³ñ½³ÛÇÝ ³ÏÝ³μáõÅ³Ï³Ý Ï»ÝïñáÝÝ»ñÇ ³ÏÝ³μáõÛÅÝ»ñÇ ·Çï»ÉÇùÝ»ñÇ Ù³Ï³ñ¹³ÏÁ:

²ÏÝ³μáõÅáõÃÛ³Ý áõëáõóÙ³Ý Ù³Ï³ñ¹³ÏÁ Ñ³ëóÝ»É ²ÏÝ³μáõÅ³Ï³Ý ÙÇç³½·³ÛÇÝ ËáñÑñ¹Ç ¨ ²ÏÝ³μáõÅ³Ï³Ý Ï³½Ù³Ï»ñåáõÃÛáõÝÝ»ñÇ ÙÇç³½·³ÛÇÝ ý»¹»ñ³óÇ³ÛÇ ÏáÕÙÇó ë³ÑÙ³Ýí³Í ã³÷³ÝÇßÝ»ñÇÝ

1. Ð³Ýñ³å»ïáõÃÛ³Ý μáÉáñ Ù³ñ½»ñÇ ·ÛáõÕ³Ï³Ý ³ÙμáõÉ³ïáñÇ³Ý»ñÇ ¨ ÁÝï³Ý»Ï³Ý μáõÅùáõÛñ»ñն ÁÝ¹·ñÏվ»É են ³é³çÝ³ÛÇÝ ûÕ³ÏáõÙ ³ÏÝ³μáõÅáõÃ¬Û³Ý í»ñ³μ»ñÛ³É »ռûñÛ³ í»ñ³å³ïñ³ëïÙ³Ý ¹³ëÁÝÃ³óÝ»ñում, որի շրջանակներում ԱՄՆ ՄԶԳ Հայկական ակնաբուժության նախագծի աջակցությամբ վերապատրաստվել է 1600 մասնագետ:

Կրկնակի վերապատրաստում են անցել 57 ընտանեկան բժիշկ մարզերում, վերապատրաստվել է նաև 37 ակնաբուժական բուժքույր:

62

2. ²ØÜ Ø¼¶ Հայկական ակնաբուժության նախագծի աջակցությամբ ՀՀ մ³ñ½³ÛÇÝ ³ÏÝ³μáõÅ³Ï³Ý Ï»ÝïñáÝÝ»ñÇ 61 ³ÏÝ³μáõÛÅÝ»ր í»ñ³å³ïñ³ëïվ»É են ÷áùñ Ïïñí³Íùáí ¨ Ý»ñ³ÏÝ³ÛÇÝ áëåÝÛ³ÏÇ ï»Õ³¹ñÙ³Ùμ Ï³ï³ñ³ÏïÇ ¿ùëïñ³Ï³åëáõÉÛ³ñ íÇñ³Ñ³ïáõÃÛáõÝÝ»ñÇ ï»ËÝÇÏ³ÛÇ, ·É³áõÏáÙ³ÛÇ ½³Ý·í³Í³ÛÇÝ Ñ»ï³½áïáõÃÛáõÝÝ»ñÇ ¨ μáõÅÙ³Ý, ÇÝãå»ë Ý³¨ ¹Ç³μ»ïÇÏ é»ïÇÝáå³ÃÇ³ÛÇ É³½»ñ³ÛÇÝ μáõÅÙ³Ý áõÕÕáõÃÛ³Ùμ:

3. ²ÏÝ³μáõÅáõÃÛáõÝ áõëáõó³ÝáÕ áõëáõÙÝ³Ï³Ý Ñ³ëï³ïáõÃÛáõÝÝ»ñÇ áõëáõÙÝ³Ï³Ý Íñ³·ñ»ñը ÙÇç³½·³ÛÇÝÇ Ù³Ï³ñ¹³ÏÇÝ Ñ³Ù³å³ï³ëË³Ý»óÝ»Éու պահանջը կատարվում է սկսած 2009 թվականից, համաձայն ՀՀ կառավարության որոշման, ըստ որի` բոլոր կրթական ծրագրերը, այդ թվում նաև ակնաբուժական, համապատասխանեցվում է միջազգային չափանիշներին:

Üå³ï³Ï V. ´³ñÓñ³óÝ»É ÏáõñáõÃÛ³Ý, áñå»ë Ï³ñ¨áñ³·áõÛÝ Ñ³Ýñ³ÛÇÝ ³éáÕç³å³Ñ³Ï³Ý ÑÇÙÝ³Ñ³ñóÇ í»ñ³μ»ñÛ³É μÝ³ÏãáõÃÛ³Ý Çñ³½»ÏáõÃÛáõÝÁ:


²ÝóÏ³óÝ»É μÝ³ÏãáõÃÛ³Ý Çñ³½»ÏáõÃÛ³Ý μ³ñÓñ³óÙ³Ý ½³Ý·í³Í³ÛÇÝ ÙÇçáó³éáõÙÝ»ñ Ï³ï³ñ³ÏïÇ, ·É³áõÏáÙ³ÛÇ ¨ ¹Ç³μ»ïÇÏ é»ïÇÝáå³ÃÇ³ÛÇ í»ñ³μ»ñÛ³É:

Øß³Ï»É ¨ ³ÝóÏ³óÝ»É ³ãùÇ ³éáÕçáõÃÛ³Ý í»ñ³μ»ñÛ³É ½³Ý·í³Í³ÛÇÝ ÏñÃ³Ï³Ý ÙÇçáó³éáõÙÝ»ñ ¹åñáó³Ñ³ë³Ï »ñ»Ë³Ý»ñÇ ¨ Ýñ³Ýó ÍÝáÕÝ»ñÇ ßñç³ÝáõÙ:

1. ÀÝï³Ý»Ï³Ý μÅÇßÏÝ»ñÇ áõëáõÙÝ³Ï³Ý Íñ³·ñáõÙ ÁÝ¹É³ÛÝվ»É է ³ÏÝ³μáõÅáõÃÛ³Ý μ³ÅÇÝÁ, թ³ñÙ³óվ»É է հանրության առողջապահական ÏñÃությանն ուղղված Íñ³·ñ»ñÇ í»ñ³μ»ñÛ³É ·áÛáõÃÛáõÝ áõÝ»óáÕ ÝÛáõÃ»ñÁ:

2. ԲÝ³ÏãáõÃÛ³Ý Çñ³½»ÏáõÃÛ³Ý μ³ñÓñ³ó¬Ù³Ý ½³Ý·í³Í³ÛÇÝ ÙÇçáó³éáõÙÝ»ñն իրականացվում են ԱՄՆ ՄԶԳ ԱԱՊԲ և ԱՄՆ ՄԶԳ ՀԱՆ ծրագրերի կողմից: Պատրաստվել և բաժանվել են հանրային կրթության 12 անվանում բրոշյուրներ ` ընդհանուր 600 000 քանակով:

3. Ð³Ýñ³å»ïáõÃÛáõÝáõÙ ՀԱՆ-ի ջանքերով նշվում է î»ëáÕáõÃÛ³Ý Ñ³Ù³ßË³ñÑ³ÛÇÝ ûñÁ ուրաքանչյուր տարվա հոկտեմբերի երկրորդ շաբաթվա հինգշաբթին:

Üå³ï³Ï VI. ÎáõñáõÃÛ³Ý Ï³ÝË³ñ·»ÉÙ³Ý áÉáñïáõÙ Çñ³Ï³Ý³óÝ»É Ñ»ï³½áïáõÃÛáõÝÝ»ñ ¨ ½³ñ·³óÙ³Ý Íñ³·ñ»ñ:


Øß³Ï»É ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ í»ñ³ÑëÏÙ³Ý, ³éáÕç³å³ÑáõÃÛ³Ý Ï³é³í³ñÙ³Ý ¨ Í³é³ÛáõÃÛáõÝÝ»ñÇ Ù³ïáõóÙ³Ý Ó»éÝ³ñÏÝ»ñ ¨ áõÕ»óáõÛóÝ»ñ: Æñ³Ï³Ý³óÝ»É Ñ³Ù³×³ñ³Ï³μ³Ý³Ï³Ý ¨ ÏÉÇÝÇÏ³Ï³Ý Ñ»ï³½áïáõÃÛáõÝÝ»ñ:

63

²ÝóÏ³óÝ»É ÏáõñáõÃÛ³Ý Ï³ÝË³ñ·»ÉÙ³Ý ³½·³ÛÇÝ é³½Ù³í³ñ³Ï³Ý Íñ³·ñÇ Çñ³Ï³Ý³óÙ³Ý ·Ý³Ñ³ïáõÙ ¨ ³ÝÑñ³Å»ßïáõÃÛ³Ý ¹»åùáõÙ Ï³ï³ñ»É Ñ³Ù³å³ï³ëË³Ý áõÕÕáõÙÝ»ñ:

1. Î³ï³ñվում է ß³ù³ñ³Ëïáí ·ñ³Ýóí³Í ÑÇí³Ý¹Ý»ñÇ ïíÛ³ÉÝ»ñÇ áõëáõÙÝ³ëÇñáõÃÛáõÝÝ»ñ` որպես ÏáõñáõÃÛ³Ý å³ï×³é Ñ³Ý¹Çë³óáÕ ³ãùÇ ÑÇí³Ý¹áõÃÛáõÝÝ»ñÇ éÇëÏ³ÛÇÝ ·áñÍáÝի: Այդ նպատակով ՀՀ ԱՆ կողմից 2010 թվականից ներդրվել է Միդաս-3 ավտոմատացված հաշվետվական համակարգը` լրացվում է 002 ձևը, որում ներառվել է շաքարային դիաբետը:

2. ՀՀ ԱՆ և ԱՄՆ ՄԶԳ Հայկական ակնաբուժության նախագծի կողմից մß³Ïվ»É են ·ÛáõÕ³Ï³Ý ³ÙμáõÉ³ïá¬ñÇ³Ý»ñÇ ¨ Ù³ñ½³ÛÇÝ ³ÏÝ³μáõÅ³Ï³Ý Ï»ÝïñáÝÝ»ñÇ μáõÅ³ßË³-ïáÕÝ»ñÇ ëï³Ý¹³ñï³óí³Í ³ßË³ï³Ï³ñ·»ñ/չափորոշիչներ: Այդպիսի չափորոշիչներ մշակվում և հասցվում են համակարգին ամեն տարի: Դրանցում ներառվում են նաև ամբուլատոր – պոլիկլինիակական հաստատությունների կողմից ակնաբուժական ծառայության մատուցման կազմակերպչական մոտեցումները:

3. Նախատեսվել է իñ³Ï³Ý³óÝ»É Ù³ÝÏ³Ï³Ý ÏáõñáõÃÛ³Ý ¨ ¹åñáó³Ñ³ë³Ï »ñ»Ë³Ý»ñÇ Ùáï é»ýñ³ÏóÇáÝ Ë³Ý·³ñáõÙÝ»ñÇ ï³ñ³Íí³ÍáõÃÛ³Ý í»ñ³μ»ñÛ³É ³½·³ÛÇÝ Ñ»ï³½áïáõÃÛáõÝÝ»ñ, որի վերաբերյալ համագործակցության առաջարկներ են ներկայացվել միջազգային կազմակերպություններին, այդ թվում ԱՄՆ ՄԶԳ -ին:

65

YEREVAN2010

COUNTDOWN TOWARDS 2020

ACTIVITIES AND STATISTICS

ACTIVITIES CARRIED OUT BY THE ARMENIAN EYECARE PROJECT AND THE EYE HEALTH

SITUATION ANALYSIS IN THE REPUBLIC OF ARMENIA

This publication was made possible with the support of the American People through the U.S. Agency for International Development (USAID) and the Armenian EyeCare Project (AECP).

The contents of this publication are the sole responsibility of the authors and do not necessarily refl ect the views of USAID or the U.S. Government.

MINISTRY OF HEALTHREPUBLIC OF ARMENIA

66

This pubication presents the activities carried out by the Armenian EyeCare Project (AECP) in Armenia and services provided to the population during 2003-2009. At the same time, it presents the estimates of main indicators of eye health and in-cidence of main eye diseases in Armenia. These indicators will serve as a basis for policy makers to analyze the eye health situation and estimate the demand of eye care services in the country.

Copyright 2010 The Armenian EyeCare ProjectPrint Run - 500Printed by Velas Print Ltd.ISBN 978-99941-2-463-3

Group of AuthorGroup of Authors

Nairuhi JrbashyanRoger Ohanesian Alexander MalayanNune YeghiazaryanVarvara Kalashyan

Data Analysis by Nairuhi JrbashyanDesign by Minas Hambardzumyan

67

CONTENTS

INTRODUCTION.....................................................................................................................................68

1. THE ARMENIAN EYECARE PROJECT: OBJECTIVE AND PRESENT ACHIEVEMENTS.................................................................................69 1.1. THE 0BJECTIVE, ESSENCE AND PARTNERS OF THE PROJECT.........................................691.2. MAIN ACHIEVEMENTS OF THE PROJECT...............................................................................712. THE AECP INITIATIVE “BRINGING SIGHT TO ARMENIAN EYES”, ITS COMPONENTS AND RESULTS.................................................................................................... 712.1. THE ESSENCE AND MAIN RESULTS OF THE INITIATIVE.....................................................712.2. GENERAL DESCRIPTION OF THE INITIATIVE COMPONENTS...........................................72

General screening and medical aid.......................................................................................72• Data analysis and scientifi c-practical activities................................................................ 73• Medical education and training.............................................................................................74• Public education..........................................................................................................................74• Capacity building.........................................................................................................................75•

3. BRIEF DESCRIPTION OF THE EYECARE SERVICES PROVIDED BY THE AECP TO THE ARMENIAN POPULATION IN THE PERIOD OF 2003-2009........................................ 803.1. BRIEF DESCRIPTION OF THE AECP EYECARE SERVICES RENDERED DURING THREE MEDICAL TOURS IN THE PERIOD OF 2003-2009.......................................................... 80 3.2. BRIEF DESCRIPTION OF THE AECP ACTIVITIES DURING THE THIRD MEDICAL TOUR IN THE PERIOD OF 2007-2009....................................................84 4. SUMMARY OF THE AECP DATABASE ANALYSES..................................................................85 4.1. METHODOLOGY OF COLLECTION AND PROCESSING OF THE EYE HEALTH DATA AMONG THE POPULATION SCREENED BY THE AECP..................................86 4.2. EYE DISEASES DIAGNOSED AMONG THE RA POPULATION DURING THE AECP THREE MEDICAL TOURS IN THE PERIOD OF 2003-2009......................................874.3. ESTIMATES OF THE EYE DISEASES PREVALENCE AMONG THE RA POPULATION ACCORDING TO THE AECP DATA...........................................................91 5. EYECARE SERVICES RENDERED TO THE RA POPULATION BY THE AECP DURING THREE MEDICAL TOURS IN THE PERIOD OF 2003-2009AT THE MARZ LEVEL............................................................................................................................. 95

5.1. THE ARAGATSOTN MARZ................................................................................................95 5.2. THE ARARAT MARZ ...........................................................................................................965.3. THE ARMAVIR MARZ......................................................................................................... 97 5.4. THE KOTAYK MARZ............................................................................................................ 98 5.5. THE LORI MARZ.................................................................................................................. 99 5.6. THE SHIRAK MARZ.............................................................................................................100 5.7. THE SYUNIK MARZ.............................................................................................................1015.8. THE TAVOUSH MARZ.........................................................................................................1025.9. THE VAYOTS DZOR MARZ................................................................................................103

APPENDICES.......................................................................................................................................... 105

68

596971

7171727273747475

80

80

8485

86

87

91

95

9596979899100101102103

105

68

INTRODUCTION

The pain and suff ering of blindness is incalculable. The restoration of sight is priceless. Vision problems worldwide as well as in Armenia are ranked among public health issues. A large portion of the population, especially after 50, is in the risk group for blindness. Vision 2020, a worldwide initiative of the World Health Organization and International Agency for the Prevention of Blindness /IAPB/ calls for more active actions to reach the goal of reducing preventable blindness worldwide by 100, 000 persons by 2020. The World Sight Day, celebrat-ed annually since 1999 in many countries at the Vision2020 initiative is meant to voice the problems of those who have eye problems and remind the world of its commitments.

The motto of this year’s World Sight Day is “Countdown towards 2020”. It calls for a sum-up of the activities and accomplishments in this fi eld and for reason-able planning of the work to be done before 2020, including the implementa-tion process of National Blindness Prevention Strategies. The Armenian EyeCare Project (AECP) is one of the organizations largely involved in eyecare in Armenia. The AECP mission is to eliminate preventable blindness in Armenia and to make 21st Century eye care accessible to every Armenian child and adult. Following its mission and the priorities of the Vision2020, the AECP is pleased to mark the cel-ebration of the World Sight Day, 2010 with the publication of its analytical report “Countdown towards 2020: Activities and Statistics”, in cooperation with the RA Ministry of Health and the United States Agency for International Development.

The publication is very much in line with the motto of this year’s World Sight Day “Countdown to 2020”. It sums up the results of the work done by the AECP since its establishment in 1992, touches upon the main initiatives and achievements, and presents the results of its scientifi c research, which would allow estimating the eye health of the population and evaluating the eye care demand for the country. In addition, following the logic of the “Countdown towards 2020” the brochure provides certain information on the accomplishments of the National Blindness Prevention Strategy in Armenia and the AECP contribution in reaching the goals set up in the Strategy (the Information note was kindly provided by the RA Ministry of Health and is presented in the Annex 2) .

Impressive results are reached thanks to the coordinated work of the AECP com-prehensive program “Bringing Sight to Armenian Eyes”, the USAID/AECP “Primary and Ophthalmologic Health Care Alliance” as well as its numerous partners and donors.

69

The beauty of the statistics presented to you is also in its uniqueness for Armenia. For many years any comprehensive information on the eye care and eye diseases has been very limited. The brochure has introduced the Index of Eye Health Vulnerability for the population of 50+, cataract surgery coverage rate among the population, the prevalence of the main widespread diseases causing blindness and blindness as well as blindness and visual impairment estimates. All mentioned estimates were calculated at the country and marz level for the fi rst time. We hope that this analytical report will be useful for healthcare deci-sion makers, scientists and practitioners dealing with eye care services planning and implementation at the country and regional level. The authors would like to thank the partners, the AECP staff and medical teams involved in the preparation of this work, for their support and assistance.

1. THE ARMENIAN EYECARE PROJECT: OBJECTIVE AND PRESENT

ACHIEVEMENTS

1.1 THE OBJECTIVE OF THE PROJECT, ITS ESSENCE AND PARTNERS

The Armenian EyeCare Project (hereafter AECP) is a US-based charity organization founded in 1992 by Armenian-American ophthalmologist Dr. Roger Ohanesian. Its mission is to eliminate preventable blindness and make eye care accessible to all people in Armenia. To this end, many highly qualifi ed American academic oph-thalmologistshave been invited to visit Armenia to treat patients and share the knowledge with their Armenian colleagues. As well, large quantities of medica-tion and equipment have been brought during this time to Armenia. The AECP carries out its activities in the Republic of Armenia in close cooperation with it partners in Armenia and outside. The main partners of the AECP are as follows:

Ministry of Health • Ministry of Labor and Social Issues• Governors offi ces in all the marzes of Armenia, Yerevan municipality, commu-• nity councils,,S. Malayan Ophthalmologic Center• Kanaker Zeitun Medical Center • Yerevan State Medical University #1 eye clinic, • Regional medical centers, health centers and FAPs (village health points), • United States Agency for International Development and relevant medical • and educational programsNumerous organizations and individuals in the Diaspora• Embassies of a number of countries in Armenia • Numerous non-governmental and international organizations •

70

1.2. MAIN ACHIEVEMENTS OF THE PROGRAM

During the entire course of its operations in Armenia starting 1992, the AECP has carried out large- scale activities, resulting in impressive achievements. Some of such achievements are listed below.

Organized and carried out 36 U.S. medical missions to Armenia, with the • participation of 55 U.S. academic ophthalmologists. The latter have traveled to Armenia, at their own expense, to teach and treat patients.Initiated $18,5 million worth donations of medical equipment and supplies • to Armenian hospitals and clinics by American pharmaceutical and medical manufacturing companies and private individuals Initiated.Developed ophthalmology residency literature to improve teaching• methods in compliance with Western standards, as well as authored and • published two books “Eye Diseases” (2005) and “Essentials of Ophthalmology” (2007) for primary health care providers and ophthalmologists respectively. Developed legislation for an Eye Bank that was approved by the Government • in February 1998.Sponsored 8 ophthalmology fellowships in the United States for Armenian • physicians and 3 observerships.Sponsored and organized 11 International Ophthalmology Teaching Confer-• ences in Yerevan. Sponsored 15 patients requiring specialized surgical care in the U.S. and • provided services at no charge.Established and equipped fi ve specialty clinics in the Malayan Ophthalmo-• logic Center:

Vitreo-Retinal Disorders Clinic & Operating Room, 1998• Glaucoma Clinic & Operating Room, 2000• Corneal & Uveitis Disorders Clinic, 2001• Neuro-ophthalmology and Orbital Surgery, 2004• Eye Bank, 2005•

The Mobile Eye Hospital was designed and built with American donations • and delivered to Armenia in 2002 to travel throughout regions of the country. Up to date, it has accomplished three medical tours in the marzes of Armenia. The fourth tour started in October of 2009. Launched country-wide comprehensive program “Bringing Sight to Arme-• nian Eyes” in June 2003 Launched country-wide public education and awareness campaign in 2005. • Published 12 handouts (total of 600.000 copies) on eye care, safety and eye diseases of children and adults.Established and equipped USAID/AECP Education & Diagnostic Center in • partnership with the Malayan Ophthalmology Center in May 2006.

71

Established and equipped USAID/AECP Low Vision Center in the Kanaker • Zeitun Medical Center.Established and equipped a Wet Lab thanks to the generous donation of the • Pfi zer company, with the purpose to provide doctors and students with op-portunities for surgical practice, 2007.Launched a Screening and Treatment Program on Retinopathy of Prematurity • (ROP) in Armenia, 2010.

On the whole, the AECP activities have greatly contributed to the implementation of the “Armenian National Strategy of Blindness Prevention program” which was put into eff ect in 2006 (see appendix 2, which presents a document prepared by the Ministry of Health on the implementation of the National Strategy Blindness Prevention program , approved by the 02.11.2006 #43-N decree of the Govern-ment of the Republic of Armenia).

2. THE AECP INITIATIVE “BRINGING SIGHT TO ARMENIAN EYES”, ITS

COMPONENTS AND RESULTS

2.1. THE ESSENCE AND MAIN RESULTS OF THE INITIATIVE

Having established as “The Armenian EyeCare Project” Charitable Foundation in Armenia, the AECP launched a comprehensive program “Bringing Sight to Arme-nian Eyes” in 2003. It is aimed at strengthening the eye care delivery system and reducing preventable blindness in Armenia. Since October 2004 the USAID and the AECP has started cooperation within “Primary and Ophthalmologic Health Care Alliance” in the framework of the Global Development Alliance. The main objective of the Initiative is realized in fi ve inter-linked directions, which make up the main components of the AECP work.

Screening of the population and direct patient care, • Data analysis and scientifi c-practical research, • Medical education and training, • Public education and awareness, • Capacity building. •

The donations received from various individuals and companies, as well as the USAID Global development Alliance resources, has enabled the AECP, with its Mobile Eye Hospital and medical screening groups, to carry out regular visits to all Marzes (regions) of Armenia, including Yerevan. The AECP fi eld missions provide

72

people with full-scale services – general screening, referral, surgery and laser treatment in MEH, prescription and provision of eye-glasses. In 2006, 2007, 2008 and 2010 as a separate project, the AECP visited Nagorno-Karabakh to provide high quality eye services there too.

The main results achieved through all the components of the Initiative “Bringing Sight to Armenian Eyes” since June 2003 to September 2010 are as follows:

264,568 people (including 128,933 children) were screened by the AECP • medical groups in their villages or in adjacent settlements 27,091 people underwent thorough examination on the MEH• 11,303 patients were operated on and treated on the MEH• 29,546 eyeglasses were provided• The created database incorporates data on the people screened by the • AECP medical groups. Scientifi c-practical analyses of the data have allowed drawing estimates on the prevalence of eye diseases and visual impairment among the RA population. 1,684 health care providers, including 61 regional ophthalmologists and 37 • ophthalmic nurses, were trained in eye diseases 501,156 public education handouts were distributed• 360 public education classes for 9000 children and 900 parents and health • activists were delivered.

2.2. GENERAL DESCRIPTION OF THE INITIATIVE COMPONENTS

Screening of the population and direct patient care

The main objective of the Initiative “Bringing Sight to Armenian Eyes” is to make the quality eye care accessible to population in all the regions of Armenia which will help to prevent avoidable blindness in the country. Within the scope of the project the AECP Medical teams and the state-of-the-art Mobile Eye Hospital (MEH) travel to rural and urban communities throughout Armenia to render the following services:

General screening of children and adults • Refraction for all and provision of eyeglasses to the socially vulnerable popu-• lation On the Mobile Eye Hospital - detailed eye examination and laser treatment • for all as well as surgery for vulnerable population

73

For timely prevention and treatment of eye diseases, special emphasis is placed on detection of diseases leading to blindness such as the cataract, glaucoma, diabetic retinopathy, macular degeneration etc.

After general screening the patients get referrals to the MEH for detailed exami-nation, laser treatment or surgery as needed. To secure more accessibility, the MEH is stationed in all central cities and towns of Armenia.

Since June 2003 up to September 2009 the AECP completed three tours through-out Armenia. The fourth tour of the AECP fi eld mission started in October of 2009 and is expected to be completed in September of 2011.

Data Analysis and Research

Data analysis and scientifi c-practical research is a cornerstone of the AECP activi-ties. As a result of the AECP outreach activities carried out since 2003, a database was created incorporating data on around 160,000 screened patients. The data processed in concordance with internationally accepted methodologies has al-lowed coming up with important indicators on the prevalence of eye diseases aswell as drawing comparative analyses of the general ophthalmic health situation in the regions of Armenia.

The collected data allows detecting the main causes of eye disorders and evalu-ating prevalence rate of diseases among the population such as the cataract, glaucoma, retina and eye fundus diseases. Based on the prevalence of the main eye diseases, the eye health vulnerability index for the AECP benefi ciaries above 50 years was calculated. The latter, in fact, describes the risk factor of blindness in Armenia. The AECP has conducted two other surveys to evaluate patient satisfac-tion level with the AECP services. According to the research results, 94% of the patients who used the AECP services rated those as either good or excellent.

To assess productivity of the eye surgeries performed on the Mobile Eye Hospi-tal, the AECP conducted a follow-up survey in 2007 among the benefi ciaries in the Armavir marz who were operated in the period of 2003-2006. The survey revealed that particularly the results of the 2006 are in conformity with interna-tional standards: for 91.5% of cataract surgeries good or borderline result was recorded.

In addition, jointly with the Malayan Ophthalmic Center, the AECP has introduced a pilot monitoring system for cataract surgery outcomes based on the method-ology and recommendations of the WHO. It is expected that the system will be incorporated in other health care institutions all over Armenia as well.

74

Medical Education and Training

Medical training provides physicians at the primary, secondary and tertiary levels with up-to-date knowledge and skills to secure quality services to the population country-wide. The AECP has organized and conducted many training courses for regional ophthalmologists and family medicine doctors. Our partners in this sphere are the USAID contractors “Primary Health Care Reform” and “Academy for Educational Development” (AED). As of today, more than 1,600 primary health-care providers in Yerevan and the regions were trained.

Two books —the “Eye Diseases” and the “Essentials of Ophthalmology” authored by AECP, are the fi rst textbooks on ophthalmology in the Armenian language, are in the core of the training. These books serve as a reference for the professional upgrade of the primary healthcare specialists and ophthalmologists.

In addition, the regional primary health care workers and ophthalmologists have an opportunity to enrich their experiences by participating in the AECP screen-ings in the hometowns as well as to familiarize themselves with modern ophthal-mic equipment by undertaking observership on the MEH during its visits to the regions.

With the fi nancial support of the USAID and assistance from the Ophthalmologic Center after S. Malayan, the Armenian EyeCare Project opened the Education and Diagnostic Center furnished with state-of-the-art equipment in 2006. Thanks to this Center, the Armenian physicians and students can familiarize themselves with the latest ophthalmologic achievements and developments in electronic and print formats. The Center incorporates Haik Babikian memorial library thus providing access to one of the richest collection of the specialized ophthalmo-logic literature in Armenia.

Thanks to the generous donation of the US-based company Pfi zer, the AECP brought Wet Lab to Armenia where the Armenian ophthalmologists improve their surgical skills.

Public Education

The main goal of the Public Education program is educating the population about the measures for the prevention of eye diseases as well as highlighting the importance of using eye care services. By raising awareness through Public Education program, the AECP aims at integrating healthy eye care and safety practices into everyday life of the general public and particularly the children. In order to disseminate information about common eye diseases, eye care and

75

safety practices to a wider audience, the AECP published six hundred thousand copies of 12 educational brochures targeting diff erent groups of population. The brochures are disseminated in the regions and communities where the AECP works.To raise public awareness, the AECP works with diff erent target groups. Thematic talks on eye care and safety are conducted for schoolchildren, parents, teachers and medical personnel of the schools. During the talks they receive information about childhood and adult eye diseases, symptoms as well as safety measures and injury prevention. Thematic performances such as puppet shows and panto-mime performances were organized for schoolchildren.

In cooperation with local and international organizations, the AECP conducts training of trainers sessions with active community groups and healthcare provid-ers, who disseminate the eye care related information in their respective commu-nities, thus making the basic knowledge available for a larger number of people.

Capacity Building

The AECP and its partners aim at turning Armenia into a Center of Excellence in Ophthalmology in the Caucasus region. Building blocks of the “Capacity build-ing” are the transfer of knowledge and institutionalization of services. Since 1992, American physicians have been visiting Armenia on a semi-annual basis to transfer the know-how and skills in ophthalmology to their Armenian colleagues. In addition, 11 international training conferences were organized.

By the initiative of the AECP, six specialty clinics were established and equipped/revamped in the major ophthalmic centers of Armenia - S. Malayan Ophthal-mologic Center and Kanaker – Zeitun Medical Center. These specialty clinics are -Retina, Glaucoma, Cornea and Uveitis, Neuro-orbital, Eye bank, and Low vision. These clinics are led by the Armenian ophthalmologists who had their fellowship in the fi nest eye care institutions of the US thanks to the AECP sponsorship. The AECP fellows now transfer their knowledge to their colleagues and students.

As a separate direction, the AECP continues its program of the “Prevention and Treatment of the Prematurity of Retinopathy in Armenia”. It was launched in June of 2010 with the AECP medical mission and International Conference devoted on the prevention of the Retinopathy of Prematurity (ROP). In accordance with the respective instruction of the RoA Ministry of Health, the AECP-trained physicians regularly screen all premature infants in the Neonatal Intensive Care Units. Those in need of treatment undergo laser procedure. Annually, the program is expected to save about 100 premature infants in the risk group from lifelong blindness.

80

3. BRIEF DESCRIPTION OF THE EYECARE SERVICES PROVIDED BY THE

AECP TO THE ARMENIAN POPULATION IN THE PERIOD OF 2003-2009

The AECP impressive results are reached thanks to the coordinated work of all components and partners, nonetheless, prior to presenting the results of the AECP data analysis and scientifi c research, we would like to single out the com-ponent of medical outreach. The latter can be considered as the “base” of the Project due to its widespread nature, direct target to the population and immedi-ate results. Analysis of the information gathered through this component allows coming up with important indicators charactering the eye health of the country.

The ultimate goal of the AECP is the elimination of avoidable blindness and securing increased access to modern eye care for every citizen of Armenia. The AECP Initiative “Bringing Sight to Armenian Eyes”, launched in 2003 is meant to reach this goal. General screenings among the population of rural and urban communities in Armenia, thorough examination, surgery and laser procedures performed on the Mobile Eye Hospital bring the high quality eye care services to the population at large.

The AECP completed three medical tours all over Armenia within the Initiative “Bringing Sight to Armenian Eyes” in the period from 2003-2009 and we will pres-ent a brief summary of their logistic, organizational and medical aspects with an emphasis on the third tour in 2007-2009.

3.1. BRIEF DESCRIPTION OF THE AECP EYECARE SERVICES RENDERED DURING THREE

MEDICAL TOURS IN THE PERIOD OF 2003-2009

Since 2003 through 2009, the AECP medical groups and the Mobile Eye Hospital (MEH) engaged the overwhelming majority of urban and rural communities in the general screening. Despite certain variations, the logistical protocols, medical approaches and orientations are quite similar in all three medical tours.

During the mentioned time period, the AECP medical groups, on the whole, have visited 841 rural and urban communities of the country (nearly 90% of the RA communities)1.

Well in advance, the AECP screening and MEH activities were widely advertised in the local media (television and radio announcements). Announcements were placed in all public places (polyclinics, mayor’s offi ces, post offi ces, banks, etc). In

1 In this section, the analysis of the data received due to screening in nine marzes (excluding the marz of Gegharkunik and Yerevan) during 2003-2009 is presented.

81

addition, local health professionals and social workers encouraged visits of the patients with specifi c problems as well as the population at large. Screenings were mainly carried out in local polyclinics, ambulatories and health posts. All ser-vices rendered by the AECP are free of charge - screening, eye glasses prescrip-tion and laser treatment were available to everyone. Surgeries were performed only for the most needy (eligibility verifi ed against the vulnerability lists of the Ministry of Labor and Social Issues) while other patients identifi ed with problems were referred to tertiary care facilities. This approach stimulated signifi cant inter-est among the population at large.

Eye screening and examination were conducted by a trained team of ophthal-mologists and clinical residents from Yerevan’s tertiary care clinics. A standard protocol and eye examination record was used. Examination included testing of visual acuity using Landolt charts and Sivtsev-Golovin charts. Pinhole vision was taken for those individuals with a vision of <6/18 (either eye). Assessment of cause of vision loss was undertaken using a standard protocol with a direct ophthalmoscope. Causes of vision loss in cases that needed further examination or treatment (surgery or laser treatment) were referred to the MEH. Eye pressure was measured by a tonopen or Maklakov .

For more complicated cases, when a patient needed a thorough diagnosis or future treatment (surgery or laser procedure), s/he was referred to the MEH for a more detailed examination and/or treatment. In such cases, children were re-ferred to the Yerevan eyecare institutions. Patients needing continuous treatment or care, were referred to the local ophthalmologist.

Due to the mentioned large-scale activities in the period from 2003-2009, the AECP had screened and rendered eye services to 156,688 people (around 5% of country’s population). The overwhelming majority of them were adults (61%), while children constituted 39% (up to 16 year olds), the women exceeded in numbers and made up 57% of those screened.

Early detection and timely prevention of eye diseases among children greatly contributes to the prevention of blindness and low vision among the population. For that reason, the AECP, during its second tour, had attempted to pay more attention to school screenings. In the second medical tour, more than half of the population screened by the AECP – 55%, where children from 320 schools in 245 rural communities. This fact explains the high representation of children – 39% in the structure of the AECP screened population, in comparison with the demo-graphic structure of the population of the country (24%). Taking into consid-eration the poor access of primary and secondary eye care services for the rural

82

communities, the AECP screenings were geared towards the rural population, constituting 58% of the screened population.

The AECP had prescribed and prepared 29,549 eyeglasses for those in need from the socially vulnerable layers of the population.

The regional distribution of the screened population shows that the residents of the marzes of Ararat, Armavir, Kotayk and Lori were more represented in the total numbers.

In the period of 2003-2009, the AECP Mobile Eye Hospital (MEH) had rendered detailed examination to 16,518 persons in need of help (17.3% of the total screened), out of whom, 7,939 patents (8.3% of the screened adults) underwent a surgery or a laser procedure.

83

On the whole, in the period from 2003-2009, 8,394 surgeries and laser procedures were performed on the MEH. Most of them (70%) were cataract- related various surgeries.

84

3.2 BRIEF DESCRIPTION OF THE AECP ACTIVITIES DURING THE THIRD MEDICAL TOUR IN

THE PERIOD OF 2007-2009

During the third medical tour in 2007-2009, the AECP screening groups and the Mobile Eye Hospital have visited nine marzes of Armenia (with the exception of Yerevan, where the AECP services targeted special groups of the population and schools) and the marz of Gegharkunik 1.

During the third tour, the AECP medical groups have carried out screening activi-ties in 490 communities of the country, or in other words, in 54% of Armenia’s communities.

The AECP has screened the people from 615 diff erent communities, mainly from rural areas. On the whole, the majority of the screened - 68% were from the rural communities, where health and eye care services are especially inaccessible.

The AECP has screened 26,711 people (or around 0.9% of country’s population), out of which 16,837, or 63% were women, while 1,195 were children (up to 16 years old): More than half (52%) of those screened by the AECP were from poor, vulnerable or special layers of the population.

The overwhelming majority of the screened population by the AECP were above the reproductive age, i.e. those above 49 made up 72.3% of the screened, while people of 70 years of age and above made up one third of the screened – 31%. The age distribution of the screened population is presented below in Graph 2.

1 The AECP has restricted its activities in the marz of Gegharkunik since there is a modern eye clinic renovated and equipped with sponsorship of Garo Meghrigian Eye Institute for Preventive Ophthalmology within the American University of Armenia and the Lions Club International.

85

The MEH, while stationed in the Armenian cities and towns, has received and ex-amined 3,943 previously screened people in need of thorough diagnosis (15.5% of the screened adults). Thus, the access to high quality care was made closer not only to the residents of those towns but also for the people of the adjacent settlements. Nearly half of those people – 1893 (or 7.4% of the screened adults) underwent surgery or laser procedure on the Mobile Eye Hospital. The AECP has prescribed, prepared and provided with eyeglasses to 9,793 people belonging to vulnerable and special groups.

4. SUMMARY OF THE AECP DATABASE ANALYSES RESULTS Since 2003, the AECP has combined general screenings of the population with information collection and analysis. The data of the around 160,000 screened people were assembled in the AECP database, while the results of scientifi c analyses has made it possible to receive data on the eye health and prevalence of eye disease among the Armenian population in accordance with internationally accepted methodology and indicators. The received data also allow comparisons at the regional level.

Hereafter, we will present scientifi c estimates of the eye health and eye disease prevalence among the population of the Republic of Armenia, which will enable the decision makers to evaluate eye care situation among the population as well as determine the demand for eye care services in the country. The mentioned estimates are based on the AECP screening and MEH activities carried out in nine marzes during the third medical mission, in the period from 2007-2009, since it contains the freshest data with extensive and detailed information on the screened people1. In addition, we will present dynamic time series on the main diseases from all three tours.

1 With the exception of Yerevan, where the AECP had confi ned its activities only to schools and social institutions (children’s homes, nursing homes, soup kitchens, detention places, etc.) and the marz of Gegharkunik, which has more access to modern eye care.

86

4.1. METHODOLOGY OF COLLECTION AND PROCESSING OF THE EYE HEALTH DATA

AMONG THE POPULATION SCREENED BY THE AECP

Parallel to general screening, the Armenian Eye Project has gathered certain in-formation on those screened. Each person referred to the AECP for screening had fi lled in a questionnaire which included sets of questions related to the general health status (with an emphasis on common medical problems that aff ect vision: diabetes, hypertension, and infectious diseases); healthcare, frequency of visits to eye doctors, as well as perceptions of the population regarding healthy lifestyles and attitudes. On the last (fourth) page, the AECP medical team inserted results of eye examination, diagnostics, as well as necessary or proposed medical interven-tion. The data of the fi lled-in questionnaire was entered in a special software, which made up the AECP database. Please, see the Annex 1 for the modifi ed questionnaire, used in the tours of 2007-2009, and 2010.

Monitoring and evaluation, as well as regular feedback in the logistical, organiza-tional and conceptual aspects have allowed the AECP to work towards improve-ment during the entire process of the work. A large number of protocols, guide-lines, standards were prepared to facilitate the work of the screening groups in the fi eld, as well as standardize the reporting process. The AECP questionnaire has been modifi ed, which allowed having a more detailed breakdown of diseases and keeping comparability with the previous data at the same time. For this reason, the analysis of the available data presented in this brochure is more geared to-wards the third round.

It is worth mentioning that the AECP database is not a result of sample survey, since the participation of the population in the AECP screening has been of a voluntary nature. The screening groups have rendered services to all those who elected to come to the AECP screening. For that reason, the age-gender as well as geographic (rural-urban and marzes) proportion of the screened population had not corresponded to the demographic and geographic characteristics of the country. Therefore, to receive reliable estimates on the prevalence of eye diseas-es, the received data have been weighed. Thus, the mentioned proportions were rectifi ed to comply with the country’s overall demographic characteristics.

In this survey, estimations and indicators have been calculated mainly for the adult population (16 years old and above) and particularly, 50+, due to the fact that the latter are the main age group in risk. In addition, the database contains dynamic time series which correspond to the two-year-long three tours that the AECP has accomplished in nine marzes of Armenia in 2003-2005, 2005-2007 and 2007-2009. Therefore, the comparison of results in dynamics has certain specifi cs, which the reader should approach with caution.

87

4.2. EYE DISEASES DIAGNOSED AMONG THE RA POPULATION DURING THE AECP THREE

MEDICAL TOURS IN THE PERIOD OF 2003-2009

The RA Ministry of Health, in its statistical yearbooks, offi cially publishes two main indicators characterizing the eye health of the country’s population: the number of fi rst time revealed diseases of eye and adnexa as well as general morbidity of the population related to eye diseases and adnexa, with a specifi cation of glaucoma cases. The cases of population’s morbidity are registered when people refer for eye care or during mandatory preventive examinations1 . The dynamics of these indicators show that the number of population registered with diseases of eye and adnexa in our country has increased almost twofold in the period of 2004-2008, summing up to 2,610 persons per 100,000 persons in 2008 (total of 68,544 persons). Starting 2005, almost 47% of the patients who have mentioned diseases, were diagnosed for the fi rst time.

The offi cial statistics, however, specifi es only on the glaucoma cases among all the eye diseases and adnexa. According to the RA Ministry of Health, as of 2008, 5,320 people were diagnosed with glaucoma, out of whom 1,274 were diagnosed for the fi rst time this year. The offi cial statistics on other diseases of the eye and adnexa is non-existent.

Graph 4 demonstrates the number of diseases of eye and adnexa (assorted in certain groups) diagnosed among the adults (16 years and above) by the AECP medical teams during the three medical tours in 2003-2009. The graph evidences that on the whole, during all that period, the AECP has diagnosed 27,032 cases

1 See: “Statistical yearbook of 2008”, Republican information-analytical center of the RA Min-istry of Health, National Institute of Health, 2008

88

of cataract, while its majority - 60%, were revealed for the fi rst time. In the same period, the AECP medical groups have revealed 14, 437 various cases of fundus diseases, out of which 62% were revealed for the fi rst time; 6, 877 various cases of cornea diseases, out of which 62% - for the fi rst time; 5,411 cases of glaucoma, out of which 54.5% were revealed for the fi rst time. On the whole, during six years of work in the regions, the AECP has diagnosed 53,757 cases of the mentioned diseases (one person can have various diseases) out of which 32, 456 or 60.4% were revealed for the fi rst time in life. Early detection of diseases causing blind-ness, or fi rst time diagnoses can enable the patients to timely refer to the second and third level ophthalmologic services and prevent blindness through receiving eye care there. Hence, the AECP activities in terms of revealing potentially blind-ing diseases greatly contribute to the prevention of blindness in the country.

The distribution of the above mentioned diseases registered by the AECP in 2003-2009 on the regional level is presented below:

Source: AECP database

89


Out of the 95,607 adult population (16+) screened in the period of 2003-2009, the AECP medical teams have diagnosed some 40,000 persons with at least one disease of the eye and adnexa. It makes up 42% of those screened. However, taking into consideration the specifi cs of the screened population’s demograph-ics, this indicator cannot be considered an indicator of eye disease prevalence. The prevalence of diff erent eye diseases were estimated after having weighed the AECP database results and are presented in the next paragraph. The regional dis-tribution of the population screened by the AECP who have at least one disease is presented in the map below.


90

Since 2003 through 2009, on the whole, the AECP s diagnosed 16, 520 persons with visual impairment, out of whom 3,173 were blind, while 13, 347 had low vision2 .

The visual impairment cases are mainly caused by cataract. More than half (50%) of the adults who underwent the AECP screening and were diagnosed with visual impairment, had cataract; 8% had glaucoma; 22% had fundus problems, and 15% had corneal diseases.

2 According to the defi nition of the World Health Organization, blind is considered a person whose visual acuity in the better seeing eye with best possible correction is 3/60 (less than 0.05). A person whose visual acuity in the better seeing eye, with best possible correction, is in the interval of 3/60-6/18 (0.05-0.33) has low vision, while people with visual impairment are those who belong to either of the described groups (visual acuity is 0.0- 0.33).

91

As already stated, blindness caused by cataract can be prevented by timely sur-gery.

According to the results of the AECP third tour, 2.3% of the RoA adult population (16+), have had cataract surgery in one eye and another 0.7% in both eyes. While the cataract surgical coverage (the proportion of people with bilateral cataract who have received cataract surgery at least in one eye in the total number of people with bilateral cataract) makes up only 23.8%3 .

This means that only 24% of those who have cataract in two eyes have had cata-ract surgery at least in one eye.

4.3. ESTIMATES OF THE EYE DISEASE PREVALENCE AMONG THE RA POPULATION ACCORD-

ING TO THE AECP DATA

After having weighed the AECP data against the sex, age and geographical char-acteristics of the country, which allowed adjusting and spreading the available data, we developed median estimates for blindness, including low vision, for the two-year-long periods of 2003-2005, 2005-2007 and 2007-2009.

3 For comparison, it is worth mentioning that even developing countries have higher indica-tors of cataract surgery coverage. It is 63% for India and 44% for Pakistan.

92

In the Republic of Armenia, as of 2007-2009, blind were on average 0.7% of the population, 4.1% had low vision, according to the presented estimates. On the whole, 4.8% of country’s population had visual impairment. Over time, the blind-ness prevalence estimates have altered - decreasing from 1.3% to 0.7%, while the estimates of low vision have increased. The latter solely has contributed to the increase in the visual impairment indicators in the country. Nonetheless, for 2007-2009, the blindness prevalence estimates for Armenia are in between the lower and upper thresholds set by the World Health Organization for the Cauca-sus, while the low vision estimates exceed the upper threshold by 1.2%.

Visual impairment is more prevalent among the population of 50 years old and above. A signifi cant portion of people with visual impairment are 50 years old or more. Prevalence of blindness among this age group is essentially higher. Ac-cording to the AECP data, in 2007-2009, the prevalence of blindness in this age group had been higher than that of the average country by 2.7% and the low vision by 1.6% (see graph 7).

Weighing of the data collected by the AECP (adjustment to the age-sex struc-ture of the population of the Republic of Armenia) and spreading have allowed receiving estimates for the prevalence of eye diseases in the country (see table 6). The latter, however, has been calculated based on the data of the AECP third tour, taking into consideration two reasons: 1) regular upgrades of the AECP ques-tionnaires secured a more detailed breakdown of eye diseases, 2) these data are fresher.

93

According to these estimates, most widespread eye diseases among the RA popu-lation are cataract (8.4%) and fundus diseases (7.9%).

Prevalence estimates are especially important for eye diseases causing blindness (glaucoma, cataract, corneal diseases, diabetic retinopathy and macular degen-eration). Table 6 evidences that the portion of the population who have at least one eye disease causing blindness in country’s population makes up 13.3% and cataract is the most widespread one (8.4%).

The regional picture of the prevalence of eye diseases causing blindness is pre-sented in Map 6. It shows that the portion of the population which has at least one eye disease causing blindness is the highest in the marzes of Tavoush, Ararat and Armavir (16.3, 16 and 15.5 respectively) and the lowest are in Syunik and Vayots Dzor.

94

As already noted, eye diseases are more prevalent among the population of 50+. Table 8 demonstrates that the prevalence of eye diseases causing blindness among the population of the Republic of Armenia of 50+ is signifi cantly higher than among the population on the whole and makes up 37% as opposed to 13.3% for the general population.

The AECP has developed and calculated the Index of Eye Health Vulnerability (EHV) among the RA population of 50 years old and above. Those persons of 50+ who were screened by the AECP and were diagnosed with at least one eye disease (glaucoma, cataract, cornea diseases, diabetic retinopathy and macular degeneration) were considered vulnerable from the eye health point of view. The EHV is the percentage of people having at least one of the mentioned diseases and disorders in the total number of population above the age of 50.

The AECP data evidence, that 37% of the 50+ population has vulnerable eye health. This means that each fourth citizen of the Republic of Armenia has at least one disease causing blindness. Moreover, on the marz level, the highest EHV indi-cators were identifi ed in the Ararat, Armavir and Aragatsotn marzes (see Map 7).

95

5. THE 2003-2009 AECP SREENING AND TREATMENT SERVICES

RENDERED TO THE POPULATION OF ARMENIA THROUGH THREE MEDICAL

TOURS AT A MARZ LEVEL

This section presents the activities of the Armenian Eye Care Project within the Initiative “Bringing Sight to Armenian Eyes” in the period of 2003-2009. It sum-marizes the AECP screening and treatment work carried out through three medial tours at a marz level.

5.1. THE ARAGATSOTN MARZ

To carry out screening and treatment, the AECP medical teams and the Mobile Eye Hospital have accomplished three tours in the urban and rural communities of the Aragatsotn marz in 2003, 2005 and 2007. During that time, the AECP on the whole screened 20,750 persons, out of which 52.8 % was the adult population, while 47.2 % were children. In this marz, the screening has been signifi cantly geared towards children.

The AECP services target the rural population who are more deprived of eye care services. The rural population constitutes 68.2 % of the screened.

In the period of 2003-2007, 1,319 persons underwent thorough examination on the AECP Mobile Eye Hospital. Out of them, 552 patients received treatment and laser procedure.

96

The AECP has provided 1,924 eyeglasses to the representatives of the vulnerable population and special groups in the Aragatsotn marz.

5.2. THE ARARAT MARZ

To carry out screening and treatment, the AECP medical teams and the Mobile Eye Hospital have accomplished three tours in the urban and rural communities of the Ararat marz in 2004, 2006 and 2008. During that time, the AECP on the whole has screened 23,870 persons, out of which 51 % was the adult population, while 49 % were children.


97

The AECP has provided 2,732 eyeglasses to the representatives of the vulnerable population and special groups in the Ararat marz.

5.3. THE ARMAVIR MARZ

To carry out screening and treatment, the AECP medical teams and the Mobile Eye Hospital have accomplished three tours in the urban and rural communities of the Kotayk marz in 2003, 2006 and 2008. During that time, the AECP on the whole has screened 25,115 persons, out of which 53 % was the adult population, while 47% were children.

In the period of 2003-2008, 2,405 persons underwent thorough examination on the AECP Mobile Eye Hospital. Out of them, 1,084 patients received treatment and laser procedure.

98

The AECP has provided 1,518 eyeglasses to the representatives of the vulnerable population and special groups in the Armavir marz.

5.4. THE KOTAYK MARZ

To carry out screening and treatment, the AECP medical teams and the Mobile Eye Hospital have accomplished three tours in the urban and rural communities of the Kotayk marz in 2005, 2007 and 2009. During that time, the AECP on the whole has screened 18,949 persons, out of which 50 % was the adult population.


99

The AECP has provided 2,270 eyeglasses to the representatives of the vulnerable population and special groups in the Kotayk marz.

5.5. THE LORI MARZ

To carry out screening and treatment, the AECP medical teams and the Mobile Eye Hospital have accomplished three tours in the urban and rural communities of the Lori marz in 2005, 2007 and 2009. During that time, the AECP on the whole has screened 18,569 persons, out of which 68 % was the adult population, while 32 % were children.


100

During the second and third tours, the AECP has provided 4,653 eyeglasses to the representatives of the vulnerable population and special groups in the Lori marz.

5.6. THE SHIRAK MARZ

To carry out screening and treatment the AECP medical teams and the Mobile Eye Hospital have accomplished three tours in the urban and rural communities of the Shirak marz in 2005, 2007 and 2009. During that time, the AECP on the whole has screened 16,834 persons, out of which 86 % was the adult population, while 14 % were children.

Though the population of the marz is main urban, the AECP activities and ren-dered services have been signifi cantly targeted towards the rural residents, who are more deprived or eye care services. Given that Gyumri – the capital of the Shirak marz, has primary, secondary and tertiary level eye care services, Gyumri was not included in the AECP schedule during the third tour. Hence, the coverage of the marz’s urban and rural population do not deviate from the usual propor-tion, making up 53 and 47% (while the urban population of the marz constitutes around 63 %, according to the National Statistical Service of the Republic of Armenia).

101


During the second and third tours, the AECP has provided 3,948 eyeglasses to the representatives of the vulnerable population and special groups in the Shirak marz.

5.7. THE SYUNIK MARZ

To carry out screening and treatment the AECP medical teams and the Mobile Eye Hospital have accomplished three tours in the urban and rural communities of the Syunik marz in 2004, 2006 and 2008. During that time, the AECP on the whole has screened 12,928 persons, out of which 56 % was the adult population, while 44 % were children.


102

The AECP has provided 1.739 eyeglasses to the representatives of the vulnerable population and special groups in the Syunik marz.

5.8. THE TAVOUSH MARZ

To carry out screening and treatment the AECP medical teams and the Mobile Eye Hospital have accomplished three tours in the urban and rural communities of the Tavoush marz in 2004, 2007 and 2009. During that time, the AECP on the whole has screened 14,210 persons, out of which 65% was the adult population, while 35% were children.


103

The AECP has provided 3,171 eyeglasses to the representatives of the vulnerable population and special groups in the Tavoush marz.

5.9 THE VAYOTS DZOR MARZ

To carry out screening and treatment the AECP medical teams and the Mobile Eye Hospital have accomplished three tours in the urban and rural communities of the Vayots Dzor marz in 2003, 2006 and 2008. During that time, the AECP on the whole has screened 10,047 persons, out of which 62% was the adult population, while 38% were children.

In the period of 2003-2008, 1,071 persons underwent thorough examination on the AECP Mobile Eye Hospital. Out of them 452 patients received treatment and laser procedure.

104

The AECP has provided 549 eyeglasses to the representatives of the vulnerable population and special groups in the Vayots Dzor marz.

105

APPENDICES

APPENDIX 1

1

------------------------------------------------------------------------------------- Eye Screening Questionnaire

Questionnaire number Date day month year Location: 1. Region ___________________________________(name)

2. Community________________________________(name)

3. Community type City Village

Patient’s characteristics: Name_____________________________________ Father’s Name______________________________ Surname___________________________________ Gender : male female Year of birth: Passport serial number: Residency: 1. Region _________________ 2. Community________________ 3. Address________________________ name name street, house, appartment

Tel. number_____________________________

Registered in the Family Allowance System? (mark the answer “Yes”)

Belongs to the list of officially supported vulnerable groups? (mark the answer “Yes”)

Visited AECP doctors during the previous screenings?_____________________________

If yes, what kinds of services were provided to the patient by AECP? (mark the answers “Yes”)

Armenian EyeCare Project

AECP

1. Eye Screening

2. Eyeglasses Prescription

3. Eyeglasses

1. Yes 2. No

4. Examination on MEH

5. LASER on MEH

6. Surgery on MEH

106

2

Section A. Personal Health and Health Care

A_1. During the last 12 months did you visit a doctor or consult a health professional? A_2. If no, then when did you you visit a doctor or consult a health professional the last time?

A_3. Have you ever been diagnosed having the following types of diseases/disorders? (mark the answers “Yes”)

A_4. Do you have hypertension/high blood pressure? _________________________________

A_5. If you have it, then for how many years?_________________________

A_6. Have your hypertension been diagnosed by doctor?__________________

A_7. If yes, did the doctor refer you to the ophthalmologist?_____________

A_8. If yes, did you apply to the ophthalmologist according to the referral?

A_9. Have you ever been diagnosed having diabetes? _________________________________

A_10. If yes, how many years ago? (number of years) _____________________

A_11. If yes, did the doctor refer you to the ophthalmologist?____________

A_12. If yes, did you apply to the ophthalmologist according to the referral?_ A_13. Do you observe the following symptoms? (mark the answers “Yes”)

A_14. Do you have blood relatives diagnosed with the following diseases? (mark the answers “Yes”) General Diseases Eye Diseases Diabetes Glaucoma Cataract 1 No, I haven’t a relative having this disease 2 Yes, my parents/parent 3 Yes, my brother/sister 4 Yes, my grandparents/grandparent 5 Yes, other close blood relative

A_15. Please describe your general health condition.____________________________

A_16. Do you smoke?._______________________________________________________

1. Yes A_3 2. No

1. 1-1,5 years ago 2. 2-2,5 years ago 3. 3-4 years ago 4. 5 and more years ago 5. Never

1.Very bad 2.Bad 3.Satisfactory 4.Good 5.Very good

1. Yes 2. No

1. Cardiovascular 2. Blood 3. hyroid gland 4. Gastrointestinal

5 Kidney 6. Lungs/respiratory tract 7. Arthritis 8. Other________________________(specify)

1. Yes 2. No A 9

1. Yes 2. No A 13

1. Excessive thirst 2. Excessive urination 3. Weight gain or loss

4. Tingling or numbness of extremities 5. Persistent tiredness 6. No, didn’t observe any of above mentioned symptoms

1. Yes 2. No A 9

1. Yes 2. No

1. Yes 2. No A 13

1. Yes 2. No

1. Yes 2. No A 9

3

A_17. Do you drink alcohol systematically? ( 4-5 times per week).__________________

Section B. Eye Health and Eye Care

B_1. During the last 12 months have you had any problems or complaints related to your eyes or vision?___________________________________________________

B_2. If yes, did you applied to an ophthalmologist?____________________________________

B_3. If you had any ophthalmic complaints and didn’t apply to an ophthalmologist, then why?

B_4. When did you you visit an ophthalmologist last time? ______________________________

B _5. For what purposes did you visit an ophthalmologist last time?._________________

B _6. Have you ever been diagnosed having an eye disease or disorder?________________

B _7. If yes, what disease or disorder? (mark the answers “Yes”)

B _8. Have you ever had an eye surgery?________________________________________

B _9. Have you ever told by a doctor, that you have to ware glasses?________________

B _10. Do you wear glasses?_________________________________________________

B _11. If you have an eyeglasses prescription and don’t wear them, then why?_____________

B _12. Why did you come to the screening today?_______________________________

B _13. If you have complaints, then what type of complaints exactly? (mark the answers “Yes”)

1. During the last 12 months 2. 1-1,5 years ago 3. 2-2.5 years ago 4. 3-4 years ago 5. 5 and more years ago 6. Never B 6

1. Yes, for far vision 2. Yes, for near vision 3. Yes, both 4. No

1. Yes 2. No B_4

1. Yes B_5 2. No

1. The nearest ophthalmologist is too far 2. No time 3. No money 4. Don’t trust in local ophthalmologist 5. Other_______________________/specify/

1. Yes 2. No B 8

1. Don’t help 2. Discomfort 3. Feel shy 4. No money to buy 5. Other

1. No complaints, just want to be checked preventively finish 2. Have complaints related to my eyes/vision

1. Yes 2. No

1. Preventive checking 2. Treatment/consulting 3. Surgery 4. Eyeglasses prescription 5. Other________________________(specify)

1. Yes 2. No

1. Yes 2. No

1. Difficulties in reading 2. Worsening of vision 3. Inflammation 4. Eye itch 5. Discharge from the eyes

6. Eye pain 7. Eye watering 8. Need eyeglasses prescription/eyeglasses 9. Filling of foreign body in eye(s) 10. Filling of discomfort in eye(s) 11. Other__________________________/specify/

1. Glaucoma 2. Cataract 3. Inflammation

9. Strabismus 10. Other______________/specify/

4. Pterygium 5. Fundus

6. Low vision 7. Nearsightedness 8. Farsightedness

108

4

AECP Medical Records Station 1: Visual acuity (VA) OD OS No Globe

OD OS OD OS OD OS VA without glasses VA with pinhole VA with glasses ------------------------------------------------------------------------------------------------------------------------------------------------ OD OS OD OS Refractive error No R R ------------------------------------------------------------------------------------------------------------------------------------------------ Station 2: IOP OD OS OD OS Palpation is higher than normal PN Tonophen measurement IOP Glaucoma suspect G1 ------------------------------------------------------------------------------------------------------------------------------------------------ Station 3: Globe, eyelids, cornea and cataract OD OS Disorders of Eyelids E Strabismus S Disorders of the Globe Gl Conjunctivitis Con Pterygium P Corneal disorders K Cataract, of which: C Total or mature cataract CC ----------------------------------------------------------------------------------------------------------------------------------------------- Station 4: Previous eye surgeries OD OS Previous eye surgery, of which: SP

Operated Cataract, of which: Cp Aphakia A Pseudoaphakia PA Fibrosis Fib

Operated Glaucoma Gp Operated Cornea Kp

Station 4: Glaucoma, Optic Nerve and Fundus OD OS Glaucoma G Non-glaucomatic disorders of optic nerve N Fundus disorders, of which: F

Diabetic retinopathy DR Hypertonic retinopathy HR High myopia M Macular degeneration MD

Other___________________________________Specify

Treatment: The treatment was suggested to the patient__________________________________________

Refraction and Glasses: Refracted AECP will prepare and provide glasses AECP provided glasses

Referrals to:

Screening team doctor Clinical ordin. Nurse

AECP will prepare Glasses

Right eye

Sph. Cyl. Ax.

Left Eye

Sph. Cyl. Ax. .

DPP

mm

MEH for further examination Yerevan, ophthalmologic clinics

Local ophthalmologist Local endocrinologist

Local neurologist Local therapeutist

109

APPENDIX 2

The “Vision2020” initiated by the World Health Organization and the International Agency for Blindness Prevention, is aimed at signifi cantly reducing avoidable blindness worldwide by 2020. It urges the governments of countries worldwide to elaborate and put into implementation national blindness prevention strate-gies.

In response to the “Vision2020” call, the RA Ministry of Health, in collaboration with the American University of Armenia and Garo Meghrikian Eye Institute of Preventive Ophthalmology, started the development of the National Blindness Prevention Program (NBPP) for Armenia. To facilitate this process, the Blindness Prevention National Committee was created in 2004.

The Armenian national blindness prevention program reiterates the priorities and goals set in Vision2020 with the consideration of the Armenian reality. It is aimed at coordinating the activities of the governmental and non-governmental bodies and institutions active in eye care delivery, which would allow development of eye care services and eff ective reduction of blindness in the country. The Program was approved by the Armenian Government in 2006 (02/11/2006, decision # 43-N) and covers the period from 2006-2010.

The Armenian EyeCare Program is among the organizations that have contrib-uted to the implementation of the NBPP in Armenia. The activities of the AECP comprehensive program refer to each and all of the goals set by the Program. This is documented in the Information Note marking the completion of the NBPP implementation period prepared by the RA Ministry of Health.

INFORMATION NOTE

ON THE IMPLEMENTATION OF THE 02.11.2006 #43-N DECREE OF

THE GOVERNMENT OF ARMENIA

PREPARED BY THE RA MINISTRY OF HEALTH

OVERVEW

In 2007-2010, in cooperation with the Ministry of Health, the Armenian EyeCare Project, in the framework of the USAID/ACE “Primary and Healthcare Alliance”, has carried out large scale activities, in the regions of the RA marzes, as well as the Republic of Nagorno Karabagh. The results are as follows:

110

131, 790 people (including 72,147 children) were screened, • Out of the screened population, 11, 026 persons were referred to the Mobile • Eye Hospital4961 surgeries (including 1434 laser procedures) were performed on the • Mobile Eye Hospital 24106 eyeglasses were provided to the vulnerable population• 773 family nurses, village and school nurses were re-trained in basics of oph-• thalmology57 family medicine doctors were retrained in basics of ophthalmology • 61 regional ophthalmologists underwent intensive professional re-training• 37 regional ophthalmologist underwent intensive professional re-training • 349 public education sessions were carried out • 8814 schoolchildren participated in the public education sessions on eyecare • 841 communities were visited by the AECP medical teams• AECP medical mission has been in the marzes for 903 days on the whole. • The Initiative has developed “National program of the Prematurity of Retin-• opathy”. To start the nationwide program, the AECP is planning international conference “Prevention and Treatment of the Prematurity of Retinopathy in Armenia” on June 28-29, 2010, in cooperation with the RA Ministry of Health, and the United States Agency for International Development (USAID). This international conference will mark the start of the nationwide ROP preven-tion and treatment program. The AECP has already imported the necessary equipment. During the international conference, the selected Armenian specialists will undergo special training. The renowned ROP specialists will train the Armenian specialists through telemedicine. Thanks to the program, around 100 premature infants will be saved of blindness. A “Low vision center”, was established in the Kanaker - Zeitun Medical Center • (teaching base of the National Institute of Health). The center complies with international standards and allows rendering various services to the RA citi-zens with visual impairment problems. A “Wet Lab” was established and equipped to provide doctors and students • with opportunities for surgical practice.Developed ophthalmology residency programs and books, as well as im-• proved teaching methods to meet Western standards, as well as authored and published two books “Eye Diseases” (2005) and “Essentials of Ophthal-mology” (2007) for primary health care providers and ophthalmologists respectively. Prepared guidelines for ophthalmologists, family medicine doctors and vil-• lage nurses. Carried out a cataract surgery monitoring survey in the Mobile Eye Hospital. •

111

A pilot system of cataract monitoring system was introduced in the Malayan Ophthalmological Center.

The works accomplished in line with the objectives defi ned by the RA government decree

are:

Goal 1. Decrease the prevalence of bilateral blindness in population 50 years old and over

from 0.5 to 0.2 %

CATARACT: Increase cataract surgical rate in Armenia from 1,000 surgeries per • million population to 3,000 surgeries per million populationIncrease the total number of ECCE+IOL surgeries in the ROUs from 0.03% to • 80%Decrease % of poor outcomes from 23% to 5 % as per WHO PBL standards• GLAUCOMA: Double the proportion of glaucoma patients diagnosed at early • stages of the disease. Increase yearly number of glaucoma surgeries by 30% • DIABETIC RETINOPATHY: Increase yearly number of diabetic retinopathy • patients receiving laser treatment from 120/year to 500/year Achieve full coverage of registered diabetic patients with free ophthalmic • screening for early diagnostics of life threatening retinopathy.

1.The AECP/USAID Alliance has committed itself to supporting the regional oph-thalmological centers and continues its work up to date.

2. To secure eff ective approaches in the treatment and follow-up of cataract, surgery is performed in the ophthalmologic clinics or the eyecare departments of multi-profi le hospitals which have respective license. That secures the profes-sional quality of surgery and follow-up. In the mentioned institutions the cataract surgery is performed free of charge for the representatives of various vulnerable and special groups. Members of the families that have vulnerability points of 30 and above (family benefi t system scoring), persons eligible for free of charge healthcare since they belong to special groups, as well as those solicited by the regional authorities as extremely poor (even though they may not be registered in any of the social systems) are treated on the AECP Mobile Eye Hospital in the regions. The Malayan Ophthal-mological Center also renders free services to them as part of charity actions. In special cases, as exception, free of charge surgery for the persons not enlisted in the social groups is carried out at the permission of the RA Minister of Health, with the referral of the RA Ministry of Health.

112

3. The RA Ministry of Health issued order of #1565- A, dated 29.12.2006, to orga-nize mandatory visits of the specialists from regional/marz centers to villages and settlements (minimum once per month) and “ open door days”(minimum twice per year). The schedule of mandatory visits to the villages has been put into eff ect . In addition, primary health care became free for all groups of the population in all the polyclinics all over Armenia starting 2006.

4. In the period from 2007-2010, the AECP/USAID Alliance has visited total of 850 rural communities, where the AECP medical groups screened total of 41.000 rural residents.

During the visits in the marzes, 3,612 cataract surgeries and/or laser procedures were performed on the AECP Mobile Eye Hospital. At the same time, local special-ists participated in the AECP activities in screening and on the MEH, to improve their clinical skills.

5. Extracapsular surgeries with the implantation of the intraocular lens has be-come mandatory in the regional/marz eyecare centers, if it is not counter-indicat-ed by other diseases. IOLs are provided to the representatives of vulnerable and social groups by the Ministry of Health through various humanitarian sources. The AECP/USAID Alliance provides all services, including the IOLs for free. Extra-capsular surgeries with IOL implantation is carried out in all marzes of Armenia. The percent of IOL implants is close to 100%.

6. In accordance with the RA Government # 35 order of 18.09.2009, the “Concept of quality assurance” was developed and submitted for RA Government approval. The Concept would allow overseeing the quality of medical care and all rendered services at all levels (including eyecare).The AECP has prepared and published a teaching manual “Essentials of Ophthal-mology” to improve the knowledge of the specialists. The requirement of the Government # 1639-N decision is aimed at securing adequate quality, according to which retraining of physicians is mandatory each 5 years.

Therefore, ophthalmologists also undergo continuous education with a revised educational program. Ophthalmologists’ offi ces in all polyclinics are have equip-ment to measure intraocular pressure and examine fundus of the eye. The AECP/USAID Alliance carried out cataract surgery monitoring survey on the Mobile Eye Hospital. The pilot program of cataract surgery monitoring system has been introduced in the Malayan Ophthalmologic Center.

113

7. Glaucoma:

Starting 2008, in accordance with the standards described in the decree of the RA Ministry of Health, (which is a precondition for the state order) it has been defi ned that screening for early detection of glaucoma should be performed in the framework of mandatory preventive visit. During the screenings in 2007-2010, the AECP had diagnosed 1,653 cases of glau-coma, 622 out of which were revealed for the fi rst time. All medical ambulatories, offi ces of family medicine doctors and ophthalmologic offi ces of polyclinics have an ophthalmoscope, tonometer, the specialists are continuously being retrained and their number makes up total of 1600 specialists.

8 . Diabetic retinopathy

The AECP has performed 400 laser procedures for diabetic retinopathy. In 2008, a seminar “Diabetes and Blindness” was organized with the participation of ophthalmologists and endocrinologists.

Guidelines for the management of diabetes for the primary health care level have been elaborated and are regularly updated. The last modifi ed version has been approved by the RA Ministry of Health.

Goal 2. Reduce childhood blindness and improve children’s eye health.

REFRACTIVE ERROR: Achieve full coverage of school age children with free eye screening to detect refractive errors and provide prescribed eyeglasses for those in need ROP :Establish eff ective ROP control system in Armenia

1. In the marzes of Armenia, due to the lack of pediatric ophthalmologists there, general ophthalmologists deal with children’s issues as well. 2. Preventive school screenings are carried out at schools. Parents and teachers of children identifi ed with refraction problems during screenings are alerted of the problem. If the child comes from a vulnerable family, s/he is off ered treatment and eyeglasses (received through charity pipelines as well as by the Karageozyan foundation in Yerevan, Syunik, Lori and Shirak marzes).

3. Children’s screenings in the marzes that do not have specialized pediatric ophthalmologic services is carried out by the AECP. The AECP medical groups have screened 72,147 children in the RA marzes and Yerevan. .The ophthalmolo-gists and optometrists of «Union Médicale Arménienne de France» (UMAF) have

114

been working in the remote regions of Armenia and Karabagh providing quality screening and eyeglasses to children. 4. Provision of respective information to the parents whose children have refrac-tive problems - The AECP/USAID Alliance has conducted public education ses-sions, with the participation of 843 parents, disseminated four types of brochures related to children’s eye disorders and diseases, including refraction.

5. It is expected to organize the training of one ophthalmologist per marz related to retinopathy of prematurity by the AECP/USAID Alliance.

6. The AECP/USAID Alliance has acquired two retinal cameras and diode laser for the detection and treatment of the retinopathy of prematurity. 7. Protocols for the screening and treatment of premature and/or low weigh infants have been prepared by the AECP/USAID Alliance and adopted by the RA Ministry of Health. Large scale activities are expected to start in September of 2010.

Goal 3. Strengthen the infrastructure to support blindness prevention eff orts throughout

the country

PRIMARY EYE CARE: Strengthen primary eye care in the rural areasImprove primary eye care at the polyclinical level SECONDARY EYE CARE : Up-grade and equip existing ROUs according to the WHO List*TERTIARY EYE CARE: Modernize the tertiary eye care in Armenia

1. The program has envisioned establishment of village health points in selected village ambulatories or family medicine offi ces that would serve as primary oph-thalmologic centers (one center per 20,000 inhabitants). For the purpose of sav-ing resources, ophthalmologic offi ces in the regional polyclinics or medical units, which are furnished with equipment within the World Bank loan program or have received certain support from international organizations (namely the USAID) are viewed as an option of such centers .

2. Starting 2008, in accordance with the standards described in the decree of the RA Ministry of Health, (which is a precondition for the state order) it was defi ned that screening for early detection of glaucoma should be performed in the frame-work of mandatory preventive visit. During general screenings in the regional polyclinics, the AECP/USAID Alliance has identifi ed 1730 cases of glaucoma suspect.

115

3. The upgrade and provision of equipment (including lasers) to the ophthalmic offi ces in regional polyclinics (RP) is carried out within the framework of the World Bank Health program “Modernization program of regional hospitals”.

4. The American University of Armenia, in cooperation with the Lions Club and the Ministry of Health has renovated and equipped an Eye Center in the city of Sevan. It received a MOH license in 2008 and covers the needs of the Gegharkunik population. The renovation of the Vanadazor ophthalmologic center has not taken place.

5. A low vision center was established in the Kanaker-Zeitun Medical Center, which is the teaching base of the National Health Institute. The Low vision Center established by the AECP/USAID Alliance, corresponds to international standards.

Goal 4. Develop human resources to provide appropriate eye care to the population

PRIMARY EYE CARE Reinvigorate primary eye care education in the country; SECONDARY EYE CARE Strengthen training of ROU ophthalmologistsTERTIARY EYE CARE Upgrade training in ophthalmology to correspond to the standards of International Council of Ophthalmology /International Federation of Ophthalmic Societies (ICO/IFOS)Within the educational component of the AECP/USAID alliance, family medicine and village ambulatory/FAP nurses) from all the marzes of Armenia took a three-day training course on the basics of ophthal-mology; refresher courses were organized for 57 family medicine doctors in the regions; 37 ophthalmic nurses underwent a one week intensive course.

2. The AECP/USAID conducted, in cooperation with the AED, two –week intensive courses for 61 regional ophthalmologists on theory and practical needs, as well as general screening technique for cataract, glaucoma and diabetic retinopathy. 3. The requirement of the NSP to revise curricula of the academic institutions pro-viding education in eye care to correspond to ICO/IFOS standards, is implement-ed since 2009, in accordance with the decision of the RA Government, whereby all educational programs, including the ophthalmological one, should be in line with international standards.

Goal 5. Increase awareness of blindness as a major public health issue

Conduct a public awareness campaign regarding cataract, glaucoma and diabetic retinopathy for general public. Design and deliver an eye health education cam-paign for school age children and their parents.

116

1.The ophthalmology part in the curricula of the family medicine doctors has been enhanced, public awareness materials have been reviewed and revised. 2.The AECP/USAID Alliance has prepared and published total of 600,000 copies of 12 brochures on adults’ and children’s eye diseases, eyecare and eye safety at home and workplace. The brochures are being distributed during screenings and public education sessions.

3. World Sight Day (second Thursday of October) is being celebrated in Armenia since 2003 thanks to the eff orts of the AECP.

Goal 6. Initiate research and development in the fi eld of blindness prevention

Develop tools and guidelines for disease control, health care management, and service

delivery Initiate epidemiological and clinical research.

Conduct evaluation of the National Plan and develop policy recommendations for the Government of RA.

1. Data of the patients with diabetes is analyzed as a risk factor for blindness. For this purpose, the RA Ministry of Health has introduced automated registering system “Midas 3”, form #02 including diabetes is being fi lled in.

2. The AECP/USAID Alliance and the RA Ministry of Health have elaborated stan-dards/protocols for village ambulatories and offi ces of regional ophthalmologists. Such standards are being developed and revised on a yearly basis. They also include organizational aspects of the eye care delivery. The draft of the guideline has been presented by the AECP/USAID Alliance and the RA Ministry of Health.

3. National research on children’s blindness and refractive error prevalence among the children of school age is expected to be conducted. The RA MOH has applied to international organizations, including USAID for cooperation in this matter.

The Armenian EyeCare ProjectBringing Sight to Armenian Eyes

Aygestan 5th str., house 7;Yerevan; Armenia

Phone (374 10) 55 90 68;Fax (374 10) 57 76 94

E-mail: [email protected];Web: www.eyecareproject.com

Ð³ÛÏ³Ï³Ý ³ÏÝ³μáõÅáõÃÛ³Ý Ý³Ë³·ÇÍ§ÈáõÛë Ñ³ÛÇ ³ãù»ñÇÝ¦ Íñ³·Çñ

Ð³ëó»` ²Û·»ëï³Ý 5-ñ¹ ÷., ïáõÝ 7, ºñ¨³Ý 0070, Ð³Û³ëï³Ý

Ð»é.`(374 10) 55 90 68;ü³ùëª (374 10) 57 76 94;

¿É-÷áëï` [email protected];www.eyecareproject.com

Վիճակագրական գրքույկ - 2020-ին ընդառաջ: Հետադարձ հաշվարկ

Documents

Transcript of Վիճակագրական գրքույկ - 2020-ին ընդառաջ: Հետադարձ հաշվարկ